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Long-term maintenance of bone mineral density (BMD) in premenopausal women is 
critical to preventing osteoporosis and osteoporotic fractures. This thesis aimed to 
investigate potential strategies to optimise long-term bone health in younger women 
in a cohort of women who 12 years previously had participated in a 2-year 
randomised controlled trial (RCT) of an osteoporosis education intervention. In the 
original trial, women were randomised at baseline to receive group education (the 
Osteoporosis Prevention and Self-management course (OPSMC)) or an information 
leaflet. All women also received individualised feedback of either being or not being 
at higher risk of fracture in later life (high and normal risk groups). The risk was 
based on BMD measured by Dual-energy X-ray absorptiometry (DXA) according to 
whether or not each participant’s mean T-score at spine and hip was less than 0 (high 
and normal risk groups, respectively). 
For this thesis, we performed a further 10-year follow-up, i.e. 12 years from baseline 
of the original RCT. We measured osteoporosis knowledge, self-efficacy, BMD at the 
femoral neck (FN) and lumbar spine (LS); calcium intake and calcium supplement 
use, physical activity and smoking status as in the original RCT. In addition, we 
measured serum 25-hydroxyvitamin D (25(OH)D), lower limb muscle strength 
(LMS), timed up and go test (TUG), functional reach test (FRT), lateral reach test 
(LRT) and step test (ST); total physical activity (accelerometer counts/minute of wear 




Longitudinal data were used to investigate the long-term effects for the RCT 
interventions on BMD and osteoporosis preventive behaviours. Cross-sectional data 
were used to examine associations between the modifiable factors of vitamin D levels, 
LMS and physical activity and BMD and balance measures. 
Key findings were: 
Longitudinal data: 
1. From baseline to 12 years, neither feedback of high fracture risk nor the
OPSMC had an effect on the change in osteoporosis knowledge or self-
efficacy.
2. From 2 to 12 years, the high fracture risk group had a smaller decrease in FN
BMD (β=0.023 (95% CI: 0.005-0.042) g/cm2) but similar LS BMD change as
the normal risk group. They also had a more favourable pattern of smoking
behaviour change and were more likely to use calcium supplements and be
recent users of vitamin D supplements. The OPSMC group had a more
favourable pattern of smoking behaviour change compared to the leaflet
group.
Cross-sectional data at 12 years: 
3. There were significant cut-points for associations of 25(OH)D levels with FN
BMD, LS BMD, TUG, ST, FRT and LMS (ranging from 29-33 nmol/L) but
not LRT. Below these cut-points, there were beneficial associations between




4. Weaker LMS was associated with poorer performance on all balance tests.
Significant cut-points of LMS were identified for all balance tests (29-50 kg)
but excepting ST, these did not persist after excluding potentially influential
data points.
5. Total physical activity was beneficially associated with FN BMD, LMS and
TUG. MVPA was also beneficially associated with FN BMD, LMS, ST and
TUG, and these associations (except for FN BMD) persisted after further
adjusting for sedentary time. Sedentary time was detrimentally associated with
TUG but not after further adjustment for MVPA.
In conclusion, feedback of high fracture risk to younger women was associated 
with long-term improvements in osteoporosis preventive behaviours and 
attenuated FN BMD loss and could be considered as a strategy to improve long-
term bone health and prevent osteoporosis. Furthermore, we identified other 
potential strategies for maintaining BMD and balance in middle-aged women, 
namely: 
 Maintaining adequate serum 25(OH)D noting that the current cut-off
defining vitamin D deficiency of 50 nmol/L may be higher than needed
for some musculoskeletal outcomes but appears warranted overall.
 Improving LMS.
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Chapter 1: Literature review 
1.1 The importance of osteoporosis and associated fractures 
Osteoporosis is a progressive bone disorder characterised by low bone mass, micro-
architectural deterioration of bone tissue, and skeletal fragility, leading to reduced bone 
strength and increased susceptibility to fracture. Bone strength primarily reflects the 
integration of bone density and bone quality(1). Given the difficulty in measuring bone 
strength, bone mass has long been recognized as the most useful surrogate for strength, 
although they are not perfectly correlated(2). In the absence of a fragility fracture, bone 
mineral density (BMD, measured by dual-energy x-ray absorptiometry (DXA)) is used for 
the diagnosis of osteoporosis according to the World Health organization (WHO), which has 
defined osteopenia (also known as low bone mass, T-score -1 to -2.5) and osteoporosis (T-
score < -2.5) based upon T-score, that is, the number of standard deviations by which an 
individual’s BMD deviates from the mean BMD in healthy young adults of the same gender 
and ethnicity(3). 
Osteoporosis is a major public health issue, currently affecting over 200 million people 
worldwide(4). The number of affected persons continues to increase as the global population 
ages. Importantly, osteoporosis in many cases remains “silent” and asymptomatic until a 
fracture occurs: Fragility fractures (also known as osteoporotic fractures or low-trauma 
fractures), which occur from a fall from a standing height or less, with no or low trauma, are 
the most important clinical consequence of osteoporosis. These fractures are common 
throughout the world. It was estimated that nine million osteoporotic fractures occurred 
worldwide in 2000, of which 1.6 million were at the hip, 1.7 million at the forearm, and 1.4 
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million were clinical vertebral fractures(5). In Australia, a recent report launched by 
Osteoporosis Australia indicated that 4.74 million people aged over 50 years (66%) have 
osteoporosis or osteopenia (low bone mass, T-score -1 to -2.5), and this number is estimated 
to increase to 6.2 million by 2022(6). Older adults have a very high estimated residual lifetime 
fracture risk. In the Dubbo Osteoporosis Epidemiology Study (Australia), it was estimated a 
residual lifetime risk of 29% for men and 56% for women aged 60 years and older(7). The 
report also indicated that there were 140,822 fractures arising from osteoporosis or 
osteopenia in 2012, and this will increase to over 183,105 fractures by 2022(6). In the United 
States, it has been estimated 54 million adults aged 50 and older were affected by 
osteoporosis or osteopenia in 2010(8) and this number will increase significantly to an 
estimate of 64 million by 2021 and 71 million by 2031(8). According to the 2004 Surgeon 
General’s Report on Bone Health and Osteoporosis, almost 40% of White American women 
aged 50 or older is expected to experience a hip, spine, or wrist fracture during the remainder 
of their lives. 
The consequences of fractures are substantial in both the short and long term. These include 
increased risk of mortality and disability, and decreased quality of life. Sustaining one 
fracture also increases the risk of subsequent fracture: a meta-analysis of 11 cohort studies 
(15259 men and 44902 women) demonstrated that individuals who previously suffered from 
a fracture had significantly increased risk of any fracture compared with those who did not 
(relative risk (RR) = 1.86; 95% confidence interval (CI) = 1.75-1.98)(9). A systematic review 
of 22 studies showed that individuals with hip fractures have a significant excess risk for 
mortality of at least double that of the age-matched controls (the smallest risk among the 
included studies); this excess risk persists for several years after the index fracture, although 
no meta-analysis or pooled analysis were conducted due to lack of consistency in the study 
Chapter 1: Literature review 
Page 3 
 
designs and statistical analyses across studies(10). In 2000, the total global loss of Disability 
Adjusted Life Years (DALYs) was 5.8 million, of which 51% were accounted for by 
fractures that occurred in Europe and the Americas(5). 
The financial implications of osteoporosis and fractures is also of concern, both for 
governments and the community. In Australia the total health expenditure for osteoporosis 
and osteopenia in individuals over 50 years of age was $2.75 billion in 2012 and it is 
predicted that this will increase to $3.84 billion in 2022(6). It is predicted that total direct and 
indirect cost of osteoporosis, osteopenia and consequent fractures will be $33.6 billion from 
2012 to 2022(6). It is estimated that annual costs of all osteoporotic fractures are around $20 
billion for the United States and $30 billion for Europe(11,12). 
1.2 Peak bone mass and age-related bone loss 
1.2.1 Peak bone mass acquisition 
Peak bone mass refers to the amount of bony tissue present at the end of the skeletal 
maturation(13). While the exact age at which peak bone mass is achieved varies with genetic, 
hormonal, and environmental factors and to skeletal site and method by which BMD is 
measured, the acquisition of bone mass persists in most individuals until the third decade of 
life, with up to 90 percent of peak bone mass achieved by age 18 in girls(14) and by age 20 in 
boys(15). 
1.2.2 Maintenance of bone mass is important for the prevention of fractures 
BMD in later life is determined by peak bone mass achieved by an individual and the rate of 
subsequent bone loss(13), with low BMD independently predicting fractures in later life(12). In 
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a meta-analysis of 11 prospective studies, for one standard deviation (SD) decrease in 
femoral BMD below age adjusted mean, there was a 2.6-fold increase in relative risk of hip 
fracture(16). Therefore, the main strategies for preventing low bone mass in older adulthood 
are to maximize peak bone mass and minimize the rate of bone loss, and ultimately to 
maintain bone strength and prevent osteoporosis and fractures. 
1.2.3 Premenopausal bone loss  
Longitudinal data suggest that age-related bone loss begins prior to the onset of 
menopause(17-21), although the magnitude of this loss varies, including by bone site. The exact 
time at which this decline begins is uncertain, but it is most likely to occur at approximately 
30 years of age(18,22), and persists at a slow rate until menopause. A 6-yr prospective study 
reported an annual loss of 0.3% at the femoral neck BMD in a cohort of 614 women aged 24-
44 years at baseline(20). Similarly, longitudinal data have shown a decrease of femoral neck 
bone mineral content (BMC) at a rate of 0.22% per year and BMD at a rate of 0.43% per year 
in 130 healthy premenopausal white women aged 31-50 years while there was significant 
increase of the spine (L2-L4) BMD (0.19% per year) and BMC (0.41% per year) but no 
significant change of these measures at the total hip(21). This might be partly due to the site 
specific response of BMD to lifestyle and environmental factors, for example, exercise(23). 
Also, age-related bone loss may also be site-specific as the age of attaining peak bone mass 
may differ by site of bone measured(24). 
This slow rate of change is important, as the cumulative bone loss from age 30 until 
menopause (at around 50 years old) is substantial. For example, there would be a decline of 
about 0.5 SD from peak bone mass during a period of 20 years even if the annual loss is only 
0.2%. 
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1.2.4 Menopause transition and bone mass 
Longitudinal studies have documented a substantial decline in bone mass in women in the 
perimenopausal(22,25) and newly post-menopausal periods(26), in data from different cohorts. 
Seifert-Klauss et al. showed acceleration of bone loss at the lumbar spine (measured by 
quantitative computer tomography) during perimenopause, reaching > 50% of the maximal 
total bone loss measured around menopause, regardless of adequate serum estradiol levels(25). 
In a cohort of 75 women aged > 46 years having premenopausal estradiol and gonadotropin 
levels and regular menses, a sigmoid pattern of bone loss was observed across menopause in 
those who experienced normal menopause during 9.5 years of follow-up, beginning around 2-
3 years prior to the last menses and ending around 3-4 years after the last menses(26). The total 
estrogen-deprivation bone losses were 10.50, 7.73, and 5.30% for the spine, total body, and 
femoral neck, respectively. In a larger cohort of 1902 multiethnic women aged 42-52 years at 
baseline with an average follow-up of 3.9 years, little change occurred in lumbar spine or 
total hip BMD during the pre- or early perimenopause (menopause stage was determined 
based on reports about frequency and regularity of menstrual bleeding at each annual 
visit)(22). However, BMD declined substantially in the late perimenopause, with an average 
loss of 1.6% per year in the lumbar spine and 1.0% per year in the total hip, while in 
postmenopausal women, there was an even larger bone loss at an annual rate of 2.0% and 
1.4% at lumbar spine and total hip, respectively(22). 
1.2.5 Tracking of BMD in adult women 
Although a number of studies have been conducted on the tracking of BMD in children and 
adolescents(27-30), this has rarely been investigated in adults and has not been studied 
exclusively in female participants. In younger adults, Emaus et al. illustrated that there was a 
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high degree of tracking of BMD at both distal and ultradistal forearm sites for both men and 
women aged 25-44 years over an average follow-up period of 6.4 years (as assessed by 
Pearson’s correlation coefficient, > 0.93 for both sites and both genders)(31). When BMD 
values measured at baseline and at follow-up were divided into quartiles, 75-80 percent 
remained in the same quartile position from baseline to follow-up. Ten to thirteen percent 
either lost or gained only one position at the distal forearm site and these individuals were 
evenly distributed across all original quartile positions(31). Another study by Emaus et al. 
showed similarly high correlation between BMD (distal and ultradistal forearm) at baseline 
and end of an average follow-up period of 6.5 years among Norwegian women and men aged 
45-84 years (r > 0.90 in women and > 0.93 in men), and less than 30% relocated in the 
quartile positions, suggesting a high degree of tracking of bone mineral density 
measurements(32). These findings suggest that adults with low BMD in younger adulthood are 
likely to also have low BMD in later life in the absence of any intervention(s), meaning that 
young adults with low BMD are at higher risk of osteoporosis and fractures in older age, 
compared to young adults with normal BMD. However, this needs to be confirmed by direct 
evidence assessing the association of BMD in early life with fractures in later life. 
1.3 Muscle strength, balance and osteoporotic fracture 
1.3.1 Relationship between muscle strength and balance in younger adults 
Muscle strength is a major factor in balance, gait and postural stability(33-35). Many studies 
have shown that age-related loss of muscle strength is an important contributor to decreased 
balance and functional limitations in older people(33-36), but studies are limited in younger 
adults(37-41). In a cross-sectional study of young healthy adults, no statistically significant 
associations were found between balance measures (displacements of the center of pressure 
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in anterior-posterior/mediolateral direction under dynamic/static conditions) and  isometric 
muscle strength (r ranged from +0.041 to +0.387, p > 0.05 for all)(37). This may partly be 
explained by the small sample size (n = 27) and very young age (mean age (SD) = 23 (4) 
years), when it could be assumed most people have fairly good physical condition and muscle 
strength is above the threshold required to maintain balance. In contrast, one cross-sectional 
study in 1346 middled-aged women (age = 53 years for all participants) reported that greater 
grip strength was associated with better chair rise performance and the ability to balance on 
one leg with eyes open for 5 seconds(39). Analysis of baseline data in a pre-post study of a 
muscle strengthening intervention in 26 middle-aged women (mean age 52.8 (SD 2.4) years) 
reported that greater maximal isometric bilateral leg extension force was moderately 
associated with better performance in the test of “10-m walk time” at baseline (r = -0.6, 
p<0.01), though no effects on static balance or time of standing on 1 leg or climbing for 10 
steps were observed(40). This may be explained by the small sample size, fairly good physical 
condition (people with severe diseases or musculoskeletal problems or contraindications to 
exercise were excluded) and moderate muscle strength of study participants before 
intervention. In contrast, one small cross-sectional study did not identify any associations 
between balance and LMS measures in middle-aged adults (n=32 of whom only 9 were 
female, mean age 56 (SD 4) years)(38), probably due to the very small sample size(38). 
Longitudinal data in healthy middle-aged men (45-68 years old) has shown that those in the 
lowest and middle tertile of baseline grip strength were at greater risk of developing 
functional limitations and disabilities than those in the highest tertile (risk ratio (RR) = 1.07-
2.80 for a range of measurements)(41). 
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1.3.2 Adequate muscle strength and balance are critical for the prevention of fractures 
Falls increase the risk of hip fractures(42,43), while muscle weakness (especially of the lower 
extremities)(43,44) and impaired balance increases risk of falls(43,45), with 4-39% of falls in 
people older than 65 years attributed to gait/balance disorders(46). It is possible to improve 
muscle strength by exercise programs: a randomised controlled trial of 2-yr progressive, 
resistive back-strengthening exercise program in postmenopausal women (n = 50, aged 58-75 
years) significantly improved back extensor strength while reducing the risk of vertebral 
compression fracture by 63%, compared to a no intervention control group(47). Therefore, 
muscle weakness and impaired balance may plausibly mediate fracture risk through greater 
susceptibility to falls. 
Importantly, muscle strength and balance decline as people age, with muscle strength 
declining by 1.5% between ages 50 and 60 and by 3% thereafter(48) and balance declining 
after 45-55 years of age(49,50), particularly in women. Therefore, prevention of functional 
limitations, falls and fractures in older age via maintaining adequate muscle strength and 
balance may need to begin in early midlife. However, more clinical trials are needed to 
confirm whether improving muscle strength in younger middle life is effective at maintaining 
balance and preventing falls and fractures in later life, and whether maintaining such 
improved strength is necessary for functional improvements to persist. 
1.4 Modifiable lifestyle factors for the prevention of osteoporosis 
There are a range of potentially modifiable risk factors affecting BMD, such as poor 
nutrition, being physically inactive, and other lifestyle measures (e.g., alcohol consumption 
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and eating disorders, etc.). This chapter will focus on four key risk factors, namely, low 
calcium intake, vitamin D deficiency, smoking and being physical inactive. 
1.4.1 Calcium and vitamin D 
1.4.1.1  The impacts of calcium and vitamin D on bone health in younger women 
There is substantial evidence that sufficient intakes of calcium and adequate vitamin D levels 
are needed to maintain bone mass and to protect against osteoporosis and fractures. The 
importance of vitamin D for bone health is mainly attributed to its role in calcium 
homeostasis and bone metabolism. Several meta-analysis of RCTs have shown a beneficial 
reduction in fractures with supplementation of calcium alone(51,52) or calcium plus vitamin 
D(52-54) but not vitamin D alone(55-57), compared to placebo or no treatment in older women. 
However, evidence is unclear in premenopausal women due to an evidence gap: the 2013 
United States Preventive Services Task Force concluded that there was insufficient evidence 
to assess the benefits and harms of combined calcium and vitamin D supplementation for the 
primary prevention of fractures in premenopausal women(58). Nevertheless, a meta-analysis of 
RCTs showed that daily calcium supplementation of 1000 mg reduced bone loss by 1% 
annually at all bone sites except the ulna amongst premenopausal women(59). 
Similarly, despite the lack of clinical evidence on the efficacy of vitamin D supplementation 
for reducing fractures in younger women, Di Daniele and colleagues showed that 
supplementation of vitamin D plus calcium had beneficial effects on total body BMD in both 
peri- and post-menopausal women(60). Moreover, low vitamin D status is associated with low 
spine BMD and increased bone turnover(61), which is concerning as vitamin D deficiency 
(serum 25(OH)D concentrations < 50 nmol/L) is very common in young women (more 
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details in Chapter 1.4.1.5). However, a 2-yr double-blind crossover study failed to show 
beneficial effect of 800 IU vitamin D supplementation daily on BMD or bone turnover 
markers in 70 pre- and post-menopausal women aged 24-70 years (mean age = 47.2 years)(62). 
This may be explained by the high baseline serum 25(OH)D (mean = 68 and 76 nmol/L for 
the treatment and control group, respectively), but low daily dietary calcium intake (553 and 
586 mg) and the broad age range of study participants. 
Overall while adequate calcium and vitamin D are currently recommended as essential 
components of good nutrition for the prevention of osteoporosis in younger women, the 
evidence base supporting this is limited. 
1.4.1.2 The impacts of vitamin D on muscle strength and balance in younger women 
Muscle strength 
Most observational studies reporting associations between serum 25(OH)D and muscle 
strength were conducted in older adults; however, a few were conducted in younger 
women(63-65). A recent cross-sectional study of 137 younger women (age range 19-29 years) 
demonstrated a small but significant association between plasma 25(OH)D and handgrip 
strength (β = 0.05 (0.01-0.09) and 0.04 (0.001-0.08) for dominant and non-dominant 
hand)(64). Grimaldi et al. reported a positive association between serum 25(OH)D and both 
isometric and isokinetic arm strength as well as isometric but not isokinetic leg strength 
among 419 healthy men and women over a broad age range (20-76 yr)(65). However, 
interactions between serum 25(OH)D and gender or age were not assessed in the analyses, 
thus the actual relationship between serum 25(OH)D and muscle strength in younger women 
was unknown. In contrast, Marantes et al. showed there was only a weak relationship 
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between serum 25(OH)D and skeletal muscle mass but not muscle strength (isometric knee 
extension moment) in a subgroup analysis of women aged 21-65 years(63). The discrepancies 
between these two studies could be partly explained by differences in the age of study 
participants and parameters measured for muscle strength. 
Two recent meta-analyses of RCTs (17 studies involving 5072 participants(64) and 30 studies 
involving 5615 participants(65), respectively) have consistently shown a beneficial effect of 
vitamin D supplementation on various measures of muscle strength in men and women (most 
included studies were in older adults) with low serum 25(OH)D (below 25-30 nmol/L). 
However, there are only a few RCTs examining the effects of vitamin D with or without 
calcium supplementation on muscle strength in younger women(66-68). A small RCT among 
40 healthy young vitamin D-deficient Asian Indians (baseline serum 25(OH)D < 50 nmol/L 
for all participants, 24 males/16 females, mean age = 31.5 years) showed that six months of 
oral vitamin D and calcium supplementation (60 000 IU cholecalciferol per week for 8 weeks 
followed by 60 000 IU/month for 4 months, with 1 g of calcium daily) improved skeletal 
muscle strength (handgrip strength and gastro-soleus strength) as compared with placebo 
controls(68). However, a similar RCT of larger sample size (n = 173) of young Asian Indian 
women demonstrated that vitamin D and calcium supplementation (60,000 IU 
cholecalciferol/wk for 8 weeks followed by 60,000 IU/fortnight, with 500 mg calcium twice 
per day for 6 months) did not lead to an improvement in muscle strength (hand grip and pinch 
grip strength)(67). In support of this, a more recent study showed that 16-weeks of daily 
supplementation with 1000 IU vitamin D3 (cholecalciferol) or 400 IU vitamin D3 did not 
improve muscle strength or power among 251 healthy adult males and females from ethnic 
minorities in Norway (age range 18-50 years), compared to placebo, despite low baseline 
vitamin D status (mean = 26 nmol/L, 92% less than 50 nmol/L)(66). These findings are limited 
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by small sample sizes and short periods of supplementation, as well as differences in 
frequency and dosages of supplement and parameters used to measure muscle strength. 
Therefore, larger RCTs of longer duration of follow-up using validated and reproducible 
measurements of muscle function are needed to provide compelling evidence for clinical 
recommendations, particularly in younger people. 
Balance 
Although associations between 25(OH)D levels and balance have been described in a number 
of cross-sectional studies among younger women(69-75), no consensus has been reached and 
this could be partly explained by the high heterogeneity of parameters used to assess balance, 
such as 8-ft walk, 6-min walk, gait speed, and sway.  
Two small RCTs have been conducted in younger women(68,76). In the RCT described above, 
Gupta and colleagues demonstrated that six months of cholecalciferol (60 000 IU D3/week 
for 8 weeks followed by 60 000 IU/month for 4 months) and calcium (1 g of elemental 
calcium daily) supplementation led to enhanced performance on walking distance compared 
to those who received dual placebos(68). In contrast, a recent RCT among 130 non-western 
overweight men and women (aged 20-65 years) in Netherlands who had baseline 25(OH)D 
level <=  50 nmol/L, showed that four-months of daily supplementation with 1200 IU vitamin 
D3 and 500 mg calcium did not have an effect on physical performance (physical 
performance score, determined as the sum score of walking test, chair stand test and tandem 
stand) or exercise capacity (6-min walk test) in the intention to treat analysis, compared to the 
control group who received placebo and 500 mg calcium(76). However, a post hoc analysis 
among participants who reached a serum 25(OH)D concentration of > 60 nmol/l after 
intervention, demonstrated an improvement of 19 m in the 6-min walk test compared with the 
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control group (p = 0.053). The minimum clinically relevant change for the 6-minutes walking 
test was 30 m in older patients with heart failure(77), but the clinical importance of an 
improvement of 19 m (about 0.26 SD) in overweight adults remains unclear. The discrepancy 
between studies could be mainly explained by significantly different dose of vitamin D (> 
8500 IU/d on average vs. 1200 IU/d) supplementation and different outcomes used. Although 
compliance with supplementation might also contribute to the difference, it is unlikely to be 
the case for these two studies given their fairly good compliance (an average of >80% intake 
of the prescribed pills vs. 95% took all tablets) and large differences in the doses 
administrated. Therefore, these findings should be confirmed by larger RCTs of high vitamin 
D supplement dose using validated and reproducible measurements of balance. 
1.4.1.3 Optimal serum 25(OH)D levels 
People can obtain vitamin D in two ways, both via the action of sunlight on skin (D3 or 
cholecalciferol) and from a limited range of foods. Currently, based on serum 25(OH)D, the 
optimal indicator of vitamin D status(78), the optimal vitamin D status has been established 
based primarily on clinical evidence for skeletal health, but the value remains controversial. It 
is generally agreed that 25(OH)D levels less than 50 nmol/L are suboptimal for skeletal 
health(79). In comparison, clinical data for extraskeletal health is scarce, hampering the efforts 
of establishing the optimal level in the context of benefiting a broad spectrum of health 
conditions. 
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1.4.1.4 Recommended daily intakes of calcium and vitamin D in young and middle-aged 
women 
The Institute of Medicine (IOM) recommends a daily intake of 1000 mg of calcium is needed 
for women aged 19-50 years and 1200 mg/day for those older than 50 years (Table 1.1)(78). In 
Australia, the same amount of calcium is recommended for women aged 19-50 years but 
slightly higher for those older than 50 years, that is, 1300 mg/day (RDI in Table 1.2)(80). 
The recommended intake of vitamin D is normally established based on the assumption of 
minimal or no sun exposure. The IOM calls for 600 IU of vitamin D daily for all ages up to 
age 70, corresponding to a serum 25(OH)D level of at least 20 ng/ml (50 nmol/L) (Table 
1.1)(78). According to the IOM, this level is sufficient to meet the requirements of at least 
97.5% of the population, based primarily on bone health. In Australia, the adequate intake 
(AI) is 200 IU/d for women aged 19-50 years and 400 IU/d for those aged 50-70 years (Table 
1.2). It should be noticed that the AI for younger women (19-50 years) is based on the 
amount of vitamin D required to maintain a serum 25(OH)D level of at least 27.5 nmol/L 
with minimal exposure to sunlight. Therefore, the AI should be much higher when a serum 
25(OH)D level of at least 50 nmol/L has to be achieved. 
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Table 1.1: Calcium and vitamin D dietary reference intakes in women aged 19-70 years 









to the RDA)a 
19 to 30 years old 1000  600 20 
31 to 50 years old 1000  600 20 
51 to 70 year old 1200  600 20 
Pregnant/lactating     
    19 to 50 years old 1000  600 20 
RDA, recommended dietary allowance; 
aMeasures of serum 25(OH)D levels corresponding to the RDA and covering the requirements of at 
least 97.5% of the population. 
 
Table 1.2: Australian recommended dietary intake for calcium and vitamin D intake in 
women aged 19-70 years 
Age Calcium  Vitamin D 
 EAR RDI  AIa 
19-30 yr 840 mg/day 1,000 mg/day  200 IU/day 
31-50 yr 840 mg/day 1,000 mg/day  200 IU /day 
51-70 yr 1,100 mg/day 1,300 mg/day  400 IU /day 
EAR, estimated average requirement; RDI, recommended dietary intake. AI, adequate intake. 
aThe AI for younger adults (19-50 years) is based on the amount of vitamin D required to maintain 
serum 25(OH)D at a level of at least 27.5 nmol/L with minimal exposure to sunlight. 
Source: National Health and Medical Research Council and New Zealand Ministry of Health, 2006, 
Nutrient Reference Values for Australia and New Zealand, 
(http://www.nrv.gov.au/nutrients/calcium), last accessed 12/11/2015. 
1.4.1.5 Prevalence of inadequate calcium intake and vitamin D deficiency in younger 
women 
Inadequate dietary calcium intake is very common in Australia despite its abundant sources 
from milk and milk-based foods. In the Australian Health Survey in 2011-2012(81), over two 
in three women aged 19-50 years had inadequate calcium daily intake (based on EAR, Table 
1.3). 
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Table 1.3: Proportion of population with inadequate calcium intakes in women aged 19-
70 years (estimated as % below the EAR) 
Age (years) EAR (mg)(a) Prevalence of inadequacy (%)(b) 
19-30 840 71.3 
31-50 840 67.2 
51-70 1100 91.2 
Source: (a) National Health and Medical Research Council and New Zealand Ministry of Health, 
2006, Nutrient Reference Values for Australia and New Zealand, 
(http://www.nrv.gov.au/nutrients/calcium), last accessed 12/11/2015. 
(b) Australian Health Survey: Usual Nutrient Intake, 2011-12. 
Although severe vitamin D deficiency (defined as a serum 25(OH)D level of < 25 nmol/L), 
resulting in rickets and osteomalacia in children and osteomalacia in adults, is now 
uncommon, subclinical vitamin D deficiency (serum 25(OH)D concentrations < 50 nmol/L) 
has been reported worldwide. A 2014 systematic review of 195 studies from 44 countries 
(168 000 participants) demonstrated that 37.3% of the studies reported mean serum 25(OH)D 
< 50 nmol/L(82).  
According to the Australian Health Survey 2011-12(83), vitamin D deficiency is highly 
prevalent in Australia, particularly in winter and for those living in the southern states (Figure 
1.1). For example, a cross-sectional study showed that almost one quarter of the population 
had a serum 25(OH)D level below 50 nmol/L among 2413 adults aged 24-95 years between 
2008 and 2010 in South Australia(84). A high prevalence of vitamin D deficiency was also 
reported in younger and middle-aged Tasmanian women aged 20 to 60 years, with more than 
two in three having a serum 25(OH)D level ≤ 50 nmol/L(85). Importantly, the National Health 
Survey component of the Australian Health Survey showed that only 5% Australian adults 
were taking Vitamin D supplements in 2011-12(83).  
  





Figure 1.1: Serum vitamin D in winter in Australia by state and territory, 2011-12; 
Percentages indicate the proportion of vitamin D deficient populations (25(OH)D levels 
< 50 nmol/L) (adopted from Australian Bureau of Statistics, Australian Health Survey: 
Biomedical Results for Nutrients).
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1.4.2 Physical activity 
1.4.2.1 Physical activity and bone health in younger women 
Physical activity is beneficially associated with fractures in both older(86) and younger 
adults(87-91); however evidence of similar associations between physical activity and fracture 
outcomes in premenopausal women is lacking, due to insufficient data. 
A meta-analysis of nine controlled trials showed that exercise programmes that combine odd- 
or high-impact activity with high magnitude resistance training was effective at lessening 
reduction in BMD at femoral neck and lumbar spine in premenopausal women (weighted 
mean difference = 0.007 g/cm2 (95%CI: 0.001-0.013) and 0.009 g/cm2 (95%CI: 0.002-
0.015), respectively)(87); however, the high-impact only protocols were only effective at 
improving femoral neck BMD (weighted mean difference = 0.024 g/cm2 (0.002-0.027)). This 
suggest different types of exercise may have different effect size on various bone sites and a 
combined exercise program might be required to achieve the optimal benefits. Nevertheless, 
given that low BMD increases the relative risk of osteoporotic fracture in younger(92) and 
middle-aged women(93), it is reasonable to conclude that sufficient physical activity in 
younger women may prevent fractures. 
1.4.2.2 Prevalence of insufficient activity and physical inactivity in younger women 
For adults aged 18-64 years, the latest Australia's Physical Activity and Sedentary Behaviour 
Guidelines recommend 150-300 minutes of moderate or 75-150 minutes of vigorous physical 
activity, or an equivalent combination of both, per week(94). In 2014-15, 47% to 58% of 18-64 
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years old women were insufficiently active (less than 150 minutes in the last week) or 
inactive (no exercise in the last week)(95). 
1.4.3 Smoking  
1.4.3.1 Health impacts of smoking on bone health in younger women 
Smoking cigarettes has been associated with increased risk of fractures in older women(96).  
However, results are inconclusive with regard to BMD in premenopausal women(97-101), with 
a meta-analysis of cross-sectional studies failing to observe differences in BMD between 
premenopausal smokers and nonsmokers(99). However, this might be due to poor reporting of 
studies, as between-studies heterogeneity was not reported, nor were subgroup analyses were 
performed to assess potential effect modifiers. Indeed, the relationship between smoking and 
BMD could be significantly modified by BMI, breastfeeding and sports participation in 
premenopausal women(97). In comparison, studies which took into account potential effect 
modifiers more comprehensively, showed negative associations between smoking cigarettes 
and BMD in younger women(97,98,100). For example, a cross-sectional study found that current 
smoking was associated with significantly reduced BMD in premenopausal women (mean 
age 33 years), particularly those with a BMI < 25 kg/m2 (97). Also, the deleterious effect of 
breastfeeding and the beneficial effect of participating in competitive sports on BMD were 
only present in smokers. Therefore, it is important to consider these possible confounders in 
evaluating results of past studies and future research. Taken together, the evidence suggests 
that smoking may have a deleterious effect on BMD in premenopausal women, though this 
effect may exist only in certain subgroups. 
Despite smoking cigarettes being considered a major risk factor for osteoporosis, evidence is 
limited about the mechanisms by which it exerts effects on bone(99,102,103). Several potential 
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mechanisms have been proposed, including having lower body fat, earlier age of menopause, 
increased adrenal cortical hormones, lower serum 25(OH)D levels and calcium absorption in 
smokers compared to non-smokers(101). However, evidence supporting these hypotheses is of 
poor quality and more work is needed to provide a clear and systematic understanding about 
this. 
1.5 Osteoporosis knowledge and self-efficacy 
1.5.1 Status of osteoporosis knowledge and self-efficacy in younger women 
Numerous studies have reported that younger women had low levels of knowledge about 
osteoporosis(104-114), though the majority of them have been in a convenience sample of 
participants. Only two studies demonstrated high levels of osteoporosis knowledge(112,115). 
Chang et al. showed that community-dwelling women aged 25-45 years (n = 265) answered 
more than 80% questions related to osteoporosis correctly(112). Although this was a 
population-based study, the response rate was extremely low (16.7%), conferring a high risk 
of selection bias and lowering the generalizability of the findings. A recent cross-sectional 
study among 430 women aged 20-35 years showed similarly high levels of knowledge with 
women scoring a mean of 18.5 from a maximum score of 23, but the findings might be 
compensated by the highly-selected participants, who attended the Gynecology Clinic(115). 
Overall, younger women are likely to have low levels of osteoporosis knowledge, though 
population-based studies are lacking. 
Self-efficacy refers to “beliefs in one's capabilities to organize and execute the courses of 
action required to manage prospective situations”(116). Few studies have assessed osteoporosis 
self-efficacy in younger women. Those that have, have used a variety of scoring scales, and 
reported low to moderate levels of osteoporosis self-efficacy (53%-78% of the maximum 
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possible scores for exercise self-efficacy, 66%-78% for calcium self-efficacy, and 41%-71% 
for overall self-efficacy, respectively)(109,114,117-121). Most studies have been conducted in 
convenience samples of highly selected populations, with only two reported in randomly 
selected samples of women(114,119). Wallace and colleagues demonstrated moderate levels of 
both exercise and calcium self-efficacy (63% and 68%, respectively) in a random sample of 
female undergraduates college students in the United States (n = 273, age range 17-64 
years)(119). Another larger study (n = 470) reported a similar but slightly higher overall 
osteoporosis self-efficacy (71%) in a random population-based sample of women aged 25-44 
years in south Tasmania, Australia(114). 
1.5.2 Relationships between osteoporosis knowledge, self-efficacy and behaviours in 
adult women 
Both osteoporosis knowledge and self-efficacy are two key factors involved in behaviour 
change for osteoporosis prevention, though this is not definitely confirmed. Evidence from 
cross-sectional data has been conflicting in whether increased levels of osteoporosis 
knowledge are associated with increased participation in osteoporosis preventive 
behaviours(112,119,122-125). The discrepancy might be explained by the study populations’ 
characteristics such as age and gender. Nevertheless, these findings do not allow for drawing 
any conclusions about causal relationships. Though this could be ascertained in intervention 
studies, the findings are similarly inconclusive(120,126-135). Although an increase in 
osteoporosis knowledge could be usually observed following an educational program, only a 
few studies found a concurrent increase in the participation in osteoporosis preventive 
behaviours(120,126,132,133,135). Of note, more than half of those intervention studies had a one-
group pre-post-test design, which has a number of internal validity issues (e.g., maturation 
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and testing). Moreover, the majority of those studies had only a short education session (less 
than one hour), which precludes the inclusions of a broader spectrum of topics or greater 
interactions between the participants and the instructor (knowledge instruction and feedback). 
In comparison, our previous studies found that the group-based education (the Osteoporosis 
Prevention and Self-Management Course, a weekly two-hours session for four weeks) could 
improve osteoporosis knowledge over two years and behaviours over both two and 12 years 
(unpublished data), compared to a simple leaflet of osteoporosis information(114,126,136). 
Therefore, adequate osteoporosis knowledge could be critical for improving osteoporosis 
preventive behaviours but more well-designed RCTs of longer educational programs are 
urgently needed. 
Osteoporosis self-efficacy has been related to behaviours in three ways: the conviction that an 
individual has the ability to i) initiate the activity, ii) maintain the activity and iii) persist in 
performing the activity in the face of obstacles(137). Self-efficacy has been studied in the 
context of numerous diseases and behaviours, and it has been shown to be a critical 
contributor to improving osteoporosis preventive behaviours(119,127,135,138). For instance, in a 
study aiming to test a model of certain factors influencing people engaging in osteoporosis 
preventive behaviours, including exercise and calcium intake, self-efficacy was a better 
predictor than were the other variables (i.e., age, years of education, knowledge of 
osteoporosis, social support and social capital)(138). 
Therefore, current evidence suggests that interventions aiming at improving osteoporosis 
knowledge and self-efficacy may be important for promoting behaviour change for 
osteoporosis prevention. However, there is limited literature identifying effective innovative 
approaches to do this, particularly those with long-term follow-up. 
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1.6 Osteoporosis education and fracture risk feedback for preventing 
osteoporosis in younger women 
1.6.1 Osteoporosis education 
1.6.1.1 Public health messages and recommendations for osteoporosis prevention in 
Australia 
In Australia, a range of clinical guidelines(139,140)recommendations(141,142) and position 
statements(142-144) for osteoporosis prevention have become available since 2000, the 
beginning of our original study(126). At that time, adequate calcium and vitamin D intake, 
regular weight-bearing exercise, and cessation of cigarette smoking had been proposed for 
the prevention of postmenopausal osteoporosis(142,145). In 2002, calcium intake, vitamin D, 
engaging in regular exercise were again emphasised as treatments of postmenopausal 
osteoporosis in the Australian Fracture Prevention Summit(146). From 2005 to 2013, three 
position statements for vitamin D(79,144,147) and one for calcium(143) had specifically discussed 
their importance for bone health. In 2012, the latest recommendations for physical activity for 
adults had also been released(148). In 2013, as the result of the Osteoporosis Australia Summit 
in 2011, building healthy bones throughout lifetime was propounded as an approach to 
osteoporosis prevention(149); three conventional and affordable strategies were reconfirmed to 
be important for bone health throughout the lifecourse: adequate daily dietary calcium 
intakes, vitamin D levels, and appropriate physical activity. In 2014, the Osteoporosis 
Australia released a medical guide of “what you need to know about osteoporosis” to provide 
a comprehensive description about osteoporosis and fractures from the following aspects: 
epidemiology, risk factors, diagnosis, management and treatment, and the prevention of re-
fracture and falls(141). Again, adequate calcium intakes, vitamin D levels, and appropriate 
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physical activity were highlighted for optimising bone mass, preserving BMD and slowing 
bone loss. 
1.6.1.2 Effects of osteoporosis education on osteoporosis knowledge and self-efficacy 
Despite the important role of osteoporosis knowledge and self-efficacy in change in 
osteoporosis preventive behaviours, the available evidence suggests that both osteoporosis 
knowledge and self-efficacy are inadequate in young women (as previously described in 
Chapter 1.5). However, the effective interventions to change this have yet to be ascertained, 
certainly at a population level. 
Previous studies have employed a variety of educational interventions to improve 
osteoporosis knowledge and self-efficacy in young women(114,120-122,131,132,135,150-153). Most of 
those studies have used the form of providing brief written educational materials to 
participants via mail or internet (an information packet or leaflet) or a few educational 
sessions, and all of which demonstrated an increase in osteoporosis knowledge but only some 
showed an increase in osteoporosis self-efficacy(121,135,150,151). Of note, these studies have 
been short-term in nature (≤ 6 months) and the majority of them have been in a convenience 
sample of participants, thereby limiting the generalizability of their results.  
Only one RCT, the original study of the 10-yr additional follow-up study from which the data 
are utilised for the present thesis, has examined the effectiveness of group-based education 
for improving osteoporosis knowledge and self-efficacy in a population-based sample of  
young women (n= 470, age range 25-44 years)(114). Specifically, participants in this study 
were randomly assigned to one of two educational interventions: a simple osteoporosis 
information leaflet produced by Osteoporosis Australia “Understanding Osteoporosis”; or the 
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Osteoporosis Prevention and Self-management Course (OPSMC). The OPSMC is a chronic 
disease self-management course developed by the Arthritis Foundation of Victoria and 
utilized by Osteoporosis Australia. The aim of this small-group patient education program is 
to increase knowledge, improve confidence and awareness and self-management of 
osteoporosis prevention with an emphasis on promoting appropriate lifestyle changes. 
OPSMC sessions of 2 hours were held weekly for 4 weeks with a maximum of 16 
participants per group. The osteoporosis information leaflet, from Osteoporosis Australia 
“Understanding Osteoporosis”, provided a comprehensive description of osteoporosis and a 
discussion of the role of lifestyle factors including diet, exercise and smoking, and optimal 
levels of calcium intake and exercise(154). They also received individualised BMD feedback, 
that is, women who had a mean T-score at spine and hip of greater than or equal to 0 were not 
at a higher risk of fracture in later life, whereas those who had a mean T-score of less than 0 
were at higher risk. After six months of the interventions, women in the OSPMC group had 
higher osteoporosis knowledge compared to the leaflet group and this persisted at 2 years (β 
= 1.33, 95% CI: 0.72-1.94 and 0.64, 95% CI: 0.0034-1.25, respectively) though the 
magnitude was reduced. In contrast, women who received feedback of higher fracture risk 
had a significant increase in osteoporosis knowledge at 2 years (β = 0.66, 95% CI: 0.0034-
1.25) but not six months, compared to those who were informed of not being at a higher risk. 
However, osteoporosis self-efficacy was not associated with either intervention. 
Nevertheless, the effects of these interventions in the long term (e.g., > 5 years) remains 
unknown. 
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1.6.1.3 Effects of osteoporosis education on preventive behaviours 
A number of controlled trials of a variety forms of educational interventions have been 
conducted in premenopausal women aimed at improving a number of osteoporosis preventive 
behaviours (Table 1.4)(120,126,132,151,155-163). This is typically by targeting aspects in the causal 
pathway (knowledge, attitudes, and self-efficacy). Some have demonstrated improvements in 
exercise(160), calcium intake(156,157,159,163), intake of dairy foods(155), calcium 
supplements(160,163) and vitamin D intake and supplements(156,159,160) but the others did not 
show any benefits(120,126,132,161,162). Overall, these studies have been short term in nature (less 
than or equal to 1 year) and were in a convenience sample of participants with only one 
exception that was our previous 2-year RCT in a randomly selected population-based sample 
of premenopausal women (age range 25-44 years) as described previously in Chapter 
1.6.1.1(126). In this study, women received one of two educational interventions: a simple 
osteoporosis information leaflet produced by Osteoporosis Australia “Understanding 
Osteoporosis”; or the OPSMC. At the end of the 2-year follow-up, women in the OPSMC 
group did not differ in the improvements in dietary calcium intake, self-reported use of 
calcium supplements, smoking cessation, increased physical activity, or BMD at either the 
femoral neck or lumbar spine, compared to the group who received the leaflet alone. Besides 
the educational intervention, a second intervention was provided: individualised BMD 
feedback i.e. women who had a mean T-score at spine and hip of greater than or equal to 0 
were informed they were not at a higher risk of fracture in later life, whereas those who had a 
mean T-score of less than 0 were at higher risk. The outcomes of this intervention are 
described in detail in Chapter 1.6.2.3.  
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Similar to osteoporosis knowledge and self-efficacy, the long-term effects of educational 
interventions on osteoporosis preventive behaviours or even prevention of fractures remains 
unknown in premenopausal women.
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Table 1.4: Characteristics of controlled trials examining effects of educational interventions for improving osteoporosis preventive 
behaviours in premenopausal women (listed in chronological order of publication year) 












Blalock et al. 
(2000)(132) 
536 (307) RCT Premenopausal North Carolina driver's 
license records 
35-43 Group 1 (intervention):  an information 
packet containing general information about 
osteoporosis; 
Group 2 (intervention): an action plan 
packet containing instructions on how to 
increase one's level of exercise and calcium 
intake; 
Group 3 (intervention): both packets; 
Group 4 (control): neither packet. 
One year No effects on calcium intake or 
physical activity behaviours. 
Peterson et al. 
(2000)(163) 
122 (80) CCT Premenopausal Convenience sample, a 
university setting in 
Memphis, Tennessee. 
18-30 Group 1 (intervention): Individualized DXA 
Feedback (no description how the DXA 
results were presented), three small group 
dietary education sessions, and 
provided with calcium 
supplements; 
Group 2 (control): usual care. 
 
Six months Greater increases in total 
calcium intake and supplemental 
calcium. Women in the 
treatment group did not 
experience significant changes 
in total BMC, but women in the 
control group experienced 











45-69 Group 1 (intervention): Attended 
multidisciplinary day long 
education on osteoporosis 
with exercise practice sessions; 
Group 2 (control): attended workshop not 
related to osteoporosis. 
Six months Smoking, exercise, vitamin D 
supplementation, calcium 
supplementation did not differ at 
the end of follow-up. Though 
calcium intake was higher in 
intervention group, this might be 
due to its higher baseline level. 
Brecher et al. 
(2002)(120) 
97 (86) RCT Mixed (n = 23, 
premenopausal) 
Convenience sample, 
southern New Jersey 
area through newspaper 
advertisements, posted 
notices, mailings, and 
word of mouth. 
25-75 (66% 
< 60) 
Group 1 (intervention): One, 3-h small 
group 
session with lecture and 
interactive exercises; 
Group 2 (control): offered educational 
session after the end of the study. 
Three 
months 
More participants had self-
reported increased calcium 
intake, but no objective 
differences in calcium intake as 
actually measured. 
Blalock et al. 
(2002)(161) 
714 (547) CCT Premenopausal Convenience sample, 12 
counties in western 
North Carolina. 
40-56 Intervention 1: 
Group 1 (intervention): Education tailored 
on stage 
of change and current behaviours; 2 
mailings and 1 phone call; 
Group 2 (control): Mailed, 2 packets of 
standardized information. 
Intervention 2: 
One year In women with inadequate 
calcium intake at baseline, 
tailored materials increased 
calcium in the short term (six 
months) but not in the longer 
term (1 year), and no effects on 
exercise participation. 
Community intervention had no 
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Group 1 (intervention): Community partners 
and stage of change provided free bone 
density Assessment; 
Group 2 (control): Community partners did 
not provide free BMD assessment. 
effects on changes in calcium or 
exercise behaviours. 
Kulp et al. 
(2004)(160) 
195 (195) RCT Mixed Attending a 
gynaecological 
examination in an 
outpatient setting. United 
States. 
35-80 Group 1 (intervention): Educational video 
10 min 
in length focusing on osteoporosis 
and prevention preceded visit 
with physician who was 
blinded to group assignment; 
Group 2 (control): usual care. 
Three 
months 
Increased calcium supplements, 
vitamin D supplements, weight-
bearing exercise, and hormone 
therapy. 
Chan et al. 
(2005)(159) 
56 (41) RCT Mixed A private beauty clinic in 
Hong Kong 
> 18 (78% 
participants 
< 46) 
Group 1 (intervention): a structured, 
individualized educational session and a 
supportive telephone follow-up programme, 
which covered the four behaviours 
(consumption of soya foods, milk and 
vitamin D/more exposure to sunlight and 
increased exercise) were discussed in one 
45-minute education session, followed by 
two telephone consultations that were 
conducted within one month. 
Group 2 (control): no education session. 
One month Increased consumption of 
calcium including soya-based 
foods, milk and vitamin D. 
Winzenberg et 
al. (2006)(126) 
470 (415) RCT Premenopausal Randomly selected in 
Southern Tasmania using 
the Tasmanian Electoral 
Roll as the sampling 
frame. 
25-44 Intervention 1: 
Group 1 (intervention): the Osteoporosis 
Prevention and Self-management Course 
(OPSMC); 
Group 2 (control): an information leaflet 
produced by Osteoporosis Australia 
"Understanding Osteoporosis". 
Intervention 2:  
Group 1 (intervention): higher risk of 
fracture in later life (mean spine and hip T-
score < 0); 
Group 2 (control): normal risk of fracture in 
later life (mean spine and hip T-score ≥ 0). 
Two years No effects on dietary calcium 
intake, self-reported use of 
calcium supplements, cessation 
of smoking, increased physical 
activity, or BMD of femoral 
neck and lumbar spine. 
Huang et al. 
(2011)(158) 
68 (68) CCT Mixed Using posters and flyers 
in two community 




> 40 Group 1 (intervention): three primary 
components associated with the HBM, 
including “individual perceptions, 
modifying factors, and likelihood of action”. 
Group 2 (control): no intervention. 
 
12 weeks Increased intake of calcium-rich 
foods, weight-bearing exercise, 
BMD T-score after intervention, 
adjusted for baseline values. 
Jung et al. 
(2011)(157) 
133 (98) RCT Premenopausal McMaster University in 
Hamilton, Ontario, 
Canada 
18-19 Group 1 (intervention): gain-framed, 
targeted materials; 
Group 2 (control): standard osteoporosis 
educational materials. 
One year Increased calcium intake 









Unknown Convenience sample, 
first-generation Chinese-
American from six 
weekend Chinese 
schools in the 
Philadelphia, 
Pennsylvania. 
35-55 Group 1 (intervention): six culturally 
focused 
weekly interactive small group 
lesions including food 
preparation demonstration, 
personal feedback, and 
involvement of family; 
Group 2 (control): six weekly nonrelated 
financial lessons by mail. 
Three 
months 
Increased calcium and vitamin D 
intake. 




RCT Premenopausal College students in a 
university campus, Johns 
Hopkins. 
20.2 Via electronic mail an 8-week educational 
intervention of: 
Group 1 (intervention): dairy intake; 
Group 2 (control): stress management.  
Eight 
weeks 
Higher intake of total dairy 
foods. 





Unknown Patients registered in two 
healthcare centres (Fasa, 
Iran). 
30-50 Group 1 (intervention): eight educational 
sessions of 55-60 minutes. Each session 
included a combination of lectures, group 
discussion, questions, and answers, showing 
posters, short videos, and PowerPoint 
displays. Moreover, educational pamphlets 
were given to the participants at the end of 
the last session. 
Group 2 (control): no intervention. 
Six months BMD T-score of lumbar spine 
and hip increased in the 
intervention group while 
decreased in the control group, 
though the difference was not 
statistically significant. Nutrition 
and jogging performance were 
higher in the intervention group 
than the control group. 
RCT, randomized controlled trial; CCT, clinical controlled trial. 
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1.6.2 The feedback of fracture risk as a potential strategy 
The feedback of fracture risk or BMD has been reported to be a potentially effective 
intervention to improving osteoporotic preventive behaviours, thus improving BMD(126). 
1.6.2.1 BMD 
The mineral content of bone can be assessed using measures of BMD. BMD can be measured 
by a number of approaches including quantitative computed tomography (QCT, measuring 
volumetric BMD in g/cm3), single photon absorptiometry (SPA), dual photon absorptiometry 
(DPA), digital X-ray radiogrammetry (DXR) and single- and dual-energy X-ray 
absorptiometry (SXA or DXA). DXA is the international standard for the clinical assessment 
of bone density, and assesses areal bone mineral density in g/cm2. Currently there is no other 
skeletal health assessment technology that provides as much clinical information as DXA for 
diagnosing osteoporosis, assessing fracture risk, and monitoring changes in BMD over 
time(164). 
Areal BMD without clinical interpretation is unlikely to be useful in communicating with 
patients and/or consumers. However, bone density results can be used to classify people into 
diagnostic categories of osteoporosis according to T-score. T-score is the expression of 
individual BMD in relation to the young healthy population in standard deviation (SD) units. 
WHO has proposed four general diagnostic categories for osteoporosis for women based on 
measurements by DXA(165). Normal: a value of BMD within one standard deviation of the 
young adult reference mean (T-score ≥ -1); Low bone mass (osteopenia): a value of BMD 
more than one standard deviation below the young adult mean, but less than two standard 
deviations below this value (T-score < -1 and > -2.5); Osteoporosis: a value of BMD 2.5 
Chapter 1: Literature review 
Page 32 
 
standard deviations or more below the young adult mean (T-score < -2.5); Severe 
osteoporosis (established osteoporosis): a value of BMD 2.5 standard deviations or more 
below the young adult mean in the presence of one or more fragility fractures. 
1.6.2.2 The importance of BMD 
BMD is a major predictor of fracture risk(16,166). Low bone mass prior to menopause is as 
important as postmenopausal rate of bone loss for the risk of fracture(167). It is therefore 
possible to translate bone density results into relative or absolute fracture risk assessments. 
For example, a prospective study showed that in postmenopausal women (n = 2161) a one 
standard deviation decrease in femoral BMD was independently associated with a 2.4-fold 
increase in relative fracture risk(166). In contrast, absolute fracture risk can be predicted by a 
variety of fracture risk calculators with or without BMD(168), for example, the Fracture Risk 
Assessment (FRAX) tool developed by WHO. One recent prospective study in US women 
aged 65 or older showed that the FRAX could well predict 10-year absolute hip fracture risk 
both with or without BMD [the area under the receiver operating characteristics curves 
(AUC) values ranged from 0.62 to 0.79](169). 
Thus, it is possible to provide interpretations of bone density measures to people that are 
likely to be meaningful and communicate potential health consequences. 
1.6.2.3 How the strategy might work 
Healthy risk awareness plays a key role in motivating osteoporosis preventive behaviours in 
preventing fracture(170). However, individuals' awareness of(171) osteoporosis is low(172), as 
described earlier. Young adult women (mean age (SD) = 42.5 (0.6) years) reported that 
osteoporosis was not serious and it was not necessary to take preventive measures(112). 
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Similarly, a recent study in Australia has shown that osteoporosis as a medical condition was 
considered of having low salience by general medical practitioners (GPs), particularly in 
comparison with other diseases(171). These highlight the importance and potential benefit of 
improving risk awareness of osteoporosis to both general populations and GPs. 
Interventions aimed at successfully communicating disease risk are beneficial across a range 
of clinical areas; those including individualised risk estimation are typically more effective 
than other forms of personal communication(173). Feedback of personalised information to 
individuals about BMD or fracture risk based is an under-explored potential osteoporosis 
intervention(174), which may promote osteoporotic preventive behaviours by improving 
individuals' health risk awareness, and thereby motivating them to improve knowledge about 
how to reduce risk, changing attitudes and improving self-efficacy. In addition, fracture risk 
and bone density feedback delivered as above can be considered a form of biofeedback. 
Successful employment of biofeedback can be beneficial for health-related behaviours. A 
study of 261 women compared self-reported changes in behaviours of osteoporotic fracture 
prevention between women who were informed that their bone density results were below 
normal and those who were informed that their results were normal(175). Participants who 
received BMD results stating that their BMD was lower than normal were much more likely 
to begin osteoporotic fracture preventive measures (94% vs. 56%, p< 0.01), to start hormone 
therapy (38% vs. 8%, p< 0.01), and to take precautions to avoid falling (50% vs. 9%, p< 
0.01), compared to those who were labelled as having normal bone density. Several 
osteoporosis preventive behaviours have been demonstrated to have positive effects on BMD 
in younger women, such as smoking cessation(176,177), increased physical activity(178-181), 
calcium(126,182) and vitamin D supplementation(60,183). Another study of 470 premenopausal 
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women found that those who received the feedback of high fracture risk had higher rates of 
increased calcium supplements use (15% vs. 3%, p<0.001) and increased physical activity 
(40% vs. 26%, p=0.001) as well as having a positive effect on bone density at the femoral 
neck (annual percentage change of 1.6 vs. 0.7, p<0.001)(126). In addition, women who started 
calcium supplements (β of annual percentage change = 1.3, 95%CI: 0.49-2.17) and reported 
change in physical activity levels (β of annual percentage change = 0.7, 95%CI: 0.22-1.22) 
had significantly higher annual gain in femoral neck BMD. Thus it seems likely that BMD 
can be improved by the feedback of fracture risk mediated through osteoporosis preventive 
behaviours. 
1.6.2.4 The effects of the feedback of fracture risk or BMD for improving osteoporosis 
preventive behaviours in younger women 
There are only a few clinical trials investigating the effectiveness of fracture risk or BMD 
feedback in improving osteoporosis preventive behaviours in younger women, as summarised 
in Table 1.5. In a controlled trial, the effects of osteoporosis education and BMD testing on 
osteoporosis preventive behaviours were assessed in women aged 18-35 years(184). 
Participants with low BMD (either lumbar spine or femoral neck Z-score ≤ -1) were informed 
that their bone mass was low. One year later, low BMD feedback was associated with 
increased calcium and vitamin D supplements but not physical activity. Another 1-yr 
controlled trial evaluated the effect of BMD feedback on lifestyle behaviours(154). Women 
were informed that their BMD was low if they had a T-score < -1.0 at either the femoral neck 
or lumbar spine, otherwise they were told that their BMD was normal. At follow-up, women 
receiving low BMD feedback had higher rates of increased calcium supplements use and 
increased physical activity but not ceased smoking compared to those who received normal 
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BMD results. Unfortunately, these two studies did not examine the effects on BMD. A 
clinical controlled trial examined the effects of BMD feedback [low fracture risk (mean spine 
and hip T-score≥0) and high fracture risk (mean spine and hip T-score<0)] and educational 
interventions on osteoporosis preventive behaviours and BMD in premenopausal women(126). 
At 2-yr follow-up, participants who received high fracture risk feedback were more likely 
than those receiving low fracture risk feedback to commence taking calcium supplements and 
to report changes in physical activity but not ceased smoking. Those women receiving 
feedback of high fracture risk had a greater increase in femoral neck BMD but not in lumbar 
spine BMD than those who received low fracture risk. Overall, while the evidence suggests in 
premenopausal women BMD or fracture risk feedback may be beneficial for osteoporosis 
preventive behaviours and BMD, the data is insufficient to be conclusive and, importantly, 
the long-term effects remain unknown.
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Table 1.5: Characteristics of controlled trials examining effects of feedback of fracture risk or BMD for preventing osteoporosis in 
pre/peri-menopausal women (listed in order of number of study participants, highest to lowest) 
Authors 
(Year) 







Age (year) Intervention Duration of 
follow-up 
Outcomes 
Barr et al. 
(2010)(185) 
4800 (2375) RCT Unknown 45-54 BMD screening with results and appropriate 
advice (according to risk of osteoporosis) 
sending to GPs, who communicated with 
participants; 
No intervention for controls. 
9 years Self-reported use of vitamin D 
and calcium at the end of 
follow-up; fractures at wrist, 
vertebral, non-vertebral, and 
total hip. 
Jamal et al. 
(1999)(184) 
669 (669) CCT Premenopausal 18-35 BMD results were sent to participants with 
statement that bone mass was maintained, bone 
mass was consistent with osteopenia, or bone 
mass was consistent with osteoporosis. Women 
with low BMD received a hand-written note 
informing them that their bone mass was low 
and reinforcing them their bone mass was low. 
1 year Self-reported calcium and 
vitamin D supplements use at 




470 (415) CCT Premenopausal 25-44 Mean spine and hip T-score: 
   ≥ 0 normal risk of fracture in later life; 
   <0 higher risk of fracture in later life. 
2 years Self-reported use of calcium 
supplements, cessation of 
smoking, increased physical 
activity, BMD of femoral neck 
and lumbar spine. 
Jones et al. 
(1999)(154) 
271 (256) CCT Premenopausal 33.5 T-score at either the femoral neck or lumbar 
spine: 
    <-1.0  BMD was low, recommending that 
they consult their family practitioner; 
    ≥ -1.0 normal. 
≈1.3 year Self-reported change in 
smoking status, use of calcium 
supplement, and increased 
physical activity. 
Rimes et al. 
(1999)(186) 
180 (176) CCT Mixed 32-73 BMD results were calculated as a percentage of 
the mean for their age: 
    the highest 30% of the percentage “high” 
BMD results; 
    the lowest 30% of the percentage “low”, of 
whom, women with a result below the “fracture 
threshold” were further informed “they may 
have lost some bone and hence may suffer 
fractures in accidents more easily than women 
who have higher bone densities”. 
3 months Self-reported use of calcium 
supplements and exercise at 
the end of follow-up. 
RCT, randomized controlled trial; CCT, clinical controlled trial. 
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Chapter 2: Rationale and research questions 
2.1 Rationale 
The public health burden both to individuals and the community arising from 
osteoporosis is substantial and is increasing as the population ages, particularly in 
women. Although a number of effective therapies are currently available, many 
patients are not diagnosed until fractures occur and compliance with drug therapies is 
poor(1). Preventive interventions have the potential to be a simple and cost-effective 
way to alleviate the rapidly growing burden. 
As low bone mineral density (BMD) is a major risk factor for osteoporotic fracture(2), 
and bone mass tracks throughout life(3,4), premenopausal women who are in the lower 
BMD range are likely to continue to have lower BMD during the postmenopausal 
period. Consequently, low premenopausal bone density, or premenopausal bone loss 
could contribute to elevated fracture risk in later life. Therefore, strategies to address 
the long-term maintenance of peak bone mass by slowing premenopausal bone loss is 
critical. 
Similarly, muscle strength and balance are both important aspects of musculoskeletal 
health. Age-related loss of muscle strength is associated with decreased balance and 
functional limitations in older people(5,6) and impaired balance increases risk of 
falls(7). Importantly, both muscle strength(8) and balance begin attenuating around 45-
55 years of age(9,10), particularly in women, leading to suggestions that prevention of 
functional limitations, falls and fractures in older age should begin in early midlife. 
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2.2 Research questions 
We performed a 10-yr further follow-up of our original 2-yr randomized controlled 
trial of osteoporosis educational interventions in a population-based cohort of 470 
premenopausal Australian women aged 25-44 years. Using this data we addressed 
five research questions. The first two questions relate to the long-term effects of the 
interventions based on longitudinal data. Questions three to five are addressed using 
cross-sectional analyses of the 10-year follow-up data. The research questions are: 
1. Is individualised BMD feedback and group education effective for improving 
osteoporosis knowledge and self-efficacy over 12 years? 
2. Does individualised BMD feedback and group education continue to be 
effective for improving osteoporosis preventive behaviours as well as BMD 
for a further 10 years subsequent to the 2 year trial? 
3. Do cut-points exist for associations between serum 25-hydroxyvitamin D 
(25(OH)D) and musculoskeletal health outcomes, below which greater 
25(OH)D levels are associated with musculoskeletal health benefits and above 
which no such associations exist? 
4.  
a. Are objectively-measured total physical activity, time spent at different 
intensities of physical activity and sedentary time associated with 
BMD, lower limb muscle strength (LMS) and balance measures in 
middle-aged women?   
b. If present, are any associations with moderate-to-vigorous physical 
activity (MVPA) independent of sedentary time, and vice versa? 
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5. Is LMS associated with balance measures in middle-aged women and are the 
associations non-linear, and, if so, is there evidence for thresholds where the 
associations change? 
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Chapter 3: Methods 
This chapter describes a further 10-yr follow-up of an original 2-yr randomized 
controlled trial. It incorporates aspects of study design, participants, and outcome 
measures of both the original (Section 3.1) and the present study (Section 3.2), and 
the methods of statistical analyses of the 10-yr follow up. Two chapters of this thesis 
(Chapter 4 and 5) use the longitudinal data from baseline to 12 years, while the other 
three (Chapter 6-8) use the cross-sectional data at 12 years. 
Please note that the subsequent data chapters are presented in the form in which they 
were accepted by, or submitted to peer-reviewed scientific journals. Therefore, there 
are some differences in the way methods are presented in those papers as compared to 
this overview chapter due to the requirements of different journals and the details 
required for different analyses. The sample sizes used in individual chapters varies for 
each of the research questions. 
3.1 Design and participants of the original trial 
The detailed methods of the original study have previously been published(1,2). 
Briefly, it was a two-year trial over 2000-2003, aiming to evaluate the effects of 
fracture risk feedback and educational interventions for improving osteoporosis 
knowledge, self-efficacy, preventive behaviours and bone mineral density (BMD) in 
premenopausal women. It included a randomised controlled trial component (random 
allocation to one of two educational interventions) and a non-randomised component 
(allocation to a fracture risk group based on bone mineral density). These 
interventions are described in detail below. 




Participants were residents of Southern Tasmania, Australia. The population of the 
region is predominantly Caucasian, with 194,389 residents at June 1999, of whom 
28,839 women were aged between 25 and 44(3).Women aged 25-44 years were 
randomly selected using the year 2000 Tasmania Electoral Roll as the sampling 
frame. The register of electors represents the most comprehensive population listing 
of Australian adults, as voting is compulsory in Australia. Participants were excluded 
if they had previous measurement of bone density, thyroid disease, renal failure, 
malignancy, or rheumatoid arthritis, a history of hysterectomy or were taking 
hormone replacement therapy, pregnant or planning pregnancy within 2 years of 
study entry, lactating. Ethics approval was obtained from the Royal Hobart Hospital 
Ethics Committee and all participants gave written informed consent. Of the 470 
women recruited at baseline, 415 (88%) were retained in the study at two years. 
3.1.2 Interventions 
Participants were randomly assigned to receive the Osteoporosis Prevention and Self-
management course (OPSMC) or an information leaflet by using a computer-
generated random number list. After the randomisation of educational interventions 
was finished, participants also received feedback of being either at normal or high risk 
of fracture in later life. The classification of fracture risk is described below. Those in 
the leaflet information group received their feedback of fracture risk with the leaflet 
by mail, and those in OPSMC group received the feedback at the first session of the 
course. While there was no allocation concealment, allocation was implemented 
sequentially for each participant number with no variations to the order in which the 
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numbers were assigned. Randomisation was also performed prior to BMD results 
being known, so allocation could not be influenced by BMD status. 
3.1.2.1 Fracture risk feedback 
Participants had their BMD measured (Hologic QDR2000, Waltham, MA) at the 
spine and hip at baseline. Those with a mean spine and hip T-score of 0 or greater 
were informed that they had a normal risk of fracture in later life, whereas those with 
a mean T-score <0 were informed that they were at a higher risk. This was based on 
the observation that those in the lower half of the BMD distribution have threefold 
higher fracture risk both in later life and in the early postmenopausal period(4). 
Although this cut-off is based on elderly women, it has been proposed that bone mass 
tracks throughout life(5), so that premenopausal women who are in the lower BMD 
range are likely to still have lower BMD during the postmenopausal period. 
3.1.2.2 Osteoporosis education 
The OPSMC is a chronic disease self-management course developed by the Arthritis 
Foundation of Victoria and utilized by Osteoporosis Australia. The aim of this small-
group patient education program is to increase knowledge, improve confidence and 
awareness and self-management of osteoporosis prevention with an emphasis on 
promoting appropriate lifestyle changes. OPSMC sessions of 2 hours were held 
weekly for 4 weeks with a maximum of 16 participants per group. The osteoporosis 
information leaflet, from Osteoporosis Australia “Understanding Osteoporosis”, 
provided a comprehensive description of osteoporosis and a discussion of the role of 
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lifestyle factors including diet, exercise and smoking, and optimal levels of calcium 
intake and exercise(6).  
3.1.3 Measurements 
A summary of when the measures used in this thesis were assessed in the original 
(baseline to two years) and the present study (12 years, see below Chapter 3.2.2) is 
shown in Table 3.1. 
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Table 3.1: Summary of when measures were assessed over 12 years a 
 Baseline 
n = 470 
1 year 
n = 463 
2 years 
n = 415 
12 years 
n = 347 
Outcomes     
Bone mineral density √  √ √ 
Osteoporosis knowledge b √  √ √ 
Osteoporosis self-efficacy b √  √ √ 
Change in behaviours     
    Smoking status  √ √ √ 
    Physical activity  √ √ √ 
    Calcium intake  √ √ √ 
    Calcium supplement use  √ √ √ 
Lower limb muscle strength √  √ √ 
Balance     
    Timed up and go test    √ 
    Step test    √ 
    Functional reach test    √ 
    Lateral reach test    √ 
Other factors     
Height, weight, body mass index √ √ √ √ 
Marital status √  √ √ 
Employment status √  √ √ 
Blood taken (vitamin D)    √ 
Accelerometer (seven consecutive 
days) 
   √ 
Calcium intake √ √ √ √ 
Behaviours     
    Smoking √  √ √ 
    Strenuous and light physical activity √ √ √ √ 
    Time watching TV or videos √ √ √ √ 
    Calcium supplement use c √ √ √ √ 
    Vitamin D supplement use d    √ 
Breastfeeding history √   √ 
Sun exposure √  √ √ 
Family history of osteoporosis/fracture √   √ 
Fracture history in the participant √   √ 
a Only the most relevant measures investigated in the original and the present study are included. 
b Osteoporosis knowledge and self-efficacy were also measured at six weeks. 
c At 12 years, participants were also asked to recall if they had regularly used calcium supplement at 
each year during the last 12 years. 
d At 12 years, participants were asked to recall if they had regularly used vitamin D supplement at each 
year during the last 12 years. 
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Subsection 3.1.3.1 and 3.1.3.2 give detail on the factors measured in the original trial. 
Details of measures in the 12 years follow-up are given in sections 3.2.2.1 and 3.2.2.2. 
3.1.3.1 Outcome factors in original trial 
1. Osteoporosis knowledge was measured by the Osteoporosis Knowledge 
Assessment Tool (OKAT) (12). The OKAT has 20 items, each having true, 
false and don’t know options. Scoring was 1 for a correct response and 0 for 
an incorrect or do not know response. The possible range of scores was 0 to 
20. The questionnaire had a Ferguson’s sigma of 0.96, a Cronbach’s alpha of 
0.70 and factor analysis consistent with only one factor (osteoporosis 
knowledge) being measured. 
2. Osteoporosis self-efficacy was measured by the osteoporosis self-efficacy 
scale (OSES) (13) and has 6 items in each of two subscales, one relating to 
calcium intake and one relating to physical activity. We used a four point 
adjectival scale modification of the original scale, with ratings of: not at all 
confident (score 1), mildly confident (2), confident (3) and very confident (4). 
The range of possible scores was from 12 to 48. 
3. BMD at the femoral neck and lumbar spine was measured by a Hologic 
QDR2000 densitometer (Waltham, MA), which was calibrated daily with 
coefficient of variation (CV) 1%. 
4. Self-reported changes in osteoporosis preventive behaviours were measured 
by asking participants to indicate if they have changed their smoking, dietary 
calcium intake, calcium supplement use and physical activity at one and two 
years. 
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5. Calcium intake was assessed by a short food frequency questionnaire which 
has been validated against 4 day weighed records and correlates well up to 12 
months(7). 
6. Light and strenuous physical activity was assessed by a questionnaire 
validated in US adolescents(8) which we modified for Tasmanian conditions 
and had used previously in women of this age where it was associated with 
bone mass at the femoral neck(6). 
3.1.3.2 Other study factors 
1. Anthropometrics (age, height, weight, body mass index). Height was 
measured by stadiometer and weight measured by a single set of calibrated 
scales. Body mass index was calculated (weight (kg)/height (m)2). 
2. Smoking history (current/former/never, cigarettes per day, age at uptake, age 
at ceasing). 
3. Breastfeeding history (ever breastfed, time since last breastfeeding). 
4. Sun exposure - by questionnaire measuring weekday and weekend sun 
exposure in summer and in winter, each in 4 categories (< 2, 2-3, 3-4 and > 4 
hours per day). 
5. Lower limb muscle strength (LMS) was measured to the nearest kilogram 
using a dynamometer (TTM Muscular Meter, Tokyo, Japan)(9). This test 
examines isometric strength, predominantly of the quadriceps and hip 
extensors. The examiner demonstrated the correct technique to the participant 
before testing. Participants stood on the back of the dynamometer platform, 
with back straight against a wall and knees flexed to an angle of 115°. They 
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held a bar, connected to the dynamometer by a chain, and lifted the bar using 
maximum force using their legs, with the back and neck straight. Two 
readings were made, and the mean calculated for analysis. 
6. Family history of osteoporosis and or fracture, and fracture history in the 
participant. 
7. Socioeconomic factors: including employment status of participant and of 
main financial provider in the household and marital status. 
3.2 Design and participants of the present study (additional 10-yr 
follow-up) 
3.2.1 Participants 
The present study was an additional 10-yr follow-up of the original 2-yr RCT 
described above (Chapter 3.1). All 470 participants from baseline in the original study 
were invited to participate, with 347 (74%) retained at 12 years. Ethics approval was 
obtained from the Human Research ethics Committee (Tasmania) Network (Approval 
number H11613: Strategies to address the long term maintenance of bone density in 
younger women: fracture risk feedback and vitamin D). We obtained written 
informed consent from all participants. 
3.2.2 Measurements 
The measures taken at the 12 year follow-up, as summarised in Table 3.1 are listed here.  
The methods for each measure are described in more detail in section 3.1.3 above where 
the measures were the same as taken at baseline, and in the relevant results chapters for 
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those measures performed only at 12 years. 
3.2.2.1 Outcomes 
1. Osteoporosis knowledge and self-efficacy (as described in Chapter 3.1.3). 
2. BMD at femoral neck and lumbar spine (as described in Chapter 3.1.3). 
3. Changes in osteoporosis preventive behaviours (see Chapter 5.2 for details of how 
they were defined): 
a. Calcium intake (increased/decreased) and calcium supplement use 
(never supplement/commenced or persistent supplement/cessation); 
b. Strenuous and light physical activity (unchanged/increased/decreased); 
c. Use of vitamin D supplements (no recent use/recent use); 
d. Smoking status (never smoked/cessation/commenced or persistent 
smoking). 
4. Lower limb muscle strength was measured as described in Chapter 3.1.3.  
5. Balance was measured using four clinical balance tests - the timed up and go test, 
the step test, the functional reach test and the lateral reach test (see Chapter 6.2 for 
details). 
3.2.2.2 Other study factors 
1. Serum 25-hydroxyvitamin D (25(OH)D) levels (see Chapter 6.2 for details). 
2. Time spent in moderate-to-vigorous and light physical activity, and time spent 
sedentary over 7 consecutive days by accelerometer (ActiGraph GTlM) (see 
Chapter 7.2 for details). 
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3. Self-reported strenuous and light physical activity (as described in Chapter 3.1.3). 
4. We determined fracture history by questionnaire. Data were collected on fracture 
site, age at fracture, circumstances surrounding fracture and an estimation of degree 
of trauma involved. 
5. Medication history. 
6. Anthropometrics, socioeconomic factors, date of last menstrual period and sun 
exposure (as described in Chapter 3.1.3). 
3.2.3 Statistical analyses 
3.2.3.1 Power calculation 
Given that the present study was a follow-up of the previous RCT and a prior power 
calculation could not be done by calculating the number of participants we needed, 
we alternatively determined the minimal detectable difference for the most important 
outcomes based on existing data from the original study, that is, BMD of femoral 
neck and lumbar spine and behavioural outcomes (use of calcium supplement and 
increased physical activity). All calculations assume control and interventions groups 
of size 180, a Type I error rate of 5% and Type 2 error rate of 20%. We assumed that 
the low risk group mean (SD) or % (as appropriate) persists for each variable. The 
detectable differences for femoral neck and lumbar spine BMD (Table 3.2) are 
equivalent to very small yearly changes (0.21 and 0.10% p.a. for the femoral neck and 
lumbar spine respectively). The proportion of participants in the low risk group who 
take calcium supplements and report increased physical activity and the proportion 
detectable in the high risk group are given in Table 3.3. These are smaller than we 
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observed at 2 years (14.7% for calcium supplements and 40.3% for changes in 
physical activity in the high risk group). 
Table 3.2: Detectable differences in BMD outcomes between fracture risk 
feedback groups 
   Change in BMD at 2 years mean (SD) 
(g/cm2) 
Detectable difference 
in BMD change 
between groups 
(g/cm2)  
Low risk High risk 
Femoral neck 0.01220 (0.04478) 0.02132 (0.08050) 0.0193 
Lumbar spine -0.0002 (0.04561) 0.0009 (0.03114) 0.0113 
Table 3.3: Detectable differences in behavioural outcomes between fracture risk 
feedback groups 
Outcome  Low risk group 
(%) 
Proportion in high risk group 
detectable at 
 12 years (%) 
Take Calcium supplement 2.94 8.47 
Increased Physical activity 25.4 12.96 or 38.49* 
3.2.3.2 Statistical analysis 
Statistical significance was determined using p-value < 0.05 and two-tailed tests 
throughout the thesis. Detailed descriptions of statistical analyses performed are 
presented in the relevant results chapters. All statistical analyses were performed on 
Stata 12 for Windows (StataCorp, College Station TX, USA). 
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Chapter 4: Effects of individualized bone density 
feedback and educational interventions on osteoporosis 
knowledge and self-efficacy: a 12-yr prospective study 
4.1 Introduction 
Osteoporosis is a major public health problem worldwide. The financial burden on the 
health system it causes is increasing dramatically. For instance, in Australia the total 
health expenditure for osteoporosis and osteopenia in individuals over 50 years old was 
$2.75 billion in 2012 and it is predicted that this will increase to $3.84 billion in 2022(1). 
Low bone mineral density (BMD) is a major risk factor for osteoporotic fracture(2). 
Since BMD in later life is a function of peak bone mass and the rate of subsequent bone 
loss(3), it is therefore critical to ensure preventative behaviours are taken up in younger 
populations that improve and maintain BMD, and consequently delay the onset of 
osteoporosis and reduce the risk of fracture. 
Osteoporosis knowledge and the concept of self-efficacy are two key factors involved 
in lifestyle behaviour change related to osteoporosis prevention. Self-efficacy refers to 
“people’s confidence in their ability to change osteoporotic preventive behaviours, 
specifically calcium intake and physical activity”, which is related to behaviours in 
three ways: the conviction that an individual has the ability to i) initiate the activity, ii) 
maintain the activity and iii) persist in performing the activity in the face of obstacles(4). 
Both osteoporosis knowledge and self-efficacy are suggested to be important 
determinants of calcium intake and exercise behaviours(5) . Despite this, levels of 
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osteoporosis knowledge(6,7) and self-efficacy(6,8,9) are low worldwide. Studies suggest 
that osteoporosis knowledge and self-efficacy can be improved by a variety of 
interventions, at least in the short-term (up to 2 years). We previously(7) examined the 
effect of individualised risk feedback based on bone density and group education (the 
Osteoporosis Prevention and Self-management Course (OPSMC)) on osteoporosis 
knowledge and osteoporosis self-efficacy in premenopausal women. In that study, 
women with T-score < 0 who were told they were at higher risk of fracture in later life, 
based on data showing that those in the lower half of the bone mineral density 
distribution have a threefold higher fracture risk in later life(10) had a greater increase in 
osteoporosis knowledge at 6 weeks and 2 years compared to those who were told they 
were not at higher risk (T-score≥0). Similarly, receiving the OPSMC was associated 
with a greater increase in osteoporosis knowledge compared to receiving an 
osteoporosis information leaflet. However, neither T-score group nor type of education 
received was associated with changes in osteoporosis self-efficacy over 2-years. 
For early life interventions to be effective at preventing osteoporosis in later life, their 
effects need to persist in the long-term, but there are no published studies, to our 
knowledge, assessing the very long-term effect of either risk feedback or osteoporosis 
education on osteoporosis knowledge and self-efficacy.  Therefore, the aim of this study 
was to conduct a 12-year follow-up of participants from our original trial to determine 
whether the effect of fracture risk feedback and the OPSMC on osteoporosis knowledge 
persisted, and which, if any, factors affect osteoporosis self-efficacy in the longer-term. 
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4.2 Materials and Methods 
4.2.1 Participants 
This was a 12-yr follow-up of a randomized controlled trial previously conducted in 
2000 in Southern Tasmania, Australia, the methods of which have already been 
described in detail(7). We randomly selected women aged 25-44 years, from the 2000 
electoral roll, excluding women if they had previous measurement of bone density, 
thyroid disease, renal failure, malignancy, or rheumatoid arthritis, a history of 
hysterectomy or were taking hormone replacement therapy, pregnant or planning 
pregnancy within 2 years of study entry, or lactating. Ethics approval was obtained 
from Royal Hobart Hospital Ethics Committee and all participants gave written 
informed consent. 
4.2.2 Interventions assignment 
A computer-generated random number list was used to randomly assign participants 
to one of two osteoporotic education groups: an information leaflet from Osteoporosis 
Australia “Understanding Osteoporosis” or the Osteoporosis Prevention and Self-
management course (OPSMC).  The OPSMC is a chronic disease self-management 
course developed by the Arthritis Foundation of Victoria and utilized by Osteoporosis 
Australia. This small-group patient education program aimed to increase knowledge, 
improve confidence and awareness and self-management of osteoporosis prevention 
with an emphasis on promoting appropriate lifestyle changes. OPSMC sessions of 2 
hours were held weekly for 4 weeks with a maximum of 16 participants per group. 
Four trained educators from Arthritis Tasmania performed this using the same 
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materials. The osteoporosis information leaflet provided a comprehensive description 
of osteoporosis and discussed the role of lifestyle factors including diet, exercise and 
smoking, and optimal levels of calcium intake and exercise(11).   
BMD at the spine and hip was measured (Hologic QDR2000, Waltham, MA) at 
baseline. Participants with a mean spine and hip T-score<0 received a letter informing 
them that their results indicated that they were at higher risk of fractures in the future 
and encouraging them to discuss the results and treatment options with their general 
practitioner, whereas those with a mean T-score≥0 were informed that they were not 
at a higher risk.  The cut-off of a T-score of 0 was chosen   based on data showing that 
those in the lower half of the BMD distribution have threefold higher fracture risk 
both in later life and in the early postmenopausal period(10). Data specific to a younger 
population was not available but as evidence suggests that bone mass tracks 
throughout life as has been recorded in children(12), young(13), middle-aged and aged 
population(14), premenopausal women who are in the lower BMD range are likely to 
still have lower BMD during postmenopausal period.   
Participants randomized to the leaflet information group received their feedback of 
fracture risk with the leaflet by mail, and those in OPSMC group received the 
feedback at the first session of the course.  
4.2.3 Measurements 
Osteoporosis knowledge was measured at baseline, 6 weeks, 2 years, and 12 years 
using the Osteoporosis Knowledge Assessment Tool (OKAT) which has previously 
been validated with demonstrated good discriminatory power (Ferguson’s sigma = 
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0.96) and Cronbach’s alpha =0.70(15).  The OKAT has 20 questions with true, false, 
and don’t know options for each. Scoring was 1 for a correct answer or 0 otherwise. 
The possible range of total scores was 0 to 20.   
The osteoporosis self-efficacy scale (OSES)(4) was used to measure osteoporosis self-
efficacy at baseline, 1 year, 2 years, and 12 years. The OSES has two subscales with 6 
items each for calcium intake and physical activity. We used a four point adjectival 
scale with ratings of: not at all confident (score 1), mildly confident (score 2), 
confident (score 3) and very confident (score 4). The possible range of total scores 
was 12 to 48. 
Other study factors measured at baseline included height by stadiometer (The 
Leicester height measure, Invicta Plastics Ltd, Oadby, England) and weight by a 
single set of calibrated scales (Heine, Dover NH USA). Body mass index was 
calculated [weight (kg)/height2 (m2)]. Smoking history, breastfeeding history, number 
of children, family history of osteoporosis and/or fracture, and fracture history in the 
subject, education level, employment status of main financial provider in the 
household, and marital status were measured by questionnaire. Calcium intake and 
calcium supplement use were assessed by a validated short food frequency 
questionnaire(16). The calcium content of food categories was determined by 
Australian food composition tables(17). Participants who reported taking a supplement 
containing calcium alone or as a main ingredient at least 4 times per week were 
classified as taking calcium supplements. Physical activity was assessed by a 
questionnaire validated in American adolescents(18), which we modified for 
Tasmanian conditions and had used previously in women of this age(19). This asked 
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participants how many days in the last 14 they performed at least 20 minutes of 
strenuous exercise and light exercise in five categories (1 = 0 days, 2 = 1-2 days, 3 = 
3-5 days, 4 = 6-8 days, 5 = 9 or more days). 
4.2.4 Statistical analysis 
Differences in baseline characteristics between participants who did and did not 
complete follow-up were tested by unpaired two-sample t-test, the Kruskal-Wallis 
test, or chi-squared test as appropriate. Linear mixed-effect models were used to test: 
a. the effects of feedback of high fracture risk and of the OPSMC on change in 
knowledge and self-efficacy from baseline to 12 years; b. the within group change in 
knowledge and self-efficacy from baseline to 12 years for each T-score group (T-
score<0 ≥0) and educational intervention (leaflet and OPSMC). Linear regression was 
used to determine the predictors of changes in knowledge and self-efficacy scores 
from baseline to 12 years by using complete cases. To handle missing data, complete 
cases were weighted by the inverse of their estimated probability of being 
observed(20). All analyses were performed in Stata version 12 (Stata Corporation, 
Texas, USA). A two-tailed p value <0.05 was considered statistically significant. 
4.3 Results 
A total of 470 women (a 64% response rate) aged 25 to 44 years were recruited at 
baseline with 74% (347) included at year 12. Three women withdrew before bone 
density and baseline assessments were performed. Baseline characteristics of the 
remaining 467 women who did and did not complete the follow-up are presented in   
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Table 4.1. Participants who were lost to follow-up were younger, had a lower level of 
education, and were more likely to be current smokers or to have ever smoked and 
less likely to be married or in a de facto relationship (a non-married couple living 
together on a genuine domestic basis) than those completing follow-up. However, the 
proportions of participants receiving each intervention and other characteristics were 
comparable. The comparison of baseline characteristics of each intervention group 
has been previously published(7) and the 248 participants receiving the information 
leaflet had lower baseline levels of knowledge than the 219 who received the OPSMC 
in spite of randomization (8.4 for both T-score≥0 and leaflet group and T-score<0 and 
leaflet group, 9.4 and 9.1 for T-score≥0 and OPSMC group and T-score<0 and 
OPSMC group, respectively). Other characteristics were comparable between groups. 
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Table 4.1: Comparison of baseline characteristics, osteoporosis knowledge and 
self-efficacy of participants who did and did not complete the study 
 
Figure 4.1 gives the changes in osteoporosis knowledge over the 12-yr follow-up by 
(a) T-score group and (b) education group. Overall, knowledge at 12 years was higher 
than at baseline in all groups (10.5±3.3 vs. 8.8±3.4 for T-score<0 group; 10.2±3.2 vs. 
8.9±3.2 for Tscore≥0 group; 10.9±3.1 vs. 9.3±3.4 for the OPSMC group; 9.8±3.3 vs. 
8.4±3.2 for leaflet group; p<0.001 for all). As previously reported (7), compared to 
participants with T-score ≥0, participants with T-score < 0 had a significantly greater 
increase in knowledge at 6 weeks (4.0±3.4 vs. 3.4±3.3, p=0.03) and 2 years (2.8±3.2 
vs. 2.1±3.1, p=0.02). In the present study, the between-group difference did not 
 Completed study Withdrawals  
P-value Characteristic (N= 347)  
n (%) 
(N= 120)  
n (%) 
Age (yr.) (mean±SD) 38.3±5.2 36.3±5.6 <0.001 
Mean T-score <0 177 (51) 60 (50) 0.892 
Received OPSMC 160 (46) 60 (50) 0.462 
Knowledge (mean±SD) 9.0±3.3 8.4±3.2 0.107 
Self-efficacy (mean±SD) 34.5±7.1 33.8±7.0 0.334 
Height (cm) (mean±SD) 163.5±6.3 162.1±6.6 0.084 
Weight (kg) (mean±SD) 69.6±13.4 69.3±14.3 0.819 
BMI (kg/m2) (mean±SD) 26.1±4.8 26.3±4.9 0.432 
Education level   0.038 
    ≤Grade 10 104 (30) 52 (43)  
    Grade 11-12 76 (22) 22 (18)  
    >Grade 12 167 (48) 47 (39)  
Provider unemployed 21 (6) 8 (7) 0.719 
Employment status   0.473 
    0 h/wk. 45 (13) 20 (17)  
    ≤20 h/wk. 83 (24) 25 (21)  
    >20 h/wk. 219 (63) 75 (62)  
No. of children median  2  2 0.192 
Family history of osteoporosis 58 (17) 22 (18) 0.685 
Family history of fracture 129 (37) 49 (41) 0.477 
Prevalent fracture 99 (29) 36 (30) 0.759 
Current smoker 43 (12) 36 (30) <0.001 
Ever smoked 157 (45) 69 (58) 0.022 
Married or de facto 264 (76) 78 (65) 0.026 
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persist at 12 years (change in knowledge of 1.6±3.4 vs. 1.1±3.4; β=-0.4, 95%CI=-0.3 
to 1.1). There was no difference in the change between groups over time (p-value for 
group by time interaction=0.286). Similarly, participants who received the OPSMC 
had a significantly greater increase in knowledge at 6 weeks (4.4±3.4 vs. 3.1±3.2, 
p<0.001) and 2 years (2.7±3.4 vs. 2.2±2.8, p=0.048) but not at 12 years (1.4±3.5 vs. 
1.3±3.4; β=0.2, 95% CI=-0.5 to 0.9) compared to participants receiving information 
leaflet. There was no difference in the change between groups over time (p-value for 
group by time=0.534), namely, no effects of interventions on knowledge. 
 
Figure 4.1: Change in osteoporosis knowledge score by (a) T-score group and (b) 
educational intervention (The error bars are 95% confidence interval). 
Figure 4.2 shows the changes in osteoporosis self-efficacy over 12 years by T-score 
group and by education group. Osteoporosis self-efficacy at 12 years remained lower 
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than at baseline regardless of T-score group or educational intervention but the 
difference was small and only reached statistical significance in the low T-score 
group (32.9±6.9 vs. 34.0±6.9, p=0.014 for T-score<0 group; 34.5±7.8 vs. 34.7±7.3, 
p>0.05 for T-score≥0 group; 33.6±7.0 vs. 34.4±6.8, p>0.05 for the OPSMC group; 
33.8±7.7 vs. 34.3±7.3, p>0.05 for leaflet group). The differences in change in self-
efficacy between T-score groups were not significant at either 1 or 2 years as reported 
in previous study(7) (-1.4±7.1 vs. -1.4±5.9 at 1 year, -1.7±6.6 vs. -1.1±6.2 at 2 years, 
for T-score<0 and T-score≥0 groups, respectively; p>0.05 for all) or at 12 years in the 
current study (-1.3±6.8 vs. -0.4±6.4 for T-score<0 and T-score≥0 groups, 
respectively; β=-1.1, 95% CI=-2.5 to 0.4, p for group by time=0.150). Similarly, there 
were no significant differences in the decrease in self-efficacy between educational 
intervention groups at either 1 or 2 years (-1.7±6.4 vs. -1.1±6.7 at 1 year, -1.5±6.4 vs. 
-1.3±6.4 at 2 years for the OPSMC and leaflet groups, respectively; p>0.05 for all) or 
12 years (-1.1±6.1 vs. -0.6±7.1 for the OPSMC and leaflet groups, respectively; β=-
0.2, 95%CI=-1.6 to 1.3, p for group by time=0.805). 
 
Chapter 4: Effects of individualized bone density feedback and educational 
interventions on osteoporosis knowledge and self-efficacy 
Page 79 
 
Figure 4.2: Change in osteoporosis self-efficacy score by (a) T-score group and 
(b) educational intervention (The error bars are 95% confidence interval). 
The results of regression of potential factors affecting changes in knowledge and self-
efficacy over 12 years are given in Table 4.2. Compared to baseline, women in 
households with an unemployed main financial provider had a slight decrease (-0.3, 
95%CI=-1.7 to 1.1) in knowledge at 12-years compared to those in household with an 
employed main financial provider where knowledge was increased (1.4, 95% CI =1.1 
to 1.8) (β=-1.95, 95%CI=-3.40 to -0.50). No other factors had a significant effect on 
change in knowledge over 12 years. Neither intervention nor any sociodemographic 
factors were associated with 12-year change in osteoporosis self-efficacy. The results 
did not materially change when inverse probability weighting was not used 
(Supplemental Table 4-1). 
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Table 4.2: Factors affecting changes in knowledge and self-efficacy over 12 years 
with inverse probability weighting 
 Univariable β (95% CI) Multivariable  βb (95% CI) 
Knowledge   
  Ever smoked 0.41 (-0.32, 1.14) 0.55 (-0.18, 1.29) 
  No. of children 0.10 (-0.21, 0.41) -0.05 (-0.43, 0.33) 
  Employment level   
      0 h/wk Reference Reference 
      ≤20 h/wk 0.58 (-0.61, 1.77) 0.30 (-0.88, 1.49) 
      >20 h/wk -0.07 (-1.14, 1.00) -0.67 (-1.77, 0.43) 
  Provider unemployed -1.66 (-2.96, -0.35) a -1.95 (-3.40, -0.50) a 
  OPSMC 0.16 (-0.58, 0.89) 0.28 (-0.45, 1.02) 
  T-score group 0.47 (-0.26, 1.20) 0.42 (-0.33, 1.16) 
Self-efficacy   
  Ever smoked -0.10 (-1.64, 1.43) -0.02 (-1.56, 1.53) 
  No. of children -0.30 (-0.91, 0.30) -0.26 (-1.00, 0.48) 
  Employment level   
      0 h/wk Reference Reference 
      ≤20 h/wk -2.56 (-5.21, 0.09) -2.59 (-5.31, 0.13) 
      >20 h/wk -0.96 (-3.21, 1.30) -1.40 (-3.85, 1.05) 
  Provider unemployed -0.68 (-5.93, 4.56) -0.60 (-5.71, 4.50) 
  OPSMC -0.28 (-1.77, 1.21) -0.23 (-1.78, 1.32) 
  T-score group -1.07 (-2.57, 0.44) -0.90 (-2.39, 0.59) 
 aBold denotes P<0.05. 
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Supplemental Table 4-1 Factors affecting changes in knowledge and self-efficacy 




 Univariable β (95% 
CI) 
Multivariable  βb (95% 
CI) Knowledge   
  Ever smoked 0.33 (-0.40, 1.05) 0.48 (-0.26, 1.22) 
  No. of children 0.08 (-0.21, 0.37) -0.04 (-0.38, 0.30) 
  Employment level   
      0 h/wk Reference Reference 
      ≤20 h/wk 0.49 (-0.76, 1.74) 0.26 (-1.00, 1.53) 
      >20 h/wk -0.04 (-1.16, 1.07) -0.63 (-1.80, 0.55) 
  Provider 
unemployed 
-1.74 (-3.28, -0.20) a -2.04 (-3.69, -0.39) a 
  OPSMC 0.12 (-0.60, 0.85) 0.26 (-0.47, 0.99) 
  T-score group 0.54 (-0.18, 1.26) 0.44 (-0.28, 1.17) 
Self-efficacy   
  Ever smoked -0.25 (-1.67, 1.17) -0.15 (-1.62, 1.32) 
  No. of children -0.31 (-0.88, 0.27) -0.26 (-1.00, 0.48) 
  Employment level   
      0 h/wk Reference Reference 
      ≤20 h/wk -2.31 (-4.73, 0.10) -2.32 (-4.80, 0.16) 
      >20 h/wk -1.04 (-3.19, 1.11) -1.41 (-3.73, 0.91) 
  Provider 
unemployed 
0.11 (-2.89, 3.12) 0.09 (-3.15, 3.32) 
  OPSMC -0.45 (-1.86, 0.96) -0.39 (-1.83, 1.05) 
  T-score group -0.88 (-2.29, 0.53) -0.79 (-2.22, 0.64) 
 aBold denotes P<0.05. 




This 12-yr prospective population-based study is the first study (that we know of) to 
evaluate the long-term effects of any intervention for improving osteoporotic 
knowledge and/or self-efficacy in premenopausal women. While both the OPSMC 
and feedback informing women they were at higher fracture risk improved 
osteoporosis knowledge for 2-years post-intervention, these beneficial effects did not 
persist in the long-term. Nonetheless, overall knowledge increased in all intervention 
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groups over 12 years, suggesting that these increases were due to factors other than 
the interventions provided. Neither intervention improved osteoporosis self-efficacy 
at 2 or 12 years. These results suggest that more frequent osteoporosis education and 
bone density feedback may be necessary to maintain the increased short-term 
knowledge gains from these interventions, though there are no current data that allow 
an estimate of optimal frequency to be made. This requires further investigation. The 
results also suggest that alternative interventions are required to improve self-efficacy. 
Previous studies have employed a variety of educational interventions to improve 
osteoporotic knowledge, but only a few have been conducted in younger women(21,22), 
and only two have specifically investigated the OPSMC(6,8)  in addition to our 
previous 2-yr study(7). Overall, these studies have been short-term in nature (≤3 
months) and participants were not selected using random sampling(6,8,21,22), thereby 
limiting the generalizability of their results.  The two studies in younger women 
(age≤25) reported that brief education interventions could produce moderate increases 
in knowledge (up to 44%) in the short-term (≤4 weeks)(6) Studies using the OPSMC 
in older populations (average age>60, up to 3 months follow-up(8) and people aged 40 
or over (92% women) with 6 weeks follow-up(6) showed similar short-term effects of 
the OPSMC on knowledge. These are similar to the short-term increases we 
previously reported in  our younger study population(7). 
Osteoporosis knowledge decreased after 6 weeks across all groups but was still higher 
than at baseline after 2 and 12 years. While this may be due to the effects of the 
interventions, it is also possible that this reflects the natural history of osteoporosis 
knowledge acquisition with increasing age, and presumably increasing awareness of 
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the issue of osteoporosis.  Even though women in households with an unemployed 
main financial provider only accounted for 6% of our study participants, they were 
more likely to have a slight decrease in osteoporosis knowledge compared to those 
with an employed main financial provider where knowledge was increased. It may be 
that women living in such households would place less emphasis on osteoporosis due 
to financial circumstances, and/or they may have limited access to educational 
resources, healthcare providers and other societal supports that could assist them in 
acquiring and maintaining knowledge of osteoporosis(23). Future research on 
improving osteoporosis knowledge should focus on this population. 
Only two other studies have evaluated the short-term (up to 3 months) effects of the 
OPSMC on self-efficacy(6,8) other than our previous 2-yr study, but these two studies 
are not directly comparable with ours because they had a shorter duration of follow-
up (maximum of 3 months) and included older participants (mean age>63). 
Nonetheless, as in our previous 2-yr study(7) and in our current data, these two studies 
reported no significant change in self-efficacy from the  OPSMC (4% for both 
studies) as compared to the no intervention (1%)(6) or one session course control 
group (3≤%)(8). Thus it seems that the OPSMC may not be an effective approach for 
changing osteoporosis self-efficacy in either younger or older women. Information on 
the effect of fracture risk feedback on osteoporosis knowledge is limited. One study 
reported no significantly higher increase in osteoporosis knowledge after 4 months in 
peri- or post-menopausal women (mean age=54) who received immediate verbal 
information from the consultant regarding BMD results, diagnosis and implications 
compared to those who received a standardized letter regarding the results only from 
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their general practitioner (13% vs. 28%)(24). This may be due to no educational 
intervention being provided. 
As we observed in our study at 2 years follow-up(7), changes in osteoporosis self-
efficacy over12-year were independent of whether participants had received feedback 
of high fracture risk. We also observed that the negative associations of both 1-year 
and 2-year changes in osteoporosis self-efficacy with number of children and hours of 
employment were no longer significant. This short-lived relationship might be a result 
of the lengthy study period as employment status might have changed and the impact 
of the number of children on daily routines is likely to change as children grow up 
and become independent. 
Our study has several important strengths. The educational intervention component of 
the study was a robustly designed randomized controlled trial. In addition, our study 
was population-based with randomized sampling to ensure a low selection bias and so 
a high generalizability. The large sample size allowed us to have a very long-term 
follow-up with sufficient statistical power for these analyses. Furthermore, the 12 
years follow-up made our study unique as no other relevant studies have been 
conducted for such a long period. 
A limitation of the study is that follow–up was incomplete, with 26% of participants 
lost to follow-up over 12 years.  However, the proportions of participants receiving 
the OPSMC and low T-score feedback were comparable between those who did and 
did not complete the study suggesting that the risk of bias from loss to follow up is 
low and unlikely to have affected study findings. This is supported by data from 
analyses using linear mixed model and inverse probability weighting to adjust for 
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missing data, as the results did not vary from those without using inverse probability 
weighting. 
The OPSMC was modelled upon a chronic disease self-management course for 
arthritis effective in symptomatic populations(25,26), which are likely to be different 
from the healthy, asymptomatic participants in the current study. However, a recent 
study indicated that the OPSMC intervention led to a significant increase in 
osteoporosis knowledge but not osteoporosis self-efficacy for calcium or exercise in 
adults aged ≥ 50 having sustained an acute bone fracture due to minimal trauma(8). 
This suggests the OPSMC is effective for improving knowledge but not self-efficacy 
in both symptomatic and healthy populations. A more specific education session 
focusing on improving self-efficacy may be useful, and it should be designed based 
on the four main sources that form and affect self-efficacy: personal accomplishment, 
verbal persuasion, vicarious experience, and physiological or affective states(8). 
In conclusion, in this population-based randomized controlled trial in healthy women 
aged 25-44, both the OPSMC and high fracture risk feedback increased osteoporosis 
knowledge over 2 but not 12 years. Women in households with unemployed main 
financial providers were more likely to have decreased knowledge in a long-term, 
suggesting that this population should be a focus of future research. Neither 
intervention improved osteoporosis self-efficacy, either at 2-years or 12-years. 
Therefore, more frequent osteoporosis education and bone density feedback is 
necessary to maintain knowledge and new interventions may be required to improve 
self-efficacy. 
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Chapter 5: The effect of feedback of fracture risk and 
educational interventions on osteoporotic preventative 
behaviours and bone mineral density in premenopausal 
women 
5.1 Introduction 
 Fractures are a major public health problem and can result in lower quality of life(1), 
disability and increased mortality rates(2). Low bone mineral density (BMD) is a 
major contributor to fracture risk(3). BMD in later life depends on the amount of bone 
gained in early life (peak bone mass) and the rate of subsequent bone loss(4). There is 
significant age-related bone loss in premenopausal women(5) and premenopausal low 
bone mass is as important as fast rate of bone loss for the risk of fracture in later 
life(6). Therefore, long-term maintenance or even improvement (for women whose 
peak bone mass is still accruing) in BMD in younger women is critical to preventing 
fractures in later life, and strategies to address this need to be identified. 
Cigarette smoking(7), low levels of physical activity(8), and inadequate calcium 
intake(9) are well-accepted modifiable risk factors for low BMD. However, as 
osteoporotic fractures predominantly occur in later life, for early life interventions 
targeting these behaviours to be effective, they must result in persistent and/or 
ongoing improvements in behaviour and bone density.  Research on how to make 
these changes is scarce in premenopausal women. One potential approach is to use 
individualised risk feedback(10), where information on fracture risk is provided 
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directly to participants.  Previous controlled trials examining the effect of providing 
feedback of BMD screening in combination with osteoporosis education(11-13) suggest 
that women informed of having low BMD and/or higher fracture risk improve 
osteoporosis preventive behaviours. Our previous 2-yr randomised controlled trial 
aimed to determine the effects of individualised BMD feedback (normal vs. high 
fracture risk defined by mean spine and hip T-score) and two different educational 
interventions (the Osteoporosis Prevention and Self-management course (OPSMC) 
vs. an osteoporosis information leaflet) on osteoporosis preventive behaviours and 
BMD in premenopausal women(11).  In addition to favourable effects on behaviour, 
there were greater increases in femoral neck BMD in women receiving feedback of 
being at high fracture risk after 2 years of follow-up.    
To our knowledge, there are no published trials with long-term follow-up (in excess 
of 2 years) of the effect of providing individualised information on fracture risk on 
behaviours likely to change fracture risk, or of BMD. Therefore, the aim of this study 
was to perform a further 10-yr follow-up of our previous 2-yr trial to examine the 
long-term effects of the feedback of fracture risk (high risk vs. normal risk) and 
educational interventions (OPSMC vs. an information leaflet) on BMD of femoral 
neck and lumbar spine as well as osteoporosis preventive behaviours. 
5.2 Methods 
5.2.1 Study population 
This was an additional 10-yr follow-up of a registered (NCT00273260) 2-yr parallel 
randomised controlled trial previously conducted in 2000 in Southern Tasmania, 
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Australia, and the methods of which have been described in detail(11). Women aged 
25-44 years were randomly selected from the 2000 Tasmanian Electoral Roll and 
recruited between April and November 2000. As previously reported the population 
of southern Tasmania was predominantly Caucasian(11).  Women were excluded if 
they had previous measurement of bone density, thyroid disease, renal failure, 
malignancy, or rheumatoid arthritis, a history of hysterectomy or were taking 
hormone replacement therapies, were pregnant or planning pregnancy within 2 years 
of study entry, or were lactating. Ethics approval was obtained from Royal Hobart 
Hospital Ethics Committee and all participants gave written informed consent. 
5.2.2 Intervention 
Osteoporosis education 
At baseline, 470 women were randomised 1:1 to receive one of two osteoporosis 
educational interventions: the OPSMC (OPSMC group, n=219) or an information 
leaflet (leaflet group, n=251). An independent statistician generated a list of random 
numbers as previously described (11).  Each participant was given a participant number 
on recruitment. While there was no allocation concealment, allocation was 
implemented sequentially for each participant number with no variations to the order 
in which the numbers were assigned. Randomisation was also performed prior to 
BMD results being known, so allocation could not be influenced by BMD status. The 
OPSMC is a chronic disease self-management course developed by the Arthritis 
Foundation of Victoria and utilized by Osteoporosis Australia. It aims to increase 
knowledge, improve confidence and awareness and self-management of osteoporosis 
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prevention with an emphasis on promoting appropriate lifestyle changes. OPSMC 
sessions of 2 hours were held weekly for 4 weeks with a maximum of 16 participants 
per group. The osteoporosis information leaflet, from Osteoporosis Australia 
“Understanding Osteoporosis”, provided a comprehensive description of osteoporosis 
and a discussion of the role of lifestyle factors including diet, exercise and smoking, 
and optimal levels of calcium intake and exercise(12). 
Feedback of fracture risk 
Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry 
(DXA, Hologic QDR2000 densitometer, Waltham, MA) which was calibrated daily 
with coefficient of variation (CV) 1%. Measures were taken at the spine and hip at 
baseline, 2 years and 12 years by operators blinded to intervention status. At baseline, 
those with a mean spine and hip T-score <0 were informed that they were at a higher 
risk of fracture in later life (high risk group, n=232) whereas those with a mean T-
score of 0 or greater were informed that they were not at higher risk (normal risk 
group, n=238). This was based on the observation that those in the lower half of the 
BMD distribution have threefold higher fracture risk both in later life and in the early 
postmenopausal period(14). Although this cut-off is based on older women, it has been 
proposed that bone mass tracks throughout life as has been recorded in children(15), 
young(16), middle-aged, and aged populations(17), so that premenopausal women who 
are in the lower BMD range would still be expected to have lower BMD in the 
postmenopausal period. Participants in the leaflet information group received written 
feedback of fracture risk with their leaflet by mail, and those in OPSMC group 
received written feedback at the first session of the course. The comparison for the 
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fracture risk feedback component of the intervention is between women informed 
they were at higher risk (T-score <0) vs those who were not (T-score ≥ 0).   
5.2.3 Outcomes 
Primary outcomes for the 12-year follow-up were BMD at the femoral neck and 
lumbar spine; and calcium intake and calcium supplement use, and physical activity. 
These were measured yearly for first 2 years and again at 12 years as described 
below.  Secondary outcomes were use of vitamin D supplements and smoking status. 
Calcium intake was assessed by a short food frequency questionnaire (FFQ), which 
has been validated against 4 day weighed records and correlates well for estimated 
calcium intake (r=0.79, p=0.001)(18). The calcium content of food categories was 
determined by the same Australian food composition tables(19) at each time point. This 
FFQ also assessed calcium supplement use. Participants were classified as taking 
calcium supplements if they reported taking a supplement containing calcium alone or 
as a main ingredient, and at a frequency of ≥ 4 times weekly. 
Physical activity was assessed by a questionnaire validated in American 
adolescents(20), which we modified for Tasmanian conditions and had used previously 
in women of this age (21). This questionnaire, asked how many days in the last 14 the 
participants reported performing at least 20 minutes of strenuous exercise and light 
exercise, measured in five categories (1 = 0 days, 2 = 1-2 days, 3 = 3-5 days, 4 = 6-8 
days, 5 = 9 or more days).  
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Smoking status was assessed by questionnaire at baseline, 2 and 12 years. Participants 
were asked whether they were regular smokers, defined as smoking at least 7 
cigarettes, cigars or pipes every week for at least 3 months. 
Changes in osteoporosis preventive behaviours were determined by the status of 
behaviours at 2 and 12 years. Specifically, participants who smoked at 2 years but had 
quit smoking at 12 years were classified as ceased smoking, those who did not smoke 
at either 2 or 12 years as never smoking, those who did not smoke at 2 years but were 
smoking at 12 years as commenced smoking, and as persistent smoking otherwise. A 
similar classification was used for change in use of calcium supplements. Depending 
on the difference between 2 and 12 years, change in calcium intake was categorized 
as increased (higher at 12 years) or decreased (lower at 12 years) and change in 
physical activity was classified as unchanged, increased and decreased. 
Use of vitamin D supplements was assessed at 12 years.  Participants were asked to 
recall if they had regularly used vitamin D supplement at each year during the last 12 
years. Regular use was defined as taking supplements at least 5 times per week for 
more than 9 months of the year. Participants were categorised into 2 groups: recent 
use if using vitamin D supplements for the preceding 2 consecutive years and no 
recent use otherwise. 
5.2.4 Other study factors 
Serum 25-hydroxy vitamin D (25(OH)D) level was assessed at 12 years, from venous 
blood samples, using liquid chromatography (LC)-tandem mass spectrometry (MS) 
(CV 3-6%, using an internal standard). 
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Other study factors measured at baseline, 2 years and 12 years included height by 
stadiometer (The Leicester height measure, Invicta Plastics Ltd, Oadby, England) and 
weight by a single set of calibrated scales (Heine, Dover NH USA). Body mass index 
was calculated [weight (kg)/height2 (m2)]. Breastfeeding history, number of children, 
family history of osteoporosis and/or fracture education level, employment status of 
main financial provider in the household, and marital status were assessed by 
questionnaire at baseline, 2 years and 12 years. Self-reported fractures with age at 
each fracture and menopausal status was also reported at 12 years.  Date of fracture 
was estimated from age at fracture. A women reporting at least one fracture occurring 
after the date of the baseline assessment was considered to have sustained an incident 
fracture.     
5.2.5 Statistical analysis 
The sample size was calculated for the original study, as described previously(11). All 
analyses were based on original assigned groups.  
Mean (SD) and number (%) were used to describe continuous and categorical 
variables, respectively. Linear mixed-effects modelling was used to estimate the 
effects of the feedback of fracture risk and the educational intervention on absolute 
changes in FN and LS BMD from 2 to 12 years, with adjustment for potential 
confounders. Intervention groups (educational intervention group and fracture risk 
feedback group), time (coded as a binary variable to denote follow-up number) and 
the interaction between the interventions and time (treatment effect, i.e., group by 
time in Table 5.2) were entered as fixed factors in the model. Participant identification 
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number was included as a random effect to account for the dependence of repeated 
observations. Log binomial and log multinomial regression models were used to 
estimate the relative risk (RR) of categories of behaviour change, from 2 to 12 years, 
associated with the fracture risk feedback and educational interventions. Models were 
further adjusted for age, anthropomorphic and sociodemographic factors, and 
menopausal status at the 12 year follow up. Covariates were retained in the model 
when the estimated coefficient for the intervention effect changed by more than 10%. 
To handle missing data, we assumed data were missing at random and used a 
weighted estimating equation method(22,23); we estimated the probability of an 
outcome being observed by fitting a logistic regression model using the baseline 
characteristics age, education level and smoking status, for which complete data were 
available. In subsequent analyses, complete cases were weighted by the inverse of 
their estimated probabilities of being observed. All analyses were performed in Stata 
version 12 (Stata Corporation, Texas, USA). A two-tailed p value <0.05 was 
considered statistically significant. 
5.3 Results 
Participant characteristics 
A total of 470 women (64% response rate) aged 25 to 44 years were recruited at 
baseline with 94% (n=415) retained at year 2 and 74% (n=347) at year 12 (Figure 
5.1). Baseline characteristics between women who did and did not reach 12-yr follow-
up were compared (  
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Supplemental Table 5-1). Women who completed 12-yr follow-up had similar 
characteristics to those who were lost to follow-up, other than being slightly (2 years) 
older.  
Table 5.1 shows the characteristics for participants at baseline: women in the high risk 
group were shorter and lighter and, as expected, had lower femoral neck (FN) and 
lumbar spine (LS) BMD than women in the normal risk group; there was a greater 
proportion of women who had ever smoked among those who received the 
information leaflet than among those who received the OPSMC.  Menopausal status 
at 12 years was similar across the groups as were other baseline characteristics. Serum 
25(OH)D level at 12 years was slightly higher in the high risk group than the normal 
risk group but was similar between educational intervention groups. Self-reported 
fracture numbers were similar between educational and fracture risk feedback groups. 
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Figure 5.1: Flow diagram of study population.  OPSMC=Osteoporosis 
Prevention and Self-management course. †Unable to continue due to health 
related issues, including illness, pregnancy, disability and mortality 
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Supplemental Table 5-1: Comparison of baseline characteristics of participants 
who did and did not complete the study 
Characteristic Completed study  Withdrawals P-value 
 n= 347  n= 120  
Age (yr.) 38.3 (5.2)  36.3 (5.6) <0.001 
Feedback of high fracture risk n 
(%) 
177 (51)  60 (50) 0.892 
Received OPSMC n (%) 160 (46)  60 (50) 0.462 
Height (cm) 163.5 (6.3)  162.1 (6.6) 0.084 
Weight (kg) 69.6 (13.4)  69.3 (14.3) 0.819 
Strenuous activity level (Median) 3  3 0.345 
Calcium intake (mg/d) 782.3 (401.5)  808.6 (391.2) 0.533 
Calcium supplement use n (%) 7 (2.0)  3 (2.5) 0.414 
BMD of FN (g/cm2) 0.93 (0.13)  0.93 (0.15) 0.797 
BMD of LS (g/cm2) 1.08 (0.12)  1.08 (0.12) 0.914 
All values are mean (SD) unless otherwise indicated. 
OPSMC=Osteoporosis Prevention and Self-management course. 
BMD=bone mineral density. 
Table 5.1: Characteristics of participants by fracture risk group, and by 
education intervention group 
 Fracture risk group  Educational intervention 
 High Normal  OPSMC Leaflet 
Baseline n=231 n=236  n=220 n=247 
Age (years) 37.9 (5.2) 37.6 (5.5)  37.4 (5.5) 38.1 (5.2) 
Height (cm) 162.0 (6.5) 164.2 (6.0)  162.7 (6.3) 163.5 (6.5) 
Weight (kg) 64.4 (10.3) 74.6 (14.5)  69.3 (13.6) 69.7 (13.6) 
Education level [n (%)]      
    ≤Grade 10 76 (33) 79 (34)  76 (35) 79 (32) 
    Grade 10 to 12 50 (22) 49 (21)  39 (18) 60 (24) 
    >Grade 12 105 (45) 106 (45)  104 (47) 107 (44) 
Employment status [n (%)]      
    0 h/week 32 (14) 32 (14)  27 (12) 37 (15) 
    ≤ 20 h/week 56 (24) 53 (22)  51 (23) 58 (24) 
    > 20 h/week 142 (62) 151 (64)  142 (65) 151 (61) 
Currently smoking [n (%)] 37 (16) 42 (18)  32 (15) 47 (19) 
Ever smoked [n (%)] 113 (49) 113 (48)  94 (43) 132 (54) 
Married or de facto [n (%)] 167 (72) 173 (73)  169 (77) 171 (69) 
Calcium intake (mg/d) 777 (379) 801 (418)  799 (397) 780 (401) 
Strenuous activity level (median) 3 3  3 3 
      
12-years n=171 n=176  n=160 n=187 
Menopause status [n (%)]      
    Post menopause 45 (26) 41 (23)  47 (29) 39 (21) 
    Pre-menopause 65 (38) 69 (39)  61 (38) 61 (38) 
    Status unclear 10 (6) 16 (9)  14 (9) 14 (9) 
    Currently menopausal 51 (30) 50 (29)  38 (24) 38 (24) 
Serum 25(OH)D levels (nmol/L) 65.5 (23.2) 60.9 (22.3)  64.0 (23.5) 64.0 (23.5) 
All values are Mean (SD) unless otherwise indicated. 
OPSMC = Osteoporosis Prevention and Self-management course. 
BMD = bone mineral density. 
Bold denotes statistical significant. 
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Changes in BMD and effects of interventions 
Unadjusted FN and LS BMD at each time point (stratified by fracture risk feedback 
group and educational intervention group) are shown in Supplemental Table 5-1.  
Table 5.2 shows the mean (95% CI) change in BMD between 2 and 12 years 
according to fracture risk feedback and educational intervention, along with the 
estimated effects of the interventions over time from the linear mixed model analyses. 
There were 325 women who had BMD measured at both 2 and 12 years. Both FN and 
LS BMD were lower at 12 years than at 2 years in both fracture risk feedback and 
both educational intervention groups as well as in the study sample as a whole (p< 
0.001 for all). We found evidence for a smaller reduction in FN BMD between 2 and 
12 years for women who received feedback of high fracture risk compared to those 
who received feedback of normal fracture risk, and this difference persisted after 
adjusting for potential confounders (β=0.023, 95% CI=0.005 to 0.041), but no 
evidence for a similar effect for LS BMD (β=-0.011, 95% CI=-0.027 to 0.006). We 
found no evidence for interaction between educational intervention and time 
(treatment effect) or interaction between fracture risk feedback and educational 
intervention for either FN or LS BMD. 
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Supplemental Table 5-2: Unadjusted FN and LS BMD at each time point 
(stratified by fracture risk feedback group and educational intervention group) 
 High fracture risk Normal fracture risk  
 (n=231) (n=236) 
FN BMD baseline 0.836 (0.823, 0.850) 1.018 (1.005, 1.030) 
LS BMD baseline 0.992 (0.982, 1.002) 1.169 (1.157, 1.181) 
 (n=213) (n=206) 
FN BMD 2-yr 0.859 (0.848, 0.870) 1.033 (1.019, 1.046) 
LS BMD 2-yr 0.994 (0.983, 1.004) 1.172 (1.158, 1.185) 
 (n=171) (n=176) 
FN BMD 12-yr 0.736 (0.723, 0.749) 0.889 (0.873, 0.905) 
LS BMD 12-yr 0.936 (0.920, 0.953) 1.130 (1.111, 1.149) 
   
 OPSMC Leaflet 
 (n=220) (n=247) 
FN BMD baseline 0.934 (0.915, 0.954) 0.923 (0.907, 0.938) 
LS BMD baseline 1.084 (1.066, 1.101) 1.080 (1.065, 1.094) 
 (n=197) (n=222) 
FN BMD 2-yr 0.945 (0.927, 0.964) 0.944 (0.928, 0.959) 
LS BMD 2-yr 1.079 (1.061, 1.098) 1.083 (1.067, 1.099) 
 (n=160) (n=187) 
FN BMD 12-yr 0.813 (0.795, 0.832) 0.814 (0.795, 0.832) 
LS BMD 12-yr 1.030 (1.007, 1.054) 1.038 (1.017, 1.060) 
Values are mean (95% confidence interval). 
Table 5.2: Absolute change in BMD in each intervention group and effect of 
fracture risk feedback and educational interventions on absolute change in BMD 
between 2 and 12 years 
 Mean of change a 
(95% CI)  
Unadjusted 
β (95% CI) 
Adjusted b 
β (95% CI) 
  Group by time Group by time 
Femoral neck (g/cm2)    
  Normal risk (n=162)d -0.145 (-0.159, -0.132) reference reference 
  High risk (n=163)c -0.123 (-0.134, -0.112) 0.022 (0.005, 0.040) 0.023 (0.005, 0.042) 
  Leaflet (n=176)d -0.130 (-0.143, -0.118) reference reference 
  OPSMC (n=149)c -0.139 (-0.152, -0. 127) -0.009 (-0.026, 0.009) -0.011 (-0.029, 0.008) 
    
Lumbar spine (g/cm2)    
  Normal risk (n=162)d -0.041 (-0.052, -0.029) reference reference 
  High risk (n=163)c -0.055 (-0.066, -0.044) -0.011 (-0.027, 0.005) -0.011 (-0.027, 0.006) 
  Leaflet (n=176)d -0.047 (-0.058, -0.036) reference reference 
  OPSMC (n=149)c -0.048 (-0.060, -0.036) 0.001 (-0.016, 0.017) 0.002 (-0.015, 0.018) 
OPSMC=Osteoporosis Prevention and Self-management course.  
CI=confidence interval. 
Linear mixed-effects model was used to test treatment effect (group by time). 
a Unadjusted absolute change in BMD from 2 to 12 years within each subgroup. 
b Adjusted for other items in column, duration of follow-up, age at 2 years, change in weight and height between 2 
years and 12 years and menopause status at 12-year. 
c Intervention group. 
d Control group. 
Bold denotes statistical significant.




Table 5.3: The effect of fracture risk groups and educational intervention on the change in behaviours between 2 and 12 years 
 Fracture risk group RR (95% CI)  Educational intervention RR (95% CI) 
 High Normal Unadjusted Adjusted†  OPSMC Leaflet Unadjusted Adjusted† 
Smoking n=151 n=144    n=132 n=163   
  Never smoked 133 (88) 121 (84.0) 1.00 1.00  116 (88) 138 (85) 1.00 1.00 
  Cessation 12 (8) 6 (4.2) 1.91 (0.74, 4.95) 1.85 (0.70, 4.89)  12 (9) 6 (4) 2.47 (0.95, 6.40) 2.27 (0.86, 6.01) 
  Commenced or persistent  
smoking 
6 (4) 17 (11.8) 0.34 (0.14, 0.83) 0.33(0.13, 0.80)  4 (3) 19 (12) 0.26 (0.09, 0.75) 0.28 (0.10, 0.79) 
Calcium intake n=162 n=161    n=149 n=174   
   Decreased 66 (41) 72 (45) 1.00 1.00  67 (45) 71 (41) 1.00 1.00 
  Increased 96 (59) 89 (55) 0.91 (0.71, 1.17) 0.89 (0.69, 1.15)  82 (55) 103 (59) 1.10 (0.86, 1.42) 1.15 (0.89, 1.48) 
Calcium supplements n=161 n=161    n=149 n=173   
  Never supplement 79 (49) 112 (70) 1.00 1.00  87 (59) 104 (60) 1.00 1.00 
  Commenced or persistent  
supplement 
74 (46) 44 (27) 1.68 (1.24, 2.28) 1.66 (1.22, 2.24)  57 (38) 61 (35) 1.08 (0.81, 1.45) 1.12 (0.83, 1.50) 
  Cessation 8 (5) 5 (3) 1.60 (0.53, 4.79) 1.52 (0.50, 4.59)  5 (3) 8 (5) 0.73 (0.24, 2.17) 0.62 (0.21, 1.87) 
Vitamin D supplements‡ n=171 n=175    n=159 n=187   
  No recent use 122 (71) 150 (86) 1.00 1.00  119 (75) 153 (82) 1.00 1.00 
  Recent use        49 (29) 25 (14) 2.01 (1.30, 3.09) 1.99 (1.27, 3.11)  40 (25) 34 (18) 1.38 (0.92, 2.08) 1.37 (0.90, 2.09) 
Strenuous Physical 
activity 
n=162 n=161    n=149 n=174   
  Unchanged 56 (35) 49 (30) 1.00 1.00  42 (28) 63 (36) 1.00 1.00 
  Increased 43 (26) 50 (31) 0.85 (0.61, 1.21) 0.90 (0.62, 1.31)  40 (27) 53 (31) 0.88 (0.62, 1.25) 0.87 (0.62, 1.24) 
  Decreased 63 (39) 62 (39) 1.01 (0.77, 1.33) 1.02 (0.77, 1.37)  67 (45) 58 (33) 1.35 (1.02, 1.78) 1.30 (0.99, 1.71) 
Light physical activity n=161 n=161    n=148 n=174   
  Unchanged 75 (47) 64 (40) 1.00 1.00  59 (40) 80 (46) 1.00 1.00 
  Increased 47 (29) 43 (2) 1.09 (0.77, 1.55) 1.13 (0.80, 1.59)  44 (30) 46 (26) 1.12 (0.79, 1.60) 1.07 (0.76, 1.52) 
  Decreased 39 (24) 54 (33) 0.72 (0.51, 1.02) 0.71 (0.51, 0.99)  45 (30) 48 (28) 1.10 (0.78, 1.55) 1.16 (0.84, 1.61) 
Values are n (%) unless otherwise indicated. RR, relative risk; CI, confidence interval; OPSMC=Osteoporosis Prevention and Self-management course. 
Log binomial and multinomial regression models were used as appropriate. 
†Adjusted for age at 2 years, baseline number of children, employment status, education level and marital status.  
‡ recent use if using vitamin D supplements for the preceding 2 consecutive years and no recent use otherwise. See content for the groupings of all behaviours in detail. 
Bold denotes statistical significant.
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Effects of interventions on osteoporosis preventive behaviours 
Table 5.3 gives the estimated relative risk of each category behaviour change from 2 
to 12 years between fracture risk feedback groups and between educational 
intervention groups. Compared to women with normal fracture risk, those with high 
fracture risk were more likely to have ceased smoking than never smoked (relative 
risk (RR) = 1.85, 95% CI = 0.70 to 4.89) and less likely to have commenced smoking 
or persistently smoked than never smoked (RR = 0.33, 95% CI = 0.13 to 0.80). 
Compared to those in the normal fracture risk group, women in the high fracture risk 
group were more likely to commence or keep using calcium supplements (compared 
to never using supplements; RR = 1.66, 95% CI = 1.22 to 2.24), and to report using 
vitamin D supplements for the preceding two consecutive years (RR = 1.99, 95% CI = 
1.27 to 3.11).  They were also less likely to report decreased than unchanged light 
physical activity (RR = 0.71, 95% CI = 0.51 to 0.99) than those with normal risk. The 
OPSMC group had a more favourable pattern of smoking behaviour change compared 
to the leaflet group (RR = 2.27, 95% CI = 0.86 to 6.01 for smoking cessation; RR = 
0.28, 95% CI = 0.10 to 0.79 for commenced or persistent smoking relative to never 
smoked group). No differences between educational intervention groups were 
observed for use of either calcium or vitamin D supplements or change in light 
physical activity. There were no between group differences in the probability of 
changing dietary calcium intake or strenuous physical activity. Serum 25(OH)D levels 
were higher in participants reporting vitamin D supplement use for the preceding 2 
consecutive years (mean (SD) 76.6 (23.8) vs.  59.4 (21.1) nmol/L, p < 0.001). 
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This 10-yr follow-up of a 2-yr randomised controlled trial in premenopausal women 
is, as far as we are aware, the first to evaluate the long-term effects of feedback of 
high fracture risk and group education on change in BMD and osteoporosis 
preventive behaviours. The feedback of high fracture risk was associated with a 
slower loss of FN BMD but not LS BMD, improved use of calcium and vitamin D 
supplements and a favourable effect on smoking status. The OPSMC was associated 
with improved smoking behaviour compared to a leaflet but not with additional 
benefits for BMD. These changes suggest that feedback of bone density testing results 
with an assessment of relative fracture risk could be considered in young women as a 
strategy to improve long-term bone health and prevent osteoporosis in later life. 
Furthermore, the improvements in behaviours may be beneficial for other health 
issues suggesting an approach targeting bone may have wider benefits. 
Previous studies have demonstrated the short-term (up to 2 years) benefits of the 
feedback of fracture risk or BMD results for improving osteoporosis preventive 
behaviours, for example, calcium supplement use as well as increased physical 
activity among young women(11-13,24).  In the first two years of follow-up of our 
study(11) , women receiving feedback of high fracture risk had a significantly greater 
increase in FN BMD than those in the normal risk group, and improved calcium 
supplement use and self-reported physical activity at two years. In comparison, the 
present study focused on long-term effects, showing that the short-term benefits for 
calcium supplements use and FN BMD (11) persisted after a subsequent 10 years 
follow-up, but improvements in self-reported physical activity did not.   
Chapter 5:  The effect of feedback of fracture risk and educational interventions on 
osteoporotic preventative behaviours and BMD in premenopausal women 
113 
 
In addition, the longer follow-up period enabled us to detect effects on smoking 
behaviour with the probability of women quitting smoking in the high risk being 
around double that of those in the normal risk group. Women in this group were also 
67% less likely to commence or have been persistently smoking by 12 years. These 
are substantial effects – they are greater than cessation rates achieved by print-based 
self-help interventions(25) and telephone counselling(26).  Similar effects of education 
intervention were found for changes in smoking behaviours. Such improvements have 
potential benefits for prevention of a wide range of diseases other than osteoporosis. 
Smoking is the leading preventable cause of mortality including atherosclerotic 
cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease 
(COPD) – the three major causes of smoking-related mortality(27). The fact that there 
was no effect on smoking cessation at 2 years is unsurprising, as smoking cessation 
was not a primary outcome of the 2 year study and the longer period of follow-up 
allowed for accumulation of the effect of the intervention over time, making it 
possible to detect differences in smoking behaviour at 12 years. The feedback of high 
fracture risk was also associated with use of vitamin D supplementation in the long-
term, with the probability of participants using vitamin D supplement consecutively 
for the preceding 2 years in the high risk group being double that of the normal risk 
group. The intervention was associated with a slowing of FN BMD loss equivalent to 
about 2.4% over 10 years. It has been estimated that for each 5% loss in FN BMD in 
elderly women there is a 40% and 90% increase in all fractures and hip fracture risk, 
respectively(28). Thus, slowing FN BMD loss by 2.4% is likely to be important for the 
prevention of osteoporosis and fracture in later life. 
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We observed no effect of feedback of high fracture risk on LS BMD which is 
unsurprising as there was also no such effect after 2 years(11). This could be explained 
by the possibility of site-specific responses of bone to lifestyle behaviour changes, 
such as physical activity. Such site specificity has been demonstrated for exercises in 
premenopausal women, with BMD of lumbar spine but not femoral neck, total hip or 
whole body being improved by lower and upper body resistance plus jump exercise, 
compared to lower body resistance plus jump exercise or no intervention control(29). 
Randomised controlled trials of calcium supplements in younger women have also 
shown variations in effects at different sites, though the reasons for this are unclear(30). 
Given the lack of effect of the OPSMC on either behaviour or BMD at 2 years(11), it 
was not surprising that the 10-year follow-up data also failed to find any additional 
effect of the OPSMC on change in BMD in comparison to an information leaflet 
intervention, although interestingly, it was associated with long-term smoking 
behaviour. Importantly, this effect is unlikely to be explained by any confounders, as 
women were randomised to either group at baseline. As we stated in our previous 
study(11), the OPSMC was designed similarly to a chronic disease self-management 
course for arthritis, which has been shown to have only a small effect on improving 
health status and behaviours even in symptomatic populations(31,32). However, our 
study was conducted in healthy women, who may be less motivated to change than 
those having a symptomatic condition. This lack of effect of the OPSMC for BMD 
and most behaviours is consistent with our finding that the effect of the OPSMC on 
osteoporosis knowledge was greatest at 6 weeks, persisted at a lower level at 2 
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years(33) but was no longer significant at 12 years(34).  Why the OPSMC would 
influence smoking but not other behaviours in such a population is unclear.  
This study has several potential limitations. The 64% response rate may have resulted 
in selection bias, but as previously discussed (11), although this sample had a lower 
proportion of current smokers (17%) compared to the Tasmanian prevalence of daily 
smoking (29%) in women aged 25 to 44 years in 1998, socioeconomic factors like 
educational levels and the unemployment rate in our study approximate the overall 
population figures. Therefore, while this sample may be not fully representative of the 
Tasmanian population and the generalizability of our study findings to other 
racial/ethnic populations is uncertain, they are likely to be generalisable to healthy 
Caucasian women in this age range given that the population of the region was 
predominantly Caucasian at study entry. Missing data due to drop-outs is another 
potential limitation, and women lost to follow-up were younger. However, we took 
this potential bias into account by using the combination of linear mixed-effects 
model and inverse probability weighting. The results were similar whether this 
method or analysis by using only complete case data was used, so the likelihood of 
loss to follow-up influencing our findings is low. Although feedback of fracture risk 
was not randomised, we adjusted for potential confounders to minimise the risk of 
bias. In comparison, the randomised nature of the trial of educational intervention 
provides the strongest evidence for the OPSMC effect to have caused the smoking 
behaviour change. Blinding is an inevitable issue given that participants were not able 
to be blinded to interventions; however, the measurement of BMD, the most clinically 
important outcome in our study, was measured by DXA, by an operator blinded to the 
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status of interventions. This objectively measured outcome would be unlikely to be 
biased by subjective factors. Self-reported behavioural measures could possibly be 
influenced, but the fact that objectively measured serum 25(OH)D concentrations at 
12 years were significantly and substantially higher in women who reported recent 
vitamin D supplement at 12 years supports the validity of our self-report data, as do  
previous studies validating self-reported smoking(35,36). It was considered unethical to 
perform DXA but withhold participants’ results so we are unable to compare any 
effects of fracture risk feedback with a no feedback control group. BMD changes 
form behavioural changes may not persist if the behaviour changes made do not 
persist. However, as there are no data of which we aware examining the effects of 
reversing 10 years of beneficial behaviours on BMD, it is unclear the magnitude any 
deteriorations in behaviour in the future might have. Moreover, given the 12 years of 
persistent improvement we have demonstrated, it seems unlikely in any case that a 
rapid reversal of all positive behaviours would be likely in the future. Finally, 
fractures were not included as a primary or secondary outcome. The sample size for 
the original two-year RCT was based on BMD and osteoporosis preventive behaviour 
endpoints rather than fracture because of the very short-term follow-up and younger 
age of study participants and the power of long-term study to assess fracture 
endpoints was also limited. 
Conclusions 
In conclusion, feedback of high fracture risk was associated with long-term benefits 
for improving calcium and vitamin D supplement use and possibly smoking 
behaviour, as well as slowing loss of FN but not LS BMD in premenopausal women. 
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The OPSMC was associated with improved smoking behaviour but not a slower 
decrease in BMD of either FN or LS. Bone density feedback with an assessment of 
fracture risk could be considered in young women as a strategy to improve long-term 
bone health and prevent osteoporosis in later life. Furthermore, its resulting 
improvements in behaviours may be beneficial for other health issues beyond bone 
suggesting an approach targeting bone may have wider benefits. However, the cost-
effectiveness of implementing a population-based osteoporosis prevention strategy 
based on DXA screening requires assessment.  
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Chapter 6: Cut-points for associations between vitamin 
D status and multiple musculoskeletal outcomes in middle-
aged women 
6.1 Introduction 
Bone mineral density (BMD)(1,2) starts to decline in the premenopausal period and 
premenopausal low bone mass is as important as fast rate of bone loss for the risk of 
fracture in later life(3). Equally important, impaired balance and mobility increases 
risk of falls(4), another important contributor to fracture risk, with 4-39% of falls in 
people older than 65 years accounted for by gait/balance disorders(5). Importantly, 
balance begins attenuating after 45-55 years of age(6,7), particularly in women(8). 
Moreover, muscle weakness is an important contributor to decreased balance and 
functional limitations in older people(9,10). Similarly, muscle mass and strength may 
also have an accelerating decline in middle-aged women(11), and the reason for this is 
multifactorial, such decreased androgen concentrations, reduced physical activity 
level, deficient nutrients, chronic inflammation, and insulin resistance(12). Therefore, it 
is critical to maintain or even improve BMD, muscle strength and balance in middle-
aged people in the effort to reduce the risk of functional limitations, falls and fractures 
in older age. 
The important role of vitamin D in bone and mineral homeostasis is well-established. 
Studies also suggest that vitamin D status is associated with muscle weakness(13-15), 
balance(15) and falls(16). However, there is controversy concerning the optimal level of 
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serum 25-hydroxyvitamin D (25(OH)D) for musculoskeletal health, particularly in 
younger people. The level of serum 25(OH)D which maximally suppresses serum 
PTH has been most commonly used to define the optimal 25(OH)D level, but these 
estimates have a wide range from 25 to 122 nmol/L(17,18). While PTH is associated 
with increased bone loss, this approach does have limitations. Levels of PTH fluctuate 
widely, varying with diet, physical activity, time of day(19) and season(20). Also, 
studies have shown a high prevalence of functional hypoparathyroidism in the elderly, 
i.e., the absence of secondary hyperparathyroidism in the presence of hypovitaminosis 
D(21,22), which also makes the use of PTH problematic. Furthermore, a recent study in 
older adults suggested that thresholds for serum 25(OH)D may differ by different 
outcomes (e.g., grip strength, falls, physical performance and fractures)(23) but as far 
as we are aware, there is limited information on the optimal level of serum 25(OH)D 
concentration for musculoskeletal outcomes in middle-aged women. Most studies 
include only a single musculoskeletal outcome and none examine muscle strength and 
balance in this age group. 
Therefore, the main objectives of this cross-sectional analysis were to: a) determine 
whether there are identifiable cut-points of serum 25(OH)D for associations between 
serum 25(OH)D and multiple musculoskeletal outcomes in middle-aged women; and 
if so, b) whether below those identified cut-points greater 25(OH)D concentrations 
have beneficial associations with those outcomes and if above them no such 
beneficial associations exist. 
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6.2 Materials and Methods 
6.2.1 Study sample 
Participants were from a 10-years additional follow-up of 2-year randomized 
controlled trial conducted in 2000 in Southern Tasmania, Australia, details of which 
have been reported elsewhere(24). At baseline, women aged 25-44 years were 
randomly selected from the 2000 Tasmanian Electoral Roll. Women were excluded if 
they had previous measurement of bone density; had medical conditions affecting 
BMD (thyroid disease, renal failure, malignancy, or rheumatoid arthritis); a history of 
hysterectomy or were taking hormone replacement therapies; or who were pregnant, 
planning pregnancy within 2 years of study entry, or lactating. At baseline, 470 
women were randomly assigned to one of two osteoporosis educational interventions: 
group education using the Osteoporosis Prevention and Self-management course 
(OPSMC) or an information leaflet. Participants had their BMD measured at the spine 
and hip at baseline, 2 years and 12.  At baseline, those with a mean spine and hip T-
score <0 were informed that they were at a higher risk in later life whereas those with 
a mean T-score of 0 or greater were informed that they were not at higher risk. The 
present study is a cross-sectional analysis of the 344 women retained in the study and 
who had serum 25(OH)D levels measured (mean age of 50.0 years, 36.2 to 56.8 years 
of age) at 12 years. Ethics approval was obtained from the Tasmania Health and 
Medical Human Research Ethics Committee and all participants gave written 
informed consent. 
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Serum 25(OH)D levels 
Venous blood samples were taken with no requirement for fasting or time. Serum 
25(OH)D was assayed by liquid chromatography tandem mass spectrometry (LC-
MS/MS). The assay measures 25(OH)D2 and 25(OH)D3 separately with a CV 3-6%, 
using an internal standard. 
BMD 
BMD was measured at the lumbar spine (LS) and femoral neck (FN) by dual-energy 
X-ray absorptiometry (DXA) using fan beam setting on an in-house Hologic Delphi 
bone densitometer (Hologic QDR2000, Waltham, MA), calibrated daily with 
coefficient of variation (CV) 1%.  
Balance measurements 
Balance was assessed using 4 clinical balance tests - the timed up and go test (TUG), 
the step test (ST), the functional reach test (FRT) and the lateral reach test (LRT). All 
have been validated in older women and have normative values determined in women 
of the age in our study(25). 
The TUG requires participants to sit in a normal armchair (45 cm high) with their back 
against the chair. They were timed when standing up, walking a distance of 3 m, 
turning around, walking back and sitting down with back against chair again. The 
average time of two trials was used for analysis. The test is reliable (intraclass 
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correlation coefficient (ICC) = 0.99 for both interrater and retest reliability)(25) and is 
strongly associated with falls risk in older adults (26). 
The ST measures speed of performing a dynamic standing task. Participants stood on 
one leg 5 cm from an 8.5-cm-high block positioned against a wall and placed the whole 
foot of the other leg onto the block and then returned it to the floor repeatedly as fast as 
possible for 15 seconds. The number of steps was recorded. Both sides were tested, and 
the mean number of steps for each side was calculated for analysis. The ST has a high 
reliability (ICCs > 0.90 in healthy older people)(27). 
The FRT measures ability to reach forward with each arm from a bilateral stance 
position(28). Participants stood with feet a comfortable distance apart behind a line 
perpendicular and adjacent to a wall. The arm closest to the wall was raised to shoulder 
height and the position of the knuckle of the middle finger measured (28). Keeping the 
feet flat they leaned forward as far as possible and the position of the knuckle was 
recorded at the point of furthest reach. FRT was the difference between the two 
measures. The mean score of three trials for each side was calculated for analysis. This 
test has a high interrater reliability (ICC = 0.98)(28). 
The LRT measures ability to reach to the side in bilateral stance(29). Participants stood 
with their backs near but not touching a wall with the heels 10 cm apart. Participants 
raised both arms to shoulder height and maintained equal weight bearing while the 
position of the third finger’s tip on the side being measured was marked on the wall. 
Participants then lowered the arm not being measured and reach sideways as far as 
possible with the arm being measured. The position of furthest reach was marked and 
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the difference between the two marks calculated. The mean of the three trials on each 
side was calculated for analysis. LRT has a high retest reliability (ICC > 0.94) in healthy 
older women(29).  
Lower limb muscle strength (LMS) 
LMS was measured to the nearest kilogram using a dynamometer (TTM Muscular 
Meter, Tokyo, Japan) (30). This test examines isometric strength, predominantly of the 
quadriceps and hip extensors. The examiner demonstrated the correct technique to the 
participant before testing. Participants stood on the back of the dynamometer platform, 
with back straight against a wall and knees flexed to an angle of 115°. They held a bar, 
connected to the dynamometer by a chain, and lifted the bar using maximum force using 
their legs, with the back and neck straight. Two readings were made, and the mean 
calculated for analysis. The intraclass correlation coefficient for LMS was 0.94 
(95%CI, 0.93, 0.95) in this study. 
Dietary intake 
Usual food intake was estimated using a food frequency questionnaire (Anti-Cancer 
Council of Victoria), which has been validated against 7-day food diaries with energy-
adjusted correlation coefficients for nutrient intakes ranging from 0.28 for vitamin A to 
0.78 for carbohydrate(31). Intakes of calcium, energy, fat, protein, carbohydrate, 
cholesterol, iron, magnesium, phosphorus, sodium, vitamin C, vitamin E, and zinc were 
calculated using NUTTAB 2010. The content of calcium in various food categories was 
determined by Australian food composition tables(32). Participants were also asked to 
recall if they had regularly used calcium and vitamin D supplements during the last 
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year, where regular use means taking supplements at least 5 times per week for more 
than 9 months of the year. 
Physical activity 
We measured physical activity using a validated questionnaire(33), which was modified 
for Tasmanian conditions and used previously in women of this age, where physical 
activity was related to bone mass of the femoral neck (34). This questionnaire assessed 
strenuous and light physical activity levels by asking participants how many days in the 
last 2 weeks they reported performing at least 20 minutes of strenuous exercise and 
light exercise, represented by five categories (1 = 0 days, 2 = 1-2 days, 3 = 3-5 days, 4 
= 6-8 days, 5 = 9 or more days). 
Anthropometry and other factors 
Height was measured by stadiometer (The Leicester height measure, Invicta Plastics 
Ltd, Oadby, England), weight by a single set of calibrated scales (Heine, Dover NH 
USA) and body mass index (BMI) (calculated weight (kg)/height (m)2). Questionnaire 
assessment was made of smoking history (current/former/never), breastfeeding history, 
number of children, family history of osteoporosis and/or fracture, and fracture history 
in the subject, education level, employment status of main financial provider in the 
household, menopausal status, and marital status. 
6.2.3 Statistical analysis 
To adjust for the seasonal variation of 25(OH)D, deseasonalized vitamin D levels 
were calculated by regressing the measured 25(OH)D level on the sinusoidal function: 
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sin(2π[day of year drawn/365]) + cos(2π[day of year drawn/365]), and then adding 
the residuals to the average estimated 25(OH)D concentration to create a 
deseasonalized vitamin D level for each individual.  
Participants’ characteristics were presented using mean (SD) or number (%) as 
appropriate. Difference in characteristics between women with deseasonalized 
25(OH)D level below and above 50 nmol/L were tested using Student’s t-test or 
Kruskal-Wallis or Chi-square test as appropriate. Residuals of all outcomes predicted 
from regression models were approximately normally distributed, so no 
transformation was made. 
To adjust for potential confounders, adjusted values were generated for each outcome 
by regressing each measured outcome on its specific confounding factors, and then 
adding the residuals to the mean of each measured outcome. Adjusted values for 
deseasonalized 25(OH)D levels were also generated in the same way using the same 
outcome specific covariates. The raw data and adjusted values were used for 
unadjusted and adjusted analyses, respectively. Both locally weighted (LOWESS) 
regression plots and nonlinear least-squares estimation were used to determine 
unadjusted and adjusted cut-points for associations of 25(OH)D with LS BMD, FN 
BMD, LMS, TUG, FRT, LRT and ST (Table 2). Segmented regression using adjusted 
values was further utilized to determine associations (beta coefficients) for 
participants with 25(OH)D below and above the identified adjusted cut-points (Table 
3).  All analyses were performed in Stata version 12 (Stata Corporation, Texas, USA). 
A two-tailed p value <0.05 was considered statistically significant. 
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Baseline characteristics of participants who did and did not complete the 12 year 
follow-up have been previously reported(35). Briefly, women lost to follow-up (26%) 
were younger, had lower levels of educational attainment, and were more likely to be 
current smokers or to have ever smoked, and less likely to be married or in a de facto 
relationship compared to those who were retained, but other anthropometric and 
demographic factors were comparable. Table 6.1 gives comparisons of characteristics 
of participants with deseasonalized 25(OH)D levels below and above 50 nmol/L. In 
comparison to women with deasonalised 25(OH)D <50  nmol/L, women with 
25(OH)D of 50 nmol/L or more were less likely to be current smokers, had lower 
weight and BMI, higher strenuous physical activity level and proportion of vitamin D 
and calcium supplement use, but had lower lumbar spine (LS) BMD. The prevalence 
of low deseasonalized 25(OH)D was 6% (<30 nmol/L) and 28% (<50 nmol/L). 
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Table 6.1: Characteristics of participants (n=344) 
 Total Deseasonalized 25(OH)D 
(nmol/L)† 
Characteristic n=344 <50 (n=98) ≥50 (n=246) 
Age (yr.) 50.0 (5.1) 49.4 (4.8)  50.2 (5.2) 
Height (cm) 164.0 (6.2) 164.3 (6.1) 163.9 (6.2) 
Weight (kg) 73.7 (15.8) 78.8 (17.9) 71.7 (14.4)** 
Body mass index (kg/m2) 27.4 (5.8) 29.2 (6.5) 26.7 (5.3)** 
Currently smoking n (%) 26 (7) 11 (11) 14 (6)* 
Strenuous activity level 3.0 (1.4) 2.5 (1.4) 3.2 (1.3)** 
Deseasonalized 25(OH)D (nmol/L)† 63.1 (22.1) 37.5 (8.6) 73.3 (17.0)** 
Serum 25(OH)D level (nmol/L) 63.1 (22.8) 37.0 (10.5) 73.5 (17.4)** 
Vitamin D supplement use n (%) 126 (36) 18 (18) 107 (44)** 
Calcium supplement use n (%) 123 (35) 19 (20) 103 (42)** 
Dietary calcium intake (mg/d) 1184 (494) 1215 (500) 1171 (493) 
Menopausal status n (%)    
    Post-menopause 86 (25) 22 (23) 63 (26) 
    Pre-menopause 134 (39) 47 (48) 84 (34) 
    Peri-menopause 102 (29) 20 (20) 82 (33) 
    Status unclear 26 (7) 9 (9) 17 (7) 
Timed up and go test (seconds) 5.3 (0.7) 5.4 (0.7) 5.3 (0.7) 
Step test (steps) 18.6 (4.7) 18.0 (2.4) 18.5 (2.7) 
Functional reach test (cm) 41.2 (6.3) 41.1 (6.6) 41.3 (6.2) 
Lateral reach test (cm) 18.7 (3.9) 19.1 (3.7) 18.6 (4.0) 
Lower limbs muscle strength (kg) 75.8 (25.5) 74.9 (26.7) 76.1 (25.1) 
Femoral neck BMD (g/cm2) 0.814 (0.125) 0.825 (0.142) 0.809 (0.117) 
Lumbar spine BMD (g/cm2) 1.035 (0.151) 1.064 (0.162) 1.023 (0.145)* 
†adjusted for season, see text for details. 
25(OH)D, 25-hydroxyvitamin D; BMD, areal bone mineral density; 
Values are Mean (SD) unless otherwise stated; 
*p<0.05, **p<0.001 compared to deseasonalized 25(OH)D <50 nmol/L group. 
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Unadjusted and adjusted LOWESS scatter plots showing exploratory views of non-
linear associations of serum 25(OH)D with multiple musculoskeletal outcomes are 
given in Figure 6.1 and Figure 6.2, respectively, with cut-points from nonlinear least 
squares estimation indicated by vertical lines. 
Table 6.2 gives the adjusted and unadjusted cut-points with their 95% confidence 
intervals. Cut-points were similar and statistically significant for most outcomes in 
adjusted and unadjusted analyses, except for LRT (33 (1-64) nmol/L unadjusted and 
42 (-8, 93) nmol/L adjusted, respectively). 
Table 6.2: Unadjusted and adjusted cut-points for associations between 
deseasonalized serum 25(OH)D level and multiple musculoskeletal outcomes 
 Cut-points of 25(OH)D (nmol/L) 
 Unadjusted Adjusted 
Femoral neck BMD (g/cm2) 32 (19, 45) 31 (18, 43) † 
Lumbar spine BMD (g/cm2) 35 (17, 54) 31 (17, 45) † 
Timed up and go test (seconds) 34 (28, 40) 30 (24, 36) ‡ 
Step test (steps) 36 (29, 43) 33 (24, 41) ‡ 
Functional reach test (cm) 27 (16, 38) 31 (18, 43) ‡ 
Lateral reach test (cm) 33 (1, 64) 42 (-8, 93) ‡ 
Lower limb muscle strength (kg) 31 (19, 44) 29 (8, 49) ‡ 
Bold denotes statistical significance, p<0.05, 25(OH)D, 25-hydroxyvitamin D; BMD, areal bone mineral density; 
†Adjusted outcomes and deseasonalized 25(OH)D level were used, adjusted for weight, height, menopausal status, 
strenuous physical activity, dietary calcium intake and currently smoking status. 
‡Adjusted outcomes and deseasonalized 25(OH)D level were used, adjusted for age, weight, height, educational 
level, strenuous physical activity and currently smoking status. 
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Figure 6.1: Unadjusted scatter plots and Locally weighted regression smoothing 
(LOWESS) curves for exploratory views of associations of serum 25(OH)D levels 
with multiple musculoskeletal outcomes, vertical lines indicate identified 
unadjusted cut-points (see Table 6.2) (raw data used). 
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Figure 6.2: Adjusted scatter plots and locally weighted regression smoothing 
(LOWESS) curves for exploratory views of associations of serum 25(OH)D levels 
with multiple musculoskeletal outcomes, vertical lines indicate identified 
adjusted cut-points (see Table 2) (adjusted values for deseasonalized 25(OH)D 
level and outcomes used, see text for details). 
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Adjusted analyses for associations between 25(OH)D level and outcomes in 
participants with 25(OH)D level above and below the adjusted cut-points are given in 
Table 6.3. Below the cut-points, greater 25(OH)D levels were associated with 
increased FN and LS BMD (equivalent to an average improvement of 1% per nmol/L 
increase in 25(OH)D concentrations at each site) as well as improved TUG, ST FRT 
and LMS (equivalent to 1.8, 0.9, 1.1 and 4.3% improvements per nmol/L increase in 
25(OH)D respectively).  Above the cut-points, there were no beneficial associations 
and the only statistically significant association was a deleterious one, being a small 
increase in TUG.
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Table 6.3: Associations between serum 25(OH)D level and multiple musculoskeletal outcomes# below and above adjusted cut-points of 
25(OH)D level 
 Cut-points  Below cut-point  Above cut-point 
  n β (95% CI) n β (95% CI) 
Femoral neck BMD (g/cm2)† 31 10 0.008 (-0.001, 0.017) 333 0.0002 (-0.0003, 0.0008) 
Lumbar spine BMD (g/cm2)† 31 11 0.010 (0.001, 0.018) 332 -0.0005 (-0.0012, 0.0002) 
Timed up and go test (seconds)‡ 30 9 -0.10 (-0.16, -0.04) 330 0.004 (0.001, 0.007) 
Step test (steps)‡ 33 22 0.16 (0.02, 0.31) 317 -0.01 (-0.02, 0.003) 
Functional reach test (cm)‡ 31 10 0.44 (-0.21, 1.09) 329 -0.01 (-0.04, 0.02) 
Lower limb muscle strength (kg)‡ 29 5 2.64 (0.74, 4.55) 334 -0.04 (-0.17, 0.09) 
Bold denotes statistically significant association within subgroup, p<0.05, 25(OH)D, 25-hydroxyvitamin D; BMD, areal bone mineral density 
#Lateral reach test was not tested as there was not a significant adjusted cut-points (see table 2). 
†Adjusted outcomes and deseasonalized 25(OH)D level were used, adjusted for weight, height, menopausal status, strenuous physical activity, dietary calcium intake and currently smoking 
status. 
‡Adjusted outcomes and deseasonalized 25(OH)D level were used, adjusted for age, weight, height, educational level, strenuous physical activity and currently smoking status.
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To our knowledge, this is the first study to assess the optimal level of serum 25(OH)D 
for musculoskeletal health using multiple clinically important endpoints and the first 
examining associations with LMS and balance in a population-based sample of middle-
aged women. Cut-points for associations between serum 25(OH)D level and the 
majority of outcomes were identified ranging from 29 to 33 nmol/L. Below these, 
greater 25(OH)D level is associated with increased FN and LS BMD, LMS and better 
performance on balance tests (an average improvement of 0.9% to 4.3% per nmol/L 
increase in 25(OH)D concentrations), while above them no beneficial associations were 
observed, suggesting these are minimum levels required for optimal musculoskeletal 
health. 
Previous estimates of the optimal serum 25(OH)D level have been inconsistent 
probably due to methodological differences, for example differences in endpoints, 
study design and population, statistical methods and serum 25(OH)D assay methods. 
Accordingly, the choice of optimal 25(OH)D level for skeletal health remains 
controversial, with a range from 50 to 100 nmol/L supported by some but not all 
experts, though there is agreement that a level of less than 50 nmol/L is suboptimal for 
skeletal health(36). The cut-points we identified should not be interpreted as values at 
which a sharp transition in slopes occurs, but rather a region of transition between 
strong and weak association as seen in the figures and as indicated by the wide 95% 
confidence intervals (CI) of the cut-points. The lower 95% CIs were less than 25 
nmol/L for all outcomes and the upper 95% CIs ranging from 36 to 49 nmol/L. 
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Therefore, even though the cut-points of 29 to 33 nmol/L we identified are somewhat 
lower for most outcomes than the currently accepted cut-off of 50 nmol/L, this higher 
level may still be warranted for optimal musculoskeletal health.   
The 1% greater BMD per 1 nmol/L higher serum 25(OH)D is a large effect size. In 
elderly women, it has been estimated that for each 5% loss in FN BMD there is a 40% 
and 90% increase in all fractures and hip fracture risk, respectively(37). This may also 
apply in younger populations because BMD tracks throughout lifetime(38,39), i.e., 
people with lower BMD during midlife remain on a trajectory for having lower BMD 
than others into old age. If raising serum 25(OH)D in deficient women by 5 nmol/L 
could increase BMD by 5%, this would be a major and clinically important effect but 
ideally a randomised controlled trial is required to confirm whether this can be 
obtained. Such a trial of correcting vitamin D deficiency in middle-aged women with 
bone density outcomes should be a high research priority, though this would have to 
be carefully designed to avoid ethical issues with implementation.   
The associations between 25(OH)D and other outcomes may also be clinically 
relevant.  For example, in the case of muscle strength, A 25-yr prospective study of 
initially healthy middle-aged men (45-68 years old) showed that compared to those in 
the highest tertile of baseline grip strength, those in the lowest and middle tertiles 
were at greater risk of developing functional limitations and disabilities in old age 
(ORs ranging from 1.07 to 2.80)(40). Similar long-term data in women are lacking.  
Interpreting effect sizes of balance tests is challenging in our setting because of a lack 
of studies. However, balance tests have been shown to accurately predict falls risk in 
older adults(26,28). In addition, Zhu et al. showed that TUG test was a risk factor for 
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incident nonvertebral fracture in elderly women (hazard ratio = 1.54 (95% CI: 1.15-
2.07) for <10.2 vs. >10.2 seconds), independent of BMD and other risk factors(41).  
However, it should be noted that direct evidence that deficits in balance in middle-age 
have effects in older adult life is lacking. Given the lengthy period of follow-up 
required to assess such associations, this is likely to remain problematic.  
Previous studies in this age group are limited. A previous large cross-sectional study 
by Bischoff-Ferrari et al. did not identify a cut-point for the relationship between 
serum 25(OH)D levels and hip BMD (42). Higher serum 25(OH)D levels were 
associated with greater BMD in the hip throughout a reference range of 22.5 to 94 
nmol/L, though most benefit was seen with a 25(OH)D level below ~50 nmol/L in 
younger women (aged 20 to 49 years) (42). This is broadly consistent with our 
findings, though in our study there was an identifiable cut-point of 31 nmol/L and 
benefit of greater 25(OH)D concentrations on FN and LS BMD only existed in those 
with 25(OH)D level below this. One potential explanation for the discrepancy is the 
relatively higher calcium intake of 1186 mg/day in our study compared to 881 mg/d 
in the study by Bischoff-Ferrari et al.(42). In elderly women with low calcium intake (< 
800 mg/day) a higher serum 25(OH)D concentration (up to 120 nmol/L) is needed to 
keep PTH within the normal range(43). Also, compared to the nonlinear least-squares 
estimation utilized in our study, the LOWESS used by Bischoff-Ferrari et al.(42) is an 
exploratory approach, which does not allow for an accurate determination of the cut-
point. 
In addition to the effect of vitamin D on calcium homeostasis and BMD, its protective 
effect on fractures may be mediated by improving lower-extremity function, thus 
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reducing falls risk(44). Significant cut-points were identified for associations between 
serum 25(OH)D, LMS and most balance tests in our study, ranging from 29 to 33 
nmol/L. Similar results were reported in a cross-sectional study in US older adults 
(aged ≥60 years), indicating that lower-extremity function (i.e. sit-to-stand test and 8-
foot walk test) increased continuously with greater serum 25(OH)D level throughout a 
reference range from 22.5 to 94 nmol/L, with most of the improvement occurred in 
25(OH)D level below around 40 nmol/L(44).  This is important because balance begins 
attenuating in midlife(6,7), and it has been suggested that the prevention of functional 
limitations in older age should begin in midlife(8).  Thus the potential for correcting 
vitamin D deficiency and maintaining ongoing adequate levels to improve muscle 
strength and balance in middle-aged women also appears worthy of exploration by 
carefully and ethically designed randomised controlled trials. 
Surprisingly, there was an association with poor performance on TUG above the cut-
point of 30 nmol/L, though the effect size was small. The reasons for this are unclear. 
One potential explanation is that high 25(OH)D levels may be detrimental for lower 
extremity function - a similar study in older adults found that participants at the 
highest 25(OH)D concentrations (>120 nmol/L) had impaired performance on sit-to-
stand test(44). Similarly, a RCT of an annual dose of 500000 IU of vitamin D3 in 
women aged over 70 years resulted in increased rates of falls and fractures in the 
vitamin D group, with a greater decline in muscle strength being observed in those 
with the greatest fluctuations in serum 25(OH)D levels(45); however, the mechanism 
for getting very high serum 25(OH)D levels in these two studies might be different, 
supplement of a single bolus versus sunlight. 
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Our study has several limitations. One is the cross-sectional design, which means that 
causal associations between vitamin D and BMD, muscle strength and balance cannot 
be demonstrated. RCTs have shown that vitamin D supplementation improved serum 
25(OH)D concentrations and decreased serum PTH levels in premenopausal 
women(46-48) but longitudinal and RCT data in younger women are otherwise lacking. 
As mentioned, well-designed RCTs are needed to directly confirm a causal 
relationship and determine the magnitude of any effect of improving vitamin D levels 
in women with sub-optimal levels(49-51). The prevalence of low serum 25(OH)D was 
relatively low so there were relatively few women with 25(OH)D below the identified 
cut-points. This lowered the precision of estimating cut-points and associations below 
those cut-points, particularly for the LMS. Although the original study(24) had a 
population-based design, the participants were exposed to an osteoporosis behavioural 
intervention and there was a dropout rate of 26% by the end of final follow-up. There 
were some differences in sociodemographic characteristics and smoking behaviour 
between women retained in the study and those lost to follow-up but the wide spread 
of education levels at baseline and employment rate at 12 years approximates the 
overall population figures for these socioeconomic factors and adjustment for 
potential confounders was performed so our findings are still likely to apply to 
healthy middle-aged women from a range of sociodemographic backgrounds. 
In conclusion, in these middle-aged Australian women cut-points for associations 
between serum 25(OH)D level and the majority of outcomes were observed, below 
which greater 25(OH)D level is associated with increased BMD and LMS as well as 
better performance on balance tests, while above which, there are no such associations. 
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A level of 25(OH)D of at least 29 to 33 nmol/L appears required for optimal 
musculoskeletal health in this population, but the current cut-off of 50 nmol/L may be 
warranted. Longitudinal studies are required to further confirm these findings and 
randomized controlled trials are necessary to accurately assess the effects of correcting 
vitamin D deficiency on musculoskeletal health in this age group. 
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Chapter 7: Moderate-to-vigorous physical activity but not sedentary 
time is associated with musculoskeletal health outcomes in a cohort of Australian 
middle-aged women 
7.1 Introduction 
Bone mineral density (BMD), muscle strength and balance are all important aspects 
of musculoskeletal health. Low BMD is a major risk factor for fractures(1) and age-
related loss of muscle strength is associated with decreased balance and functional 
limitations in older people(2,3). Consequently, impaired balance and mobility increases 
risk of falls(4), conferring a high risk of fractures(5). Declines in muscle mass, 
strength(6), BMD and bone strength(7,8) and balance start around 45-55 years of 
age(9,10), suggesting that prevention of functional limitation in older age should begin 
in early midlife(11), and in order to do so, ways to prevent age-related decline in BMD, 
muscle strength and balance need to be identified.  
The amount of physical activity recommended for adults aged 18-64 years is 150 to 
300 minutes of moderate-intensity aerobic physical activity or 75 to 150 minutes of 
vigorous-intensity aerobic physical activity weekly, or an equivalent combination(12). 
However, few people achieve this, with one in five adults being physically inactive 
worldwide(13). It is uncertain whether these recommendations are appropriate for 
musculoskeletal health in younger adults as few studies have collected data on both 
duration and intensity of physical activity using objective measures in younger adults, 
and their results are inconclusive(14-16). Time spent in sedentary and sedentary 
behaviours is negatively associated with musculoskeletal health outcomes in older 
adults(17-19), but their effects in younger adults remain uncertain. It is also unclear 
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whether sedentary time and MVPA exert independent effects on musculoskeletal 
outcomes. The relative impact of sedentary behaviour compared to physical activity 
on musculoskeletal outcomes is important information for developing physical 
activity interventions and public health guidelines for musculoskeletal health. 
Therefore, the aims of this study were to (1) describe associations of objectively-
measured total physical activity, time spent at different intensities of physical activity 
and sedentary time with BMD, lower limb muscle strength (LMS) and balance 
measures in middle-aged women, and (2) examine whether any associations with 
MVPA are independent of sedentary time, and vice versa. 
7.2 Materials and Methods 
7.2.1 Participants 
Participants were from a 10-yr follow-up of a previously reported two-year 
randomized controlled trial conducted in 2000 in Southern Tasmania, Australia. 
Details of the original trial have been reported elsewhere(20). Briefly, women aged 25-
44 years were randomly selected from the 2000 Tasmanian Electoral Roll. Women 
were excluded if they had previous measurement of BMD, thyroid disease, renal 
failure, malignancy, or rheumatoid arthritis, a history of hysterectomy, were taking 
hormone replacement therapies, pregnant or planning pregnancy within two years of 
study entry, or lactating. At baseline, 470 women were randomly assigned to one of 
two osteoporosis educational interventions: group education using the Osteoporosis 
Prevention and Self-management course (OPSMC) or an information leaflet. 
Participants had their BMD measured at the spine and hip at baseline, two years and 
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12. At baseline, those with a mean spine and hip T-score < 0 were informed that they 
were at a higher risk in later life whereas those with a mean T-score of zero or greater 
were informed that they were not at higher risk. The present study is a cross-sectional 
analysis of data obtained an additional 10-years after the original two-year trial was 
completed, comprising 347 women (aged 36-57 years). Participants were included in 
this analysis if they had at least one of the outcome measures performed and had at 
least five valid days of physical activity recorded (see below). Ethics approval was 
obtained from the Royal Hobart Hospital Ethics Committee, and all participants gave 
written informed consent. 
7.2.2 Measurements 
Measurement of physical activity and sedentary time 
Accelerometers (ActiGraph GTlM) were used to measure ambulatory physical 
activity for seven consecutive days. Accelerometer counts were recorded in 60-second 
epochs. Participants were included in the analysis if they wore the accelerometer for 
at least 10 hours per day for five days in the week. Participants recorded start and 
finish times each day in a diary, as well as the duration and reason for any time where 
they took the accelerometer off and circumstances potentially affecting accelerometer 
readings (i.e. driving on uneven ground). Total physical activity was expressed as 
total accelerometer counts divided by total monitoring time per day (counts/minutes 
of wear time, CPM). A cut-off of < 150 CPM was used to define time spent 
sedentary(21,22). Cut-offs for light physical activity and MVPA were 151-1748 and ≥ 
1749 CPM, respectively(23). Total sedentary time and time spent in light physical 
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activity and MVPA was divided by the number of valid days of accelerometer wear to 
produce an average time spent per day at each intensity. 
BMD 
BMD was measured at the lumbar spine (LS) and femoral neck (FN) by dual-energy 
X-ray absorptiometry (DXA) using fan beam setting on a Hologic Delphi bone 
densitometer (Hologic QDR2000, Waltham, MA), calibrated daily with coefficient of 
variation (CV) 1%.  
Lower limb muscle strength (LMS) 
LMS was measured to the nearest kilogram using a dynamometer (TTM Muscular 
Meter, Tokyo, Japan)(24). This examines isometric strength, predominantly of the 
quadriceps and hip extensors. The examiner demonstrated the correct technique to the 
participant before testing. Participants stood on the back of the dynamometer platform, 
with back straight against a wall and knees flexed to an angle of 115°. They lifted a bar 
connected to the dynamometer by a chain using maximum force using their legs, with 
the back and neck straight. The mean of two readings was calculated for analysis. The 
intraclass correlation coefficient for LMS was 0.94 (95%CI, 0.92, 0.95) in this study 
(from two-way random-effects model(25)). 
Balance measurements 
Balance was assessed using 4 clinical balance tests - the timed up and go test (TUG), 
the step test (ST), the functional reach test (FRT) and the lateral reach test (LRT), 
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with details described elsewhere previously(26). For each test, an average value of all 
measures taken was calculated for use in analyses. 
For the TUG participants sat in a normal armchair (45 cm high) with their back 
against the chair. The length of time required to stand up, walk a distance of 3 m, turn 
around, walk back and sit down again with their back against the chair was recorded. 
Two measures were performed. 
For the ST, participants stood on one leg 5 cm from an 8.5-cm-high block positioned 
against a wall and placed the whole foot of the other leg onto the block and returned it 
to the floor repeatedly as fast as possible for 15 seconds, with the number of steps 
recorded. Both legs were tested. 
For the FRT, participants stood with their feet behind a line perpendicular and 
adjacent to a wall. The arm closest to the wall was raised to shoulder height and the 
position of the knuckle of the middle finger marked. Keeping the feet flat, participants 
leaned forward as far as possible and the position of the knuckle was recorded at the 
point of furthest reach. FRT was the difference between the two measures. Each side 
was measured three times. 
For the LRT, participants stood with their backs near but not touching a wall with the 
heels 10 cm apart. Participants raised both arms to shoulder height and maintained 
equal weight bearing while the position of the third finger’s tip on the side being 
measured was marked on the wall. Participants then lowered the arm not being 
measured and reached sideways as far as possible with the arm being measured and 
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the position of furthest reach marked. The difference between the two marks was 
calculated. Each side was measured three times. 
Serum 25(OH)D levels 
Venous blood samples were taken. Serum 25-hydroxy vitamin D (25(OH)D) level 
was assayed using liquid chromatography (LC)-tandem mass spectrometry ((LC-
MS/MS). The assay measures 25(OH)D2 and 25(OH)D3 separately with a CV 3-6%, 
using an internal standard.  
Dietary intake 
We estimated habitual dietary intake by using a food frequency questionnaire (Anti-
Cancer Council of Victoria), which has been validated against 7-day food diaries with 
energy-adjusted correlation coefficients for nutrient intakes ranging from 0.28 for 
vitamin A to 0.78 for carbohydrate (22). Intakes of calcium, energy, fat, protein, 
carbohydrate, cholesterol, iron, magnesium, phosphorus, sodium, vitamin C, vitamin 
E, and zinc were calculated using Nutrient tables for use in Australia (NUTTAB) 
2010.  
Anthropometry and other factors 
Height was measured by stadiometer (The Leicester height measure, Invicta Plastics 
Ltd, Oadby, England), weight by a single set of calibrated scales (Heine, Dover NH 
USA).  Body mass index (BMI) was calculated (weight (kg)/height (m)2). Other items 
were assessed using questionnaires:  education level, employment status of main 
financial provider in the household, smoking history (current/former/never), marital 
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status, number of children, breastfeeding history, menopausal status, personal history 
of fracture (all types including high trauma), and family history of osteoporosis and/or 
fracture. 
7.2.3 Statistical analysis 
Mean (SD) and median (interquartile range) were used to describe continuous 
variables as appropriate. Number (%) was used to describe categorical variables. 
Univariable and multivariable linear regression models were used to describe 
associations between total physical activity (counts per minute of wear time (CPM)), 
time spent sedentary (minutes/day) and in light physical activity (minutes/day) and in 
MVPA (minutes/day) with each of the outcomes, adjusting for potential confounders. 
To explore independent associations between sedentary time and time spent in light 
physical activity and MVPA with each outcome, we further adjusted for MVPA time 
when sedentary time was the main exposure of interest and vice versa. When light 
physical activity time was the exposure of interest, we adjusted for MVPA time but 
not sedentary time due to substantial collinearity between sedentary time and time 
spent in light physical activity, as indicated in other literature(27). 
Sensitivity analyses were performed by fitting models using different cut-points taken 
from the literature in younger adults for different physical activity intensities(21,28-30). 
These were: sedentary time (< 250 CPM); light physical activity (150-1951, 150-2191 
CPM when 150 CPM was used for sedentary time, 250-1748, 250-1951, 250-2191 
CPM when 250 was used for sedentary time) and MVPA (> 1951 or 2191 CPM as 
appropriate according to the cut-point for light physical activity). 
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All analyses were performed in Stata version 12 (Stata Corporation, Texas, USA). 
7.3 Results 
Of the 347 women, 37 had fewer than five valid days of accelerometer results and one 
did not have any outcome measured, thus 309 women were included in this analysis. 
Characteristics of participants are shown in Table 7.1. The mean of total physical 
activity was 376 CPM. The median for total accelerometer wear time, sedentary time, 
and time spent in MVPA were 851, 535 and 37 minutes/day, respectively (Table 7.1). 
Table 7.1: Characteristics of participants (n=309) 
Characteristic Mean (SD)a 
Age (yr.) 50 (5) 
Height (cm) 164.2 (6.1) 
Weight (kg) 73.1 (15.3) 
Body mass index (kg/m2) 27.1 (5.5) 
Serum 25(OH)D level (nmol/L) 63.7 (23.2) 
Dietary calcium intake (mg/d) 1184.7 (492.0) 
Menopausal status, n (%)  
    Pre-menopause 118 (37.9) 
    Peri-menopause 89 (28.8) 
    Post-menopause 82 (26.5) 
    Status unclear 21 (6.8) 
History of fracture, n (%) 125 (40.5) 
Currently smoking, n (%) 22 (7) 
Timed up and go test (seconds) 5.292 (0.696) 
Step test (steps) 18.37 (2.52) 
Functional reach test (cm) 41.38 (6.20) 
Lateral reach test (cm) 18.66 (3.88) 
Lower limbs muscle strength (kg) 75.42 (25.27) 
Femoral neck BMD (g/cm2) 0.810 (0.124) 
Lumbar spine BMD (g/cm2) 1.029 (0.150) 
Total physical activity (counts/min) 376 (151) 
Time (minutes) (median, IQR)  
    Total accelerometer wearing  851(810-893) 
    Spent sedentary 535 (474-596) 
    Spent in light physical activity 267 (229-309) 
    Spent in MVPA 37 (25-58) 
aMean (SD) unless otherwise stated. 
25(OH)D, 25-hydroxyvitamin D; BMD, bone mineral density; MVPA, moderate-to-vigorous physical 
activity; IQR, interquartile range. 
Sedentary, < 150 counts/min (CPM); light physical activity, 150-1749 CPM; MVPA, ≥1749 CPM. 
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After adjustment for confounders (Table 7.2), total physical activity (per 100-CPM) 
was positively associated with FN BMD (β = 0.011 g/cm2, 95% confidence interval 
(CI): 0.003, 0.019) and LMS (β = 2.13 kg, 95% CI: 0.21, 4.06), while negatively but 
beneficially associated with TUG (β = -0.080 seconds, 95% CI: -0.129, -0.030). These 
effects equate to approximately 1.4%, 2.8%, and 1.5% difference from the average 
values of the study sample for FN BMD, LMS, and TUG, respectively. The direction 
of effect was also positive for the ST (β = 0.18 steps, 95% CI: -0.01, 0.36). There 
were no associations between total physical activity and LS BMD, FRT and LRT. 
Table 7.2: The association of total physical activity (counts/min of wear time, CPM) 
with BMD, lower limb muscle strength and balance (n=309) 
 Unadjusted  Adjustedb 
 βa (95% CI)  βa (95% CI) 
Femoral neck BMD (g/cm2) 0.006 (-0.003, 0.015)  0.011 (0.003, 0.019) 
Lumbar spine BMD (g/cm2) -0.002 (-0.013, 0.009)  0.004 (-0.007, 0.014) 
Lower limbs muscle strength (kg) 1.77 (-0.10, 3.63)  2.13 (0.21, 4.06) 
Timed up and go test (seconds) -0.116 (-0.166, -0.066)  -0.080 (-0.129, -0.030) 
Step test (steps) 0.27 (0.09, 0.46)  0.18 (-0.01, 0.36) 
Functional reach test (cm) 0.40 (-0.06, 0.86)  0.40 (-0.05, 0.86) 
Lateral reach test (cm) -0.07 (-0.36, 0.22)  -0.002 (-0.30, 0.30) 
BMD, bone mineral density. 
aCoefficients represent the change in the outcome for a 100-CPM change in total physical activity. 
Bold denotes statistical significance, p<0.05.   
bAdjusted for age, weight, height and menopausal status, calcium intake, serum 25-hydroxyvitamin D 
levels and history of fracture. 
After adjustment for potential confounders (Table 7.3 Model 2), MVPA (per 10-
minutes) was beneficially associated with FN BMD (β=0.0050 g/cm2, 95% CI: 
0.0007, 0.0094), LMS (β = 1.48 kg, 95% CI: 0.45, 2.52), ST (β = 0.12 steps, 95% CI: 
0.02, 0.23), and TUG (β = -0.043 seconds, 95% CI: -0.070, -0.016) (Table 7.3 Model 
2); this equates to approximately 0.6%, 2.0%, 0.7 % and 0.8% difference from the 
average values of the study sample for FN BMD, LMS, ST and TUG, respectively. 
Time spent in light physical activity was not associated with any outcome (Table 7.3). 
An increase in sedentary time of 60 minutes/day was detrimentally associated with 
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TUG (β = 0.075 seconds, 95% CI: 0.013, 0.137), equating to around a 1.4% increase 
in TUG time. There were no statistically significant associations with any other 
outcomes.  
After additionally adjusting for sedentary time, the association between MVPA and 
FN BMD was attenuated (β = 0.0041 g/cm2, 95% CI: -0.0008, 0.0090). The 
association with TUG was also attenuated but remained (β = -0.035 seconds, 95% CI: 
-0.066, -0.005). In contrast, adjusting for sedentary time strengthened associations of 
MVPA with LMS (β = 1.63 kg, 95% CI: 0.45, 2.81) and ST (β = 0.15 steps, 95% CI: 
0.04, 0.26) (Table 7.3 Model 3). The association between sedentary time and TUG 
did not persist after adjustment for MVPA (Table 7.3 Model 3). 
In sensitivity analyses, using different cut-points for physical activity intensity levels 
did not affect the results (data not shown).
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BMD, bone mineral density; MVPA, moderate-to-vigorous physical activity. 
aCoefficients represent the change in the outcome for a 60-minutes change in time spent sedentary and a 10-minutes change in time spent in light physical activity and MVPA. 
Bold denotes statistical significance, p<0.05. 
bAdjusted for age, weight, height, menopausal status, calcium intake, serum 25-hydroxyvitamin D levels, history of fracture and accelerometer wear minutes. 
cSedentary time and light physical activity were additionally adjusted for MVPA and MVPA was additionally adjusted for sedentary time.
  β (95% CI)a  
 Sedentary time Light physical activity MVPA 
Unadjusted    
    Femoral neck BMD (g/cm2) -0.0090 (-0.0186, 0.0007) 0.0009 (-0.0012, 0.0030) 0.0002 (-0.0032, 0.0067) 
    Lumbar spine BMD (g/cm2) -0.0007 (-0.0125, 0.0110) -0.0005 (-0.0031, 0.0021) -0.0018 (-0.0078, 0.0042) 
    Lower limb muscle strength (kg) 0.36 (-1.62, 2.33) 0.05 (-0.39, 0.49) 1.15 (0.15, 2.16) 
    Timed up and go test (seconds) 0.077 (0.023, 0.130) -0.010 (-0.022, 0.002) -0.059 (-0.086, -0.031) 
    Step test (steps) -0.07 (-0.26, 0.13) -0.02 (-0.06, 0.03) 0.16 (0.06, 0.26) 
    Functional reach test (cm) -0.16 (-0.65, 0.32) -0.002 (-0.11, 0.10) 0.17 (-0.07, 0.42) 
    Lateral reach test (cm) 0.27 (-0.03, 0.57) 0.01 (-0.06, 0.08) -0.02 (-0.17, 0.14) 
Adjustedb    
    Femoral neck BMD (g/cm2) -0.0090 (-0.0189, 0.0010) 0.0010 (-0.0009, 0.0028) 0.0050 (0.0007, 0.0094) 
    Lumbar spine BMD (g/cm2) -0.0005 (-0.0134, 0.0123) -0.0002 (-0.0026, 0.0022) 0.0018 (-0.0038, 0.0074) 
    Lower limb muscle strength (kg) -1.06 (-3.46, 1.34) -0.05 (-0.50, 0.40) 1.48 (0.45, 2.52) 
    Timed up and go test (seconds) 0.075 (0.013, 0.137) -0.008 (-0.020, 0.004) -0.043 (-0.070, -0.016) 
    Step test (steps) -0.02 (-0.25, 0.22) -0.02 (-0.06, 0.02) 0.12 (0.02, 0.23) 
    Functional reach test (cm) -0.17 (-0.73, 0.40) 0.003 (-0.10, 0.11) 0.18 (-0.07, 0.43) 
    Lateral reach test (cm) -0.03 (-0.39, 0.34) -0.002 (-0.07, 0.07) 0.04 (-0.12, 0.20) 
Adjustedc    
    Femoral neck BMD (g/cm2) -0.0046 (-0.0158, 0.0066) 0.0005 (-0.0013, 0.0023) 0.0041 (-0.0008, 0.0090) 
    Lumbar spine BMD (g/cm2) 0.0018 (-0.0127, 0.0164) -0.0005 (-0.0028, 0.0018) 0.0022 (-0.0042, 0.0086) 
    Lower limb muscle strength (kg) 0.71 (-1.98, 3.41) 0.0001 (-0.44, 0.44) 1.63 (0.45, 2.81) 
    Timed up and go test (seconds) 0.036 (-0.033, 0.106) -0.006 (-0.017, 0.005) -0.035 (-0.066, -0.005) 
    Step test (steps) 0.15 (-0.11, 0.41) -0.02 (-0.06, 0.02) 0.15 (0.04, 0.26) 
    Functional reach test (cm) 0.03 (-0.61, 0.66) -0.01 (-0.11, 0.09) 0.18 (-0.10, 0.46) 
    Lateral reach test (cm) 0.02 (-0.39, 0.44) 0.02 (-0.05, 0.09) 0.05 (-0.13, 0.23) 
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7.4 Discussion 
This is the first study, of which we are aware, to describe the independent associations 
between objectively-measured physical activity and time spent sedentary with 
musculoskeletal health outcomes in a population-based sample of middle-aged 
women. Each additional 100-counts/min of total physical activity was associated with 
1.4% greater FN BMD, 2.8% greater LMS, 1.0% more steps in ST and 1.5% shorter 
TUG. Intensity of physical activity was also important: MVPA was beneficially 
associated with FN BMD, LMS, TUG and ST but light physical activity and 
sedentary time were not independently associated. Effects of MVPA on LMS, TUG, 
ST but not FN BMD were independent of sedentary time, but not vice versa, 
suggesting that increasing time spent in MVPA may be more important than 
decreasing sedentary time for musculoskeletal health in middle-aged women, and 
sedentary time may not be influential when adequate MVPA is achieved. 
The effects observed are of sufficient magnitude to be clinically meaningful. For 
example, there is an average loss of 1.0% and 1.4% per year for total hip BMD in the 
late perimenopausal period (31), and in our study, a relatively modest 10-minute 
increase in MVPA was associated with  FN BMD improvement equivalent to 
approximately 0.6%. Similarly, the effect sizes for LMS (2.0%), ST (0.7%) and TUG 
(0.8%) compare favourably to annualized decline of 2.2% and 2.5% for grip strength, 
0.3% and 1.6% for balance (the standard Romberg test), and 0.19% and 0.25%% for 
gait velocity observed in women aged 50 and 60 years at baseline, respectively(32). 
Existing data on associations between objectively-measured physical activity and 
sedentary time and BMD are sparse in middle-aged women(14-16). In line with our 
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study, two small studies found that activities of higher intensity producing higher 
loading were significantly associated with broadband ultrasound attenuation at the 
heel(14) and change in BMD at the proximal femur(15) in middle-aged women. 
However, a 6-yr longitudinal study in 244 women aged 35-45 years reported that total 
physical activity was associated with change in hip BMD, but intensity was not(16), 
but only small numbers of women were classified as having moderate and vigorous 
intensity (27 and 17 participants respectively) limiting the study’s power. Chastin et 
al. reported a negative association between sedentary behaviour and total femur BMD 
in women aged 23 to 90+ years(27) but did not report specifically on effects in younger 
women. The association was independent of MVPA. Neither this study nor ours 
observed any association between sedentary time and LS BMD. Overall, the 
importance of the impact of sedentary time on bone density in middle-aged women 
remains unclear.  
Data on other musculoskeletal outcomes are sparse but generally consistent with our 
results. Willoughby et al. showed that greater MVPA was associated with greater 
peak torque of knee flexors and better postural stability, independent of time spent 
sedentary(33) but that the deleterious effects of sedentary time were not independent of 
MVPA. Together with our findings, this highlights the potential importance of 
increasing MVPA for maintaining muscle strength and balance, regardless of the 
amount of time spent sedentary. Chahal et al. found that both MVPA and light 
physical activity were associated with knee extension torque in middle-aged women 
(n = 34; mean (SD) age = 49.8 (7.5) years)(14), but as light physical activity included 
fast walking which is often considered as MVPA(34), their findings are essentially 
consistent with ours. 
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It is not surprising that the effects of physical activity on musculoskeletal outcomes, 
particularly bone density would be related to intensity. Physical activity produces dynamic 
mechanical loads that influence bones through ground reaction forces and by the contractile 
activity of muscles(35), and it is suggested that a threshold of mechanical strain magnitude 
should be reached before osteogenic stimulus is initiated(36). There is strong evidence from 
clinical controlled trials indicating that exercises including high impact loading (e.g., 
resistance training) are most beneficial for improving BMD in premenopausal women(37,38). 
Similar evidence for LMS and balance are lacking, being restricted to a pre-post intervention 
study showing that improved LMS and balance from strength training using a combination of 
maximal and explosive strength training protocols in middle-aged women(39). However, RCTs 
of different intensities of ambulatory physical activity for bone density, LMS and balance are 
lacking and are needed to compare the importance of different intensities of ambulatory 
physical activity for improving bone density, muscle strength and balance in younger women. 
Our study has some limitations. First, causality cannot be inferred due to the cross-
sectional design - we cannot exclude the possibility that those who have poorer BMD, 
muscle strength and balance are less likely to be physically active. However, 
intervention studies have shown that high-impact activity with high-magnitude 
resistance training are effective for improving BMD in premenopausal and 
postmenopausal women(37,40), suggesting that some degree of causation is likely. 
Nonetheless, RCTs of different intensities of ambulatory physical activity for bone 
density, LMS and balance are needed to confirm the causality and determine the 
optimal physical activity advice to give younger women for improving these 
musculoskeletal outcomes. Second, the cut-offs used for sedentary time, and physical 
activity intensities could influence the results; however, in sensitivity analyses using a 
range of published cut-offs the results remained largely unchanged, suggesting this is 
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not a significant issue. Finally, while our original study used population-based 
sampling(41), the generalizability of this analysis might be reduced due to the fact that 
it is a cross-sectional analysis of data from the 74% of the cohort retained after 12 
years. However, women who completed 12-yr follow-up had similar characteristics to 
those who were lost to follow-up, other than being slightly (2 years) older (see chapter 
5). Moreover, while there were some differences in smoking status and 
sociodemographic variables(42), the wide spread of education levels at baseline and 
employment rate at 12 years approximates the overall population figures for these 
socioeconomic factors and adjustment for potential confounders was performed. 
Therefore, our findings are still likely to apply to healthy middle-aged women across 
a range of sociodemographic characteristics. 
In summary, our study showed that in middle-aged women, greater total physical 
activity (CPM) was associated with better musculoskeletal health. Moderate to 
vigorous physical activity appears more important than light or sedentary activity for 
many musculoskeletal outcomes in younger women. These findings are important for 
developing interventions to improve habitual physical activity that are targeted at 
improving musculoskeletal health among women in midlife when an accelerated 
process of decline in BMD, muscle strength and balance begins. 
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Chapter 8: Lower limb muscle strength is associated 
with poor balance in middle-aged women: linear and 
nonlinear analyses 
8.1 Introduction 
Falls are a major health issue among older adults. Approximately one in three people 
aged 65 years and over fall each year(1,2), with rates increasing with advancing age(3). 
Falls result in substantial injury and mortality, accounting for 20-30% of moderate to 
severe injuries(4) and 40% of all injury-related deaths in the elderly(5).  
Adequate balance and mobility are critical in maintaining independence in activities 
of daily living.  Impaired balance and mobility increases risk of falls(6), with 4-39% of 
falls in people older than 65 years accounted for by gait/balance disorders (5). 
Importantly, balance begins attenuating after 45-55 years of age(7,8), particularly in 
women, leading to suggestions that prevention of functional limitations in older age 
should begin in early midlife(9).    
Age-related loss of muscle strength is an important contributor to decreased balance 
and functional limitations in older people(10,11) but has rarely been investigated in 
young(12) or middle-aged adults(13). Although linear associations between muscle 
strength and physical performance (e.g. walking speed and balance) have been widely 
reported, results of the few studies examining nonlinear associations in older 
people(14-16) suggest there is a potential cut-point below which muscle strength is more 
strongly associated with physical performance, and above which there is only a weak 
or no relationship. Such cut-points are potentially clinically important as they could 
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be used to identify people at higher risk of developing balance problems and falls, and 
they may suggest a level of strength that interventions should aim to produce to 
improve physical function. However, it is currently unknown if such cut-points exist 
in middle-aged women.   
Therefore, the aims of this study were to: 1) describe associations between lower limb 
muscle strength and balance measures in middle-aged women, and 2) determine 
whether there is evidence for  thresholds where the associations change.  
8.2 Materials and Methods 
8.2.1 Study sample 
The study sample for this cross-sectional analysis comprised 345 women (mean age 
of 49.9 years, 36.2 to 56.8 years of age) obtained at the end of the 10-year follow-up 
of a 2-year osteoporosis randomized controlled trial in Southern Tasmania, Australia, 
with details reported previously(17). Briefly, women aged 25-44 years were randomly 
selected from the Tasmanian Electoral Roll in 2000. Women were recruited if they 
were free of the following: previous measurement of bone density, history of thyroid 
disease, renal failure, malignancy, rheumatoid arthritis, hysterectomy, hormone 
replacement therapies, pregnancy or planning pregnancy within 2 years of study 
entry, or lactating. At baseline, 470 women were randomly assigned to one of two 
osteoporosis educational interventions: group education using the Osteoporosis 
Prevention and Self-management course (OPSMC) or an information leaflet. 
Participants had their bone mineral density measured at the spine and hip at baseline, 
2 and 12 years.  At baseline, those with a mean spine and hip T-score <0 were 
informed that they were at a higher risk in later life whereas those with a mean T-
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score of 0 or greater were informed that they were not at higher risk. Ethics approval 
was obtained from the Tasmania Health and Medical Human Research Ethics 
Committee and all participants gave written informed consent. 
8.2.2 Measurements 
Balance 
We measured 4 clinical balance tests: the timed up and go test (TUG), the step test (ST), 
the functional reach test (FRT) and the lateral reach test (LRT). These assess balance 
performance from either a static or dynamic aspect, and are able to differentiate 
between fallers and non-fallers in older adults(18). All have been validated in older 
women and have a high reliability, with normative values determined in women of the 
age in our study(18-20).  
TUG(21) is a test of dynamic steady-state balance and gait. Participants sat in an 
armchair (45 cm high) with their back against the chair, then stood without using the 
arms, walked 3 m using a comfortable and safe walking speed, turned, walked back, 
and sat down. The average time of two trials was used for analysis. 
The ST(22) measures speed of performing a dynamic stepping task. Participants stood 
5 cm from an 8.5-cm-high block positioned against a wall and placed the whole foot 
of one leg onto the block and then returned it to the floor repeatedly as fast as possible 
for 15 seconds. The number of steps was recorded. Both sides were tested, and the 
mean number of steps for each side was calculated for analysis. 
The FRT measures ability to reach forward with each arm from a bilateral stance 
position(19). Participants stood with feet a comfortable distance apart behind a line 
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perpendicular and adjacent to a wall. The arm closest to the wall was raised to shoulder 
height and the position of the knuckle of the middle finger marked(19). Participants 
leaned forward as far as possible and distance of the knuckle from the first mark is 
recorded. The mean of three trials on each side was calculated for analysis.  
The LRT measures ability to reach to the side in bilateral stance(20). Participants stood 
with their backs near but not touching a wall with the heels 10 cm apart. Participants 
raised both arms to shoulder height while the position of the third finger’s tip on the 
side being measured was marked. Participants then lowered the arm not being measured 
and reached sideways as far as possible with the arm being measured. The position of 
furthest reach was marked and the difference between the two marks calculated. The 
mean of three trials on each side was calculated for analysis. 
Lower limb muscle strength (LMS) 
LMS was measured to the nearest kilogram using a dynamometer (TTM Muscular 
Meter, Tokyo, Japan)(23) to assess isometric strength, predominantly of the quadriceps 
and hip extensors. The examiner demonstrated the correct technique to the participant 
before testing. Participants stood on the back of the dynamometer platform, with back 
straight against a wall and knees flexed to an angle of 115°. They held a bar, connected 
to the dynamometer by a chain, and lifted the bar using maximum force using their legs, 
with the back and neck straight. Two readings were made, and the mean calculated for 
analysis. The intraclass correlation coefficient for LMS was 0.94 (95%CI, 0.92, 0.95) 
in this study (from two-way random-effects model(24)). 
Other measurements 
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Strenuous and light physical activity levels were measured by a validated 
questionnaire(25), which was modified for Tasmanian conditions and has been used 
previously in women of this age(26). It asked how many days in the last 14 the 
participants reported performing at least 20 minutes of strenuous exercise and light 
exercise, measured in five categories (1 = 0 days, 2 = 1-2 days, 3 = 3-5 days, 4 = 6-8 
days, 5 = 9 or more days). Participants were also asked to recall if they had regularly 
used calcium and vitamin D supplements during the last year, where regular use means 
taking supplements at least 5 times per week for more than 9 months of the year. The 
information of prescription medication was collected by asking participants to report 
all medication, prescribed by a doctor that they had taken in the last 2 weeks. 
Anthropometric factors included height measured by a stadiometer (The Leicester 
height measure, Invicta Plastics Ltd, Oadby, England), weight by a single set of 
calibrated scales (Heine, Dover NH USA) and body mass index (BMI) (calculated as 
weight/height2 (kg/m2)). A standardised questionnaire was used to collect smoking 
history (current/former/never), family history of osteoporosis and/or fracture, and 
previous fractures (yes/no and site), education level, employment status of main 
financial provider in the household, menopausal status, and marital status. 
8.2.3 Statistical analyses 
Linear associations between LMS and TUG, ST, FRT and LRT were estimated using 
univariable and multivariable linear regression, adjusting for confounding by age, 
weight, height, education level and strenuous physical activity. Locally weighted 
regression smoothing (LOWESS) was used to assess evidence for nonlinear 
associations between LMS and balance tests. Nonlinear least-squares estimation was 
then used to estimate the cut-points where the slope changes, and segmented 
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regression to estimate the slopes (beta coefficients) for participants with LMS below 
and above the identified cut-points. To adjust for potential confounding, adjusted 
balance test measures and LMS were used in LOWESS, nonlinear least-squares 
estimation and segmented regression. Adjusted values for each balance test were 
calculated by regressing each measured balance test on its confounding factors, and 
then adding the residuals to the mean of each measured balance test. Adjusted LMS 
was calculated by the same approach. We selected potential confounders by three 
steps: Step 1: we performed univariable regression for each potential confounder, and 
only those with p<0.20 were further considered in the next step. Step 2: age, weight 
and height were included as a compulsory covariate and all other variables identified 
in step 1 were included in the initial multivariable model. Step 3: besides age, 
adjustments for other covariates were made only if including a covariate changed the 
estimated coefficient of the exposure of interest (LMS) by more than 10%. 
The goodness of fit of the regression models was evaluated, and sensitivity analyses 
performed by fitting models after excluding influential observations. All analyses 
were performed in Stata version 12 (Stata Corporation, Texas, USA). A two-tailed p 
value <0.05 was considered statistically significant. 
8.3 Results 
In the original study, a total of 470 women (64% response rate) aged 25-44 years 
were recruited at baseline. Three women withdrew after baseline assessments were 
performed but before bone density was assessed. Of the remaining 467 women, 347 
(74%) were retained at 12 years and 345 women with full data for LMS and balance 
were analysed in the present study. Baseline characteristics of participants who did 
and did not complete the follow-up have been previously reported(27). Briefly, women 
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lost to follow-up were younger, had lower levels of education, and were more likely 
to be current or past smokers, and less likely to be married or in a de facto 
relationship compared to those who were retained. Other anthropometric and 
demographic factors were comparable. 
Participants’ ages ranged from 36-57 years. Other characteristics are given in Table 
8.1. Unadjusted linear associations between LMS and balance tests are shown in 
Figure 8.1. Greater LMS was associated with faster TUG (β=-0.009, 95%CI: -0.012, -
0.006; second/kg), greater number of steps on the ST (β=0.032, 95%CI: 0.013, 0.052; 
step/kg), and further distance on the FRT (β=0.093, 95%CI: 0.068, 0.117; cm/kg) and 
LRT (β=0.036, 95%CI: 0.020, 0.052; cm/kg). These associations persisted after 
adjustment for potential confounders (Table 8.2). 
  




Figure 8.1: Scatter plots and linear regression lines for associations of lower limb 
muscle strength and balance. Beta coefficients and corresponding 95% 
confidence intervals from univariable linear regression are presented. Bold 
denotes statistically significant, p<0.001. Higher values of timed up and go test 
represent poorer performance whereas higher values of all the other tests 
represent better performance. 
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Table 8.1: Characteristics of study participants (n=345) 
Characteristic Value 
Age (years) 49.9 (5.2) 
Height (cm) 164.0 (6.1) 
Weight (kg) 73.8 (15.8) 
Body mass index (kg/m2) 27.4 (5.8) 
Strenuous activity level 3.0 (1.4) 
Calcium supplement n (%) 123 (35) 
Vitamin D supplement n (%) 126 (36) 
Use of antihypertensive n (%) 55 (16) 
Use of antidepressant n (%) 56 (16) 
Use of hypnotic n (%) 4 (1) 
Menopausal status n (%)  
    Post-menopause 86 (25) 
    Pre-menopause 134 (38) 
    Status unclear 26 (7) 
    Perimenopausal 102 (29) 
History of fracture n (%) 141 (41) 
No. of fracturesa 200 
    Upper limb n (%) 95 (48) 
    Lower limb n (%) 67 (33) 
    Others n (%) 38 (19) 
Family history n (%)  
    Osteoporosis 120 (35) 
    Fracture 241 (69) 
Timed up and go test (seconds) 5.30 (0.71) 
Step test (steps) 18.6 (4.7) 
Functional reach test (cm) 41.2 (6.3) 
Lateral reach test (cm) 18.7 (3.9) 
Lower limb muscle strength (kg) 75.6 (25.4) 
Values are Mean (SD) unless otherwise stated. 
aincluding high trauma fractures. 
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Table 8.2: Linear regression for the association of lower limb muscle strength 
(LMS) with balance 
 Lower limb muscle strength (kg) 
Balance measures β (95%CI)† β (95%CI)‡ 
Timed up and go test (seconds) -0.009 (-0.011, -0.006) -0.008 (-0.010, -0.005) 
Step test (steps) 0.027 (0.017, 0.037) 0.031 (0.011, 0.051) 
Functional reach test (cm) 0.077 (0.052, 0.101) 0.071 (0.047, 0.096) 
Lateral reach test (cm) 0.031 (0.014, 0.047) 0.028 (0.011, 0.044) 
Bold denotes statistical significance, p<0.05. 
Higher values of timed up and go test represent poorer performance whereas higher values of all the other tests 
represent better performance. 
†Adjusted for age, weight and height. 
‡Further adjusted for education level and strenuous physical activity. 
Figure 8.2, shows scatter plots with LOWESS curves for LMS and adjusted balance 
test data suggesting potentially nonlinear associations. Nonlinear least-squares 
estimation identified statistically significant cut-points for TUG [29 (95% CI: 24, 33) 
kg], ST [47 (28, 66) kg], FRT [50 (14, 85) kg] and LRT [33 (12, 54) kg] (Table 8.3). 
Associations between LMS and balance measures in women with LMS above and 
below the identified cut-points are given in Table 8.3. There were significant 
associations between LMS and all balance measures in women with LMS both below 
and above the LMS cut-points except for LRT, where the association was only 
significant in women with LMS above the cut-point. However, the magnitude of the 
effects of LMS on balance tests were consistently greater in participants with LMS 
below the cut-points compared to those above. 
Assessment of goodness of fit for the regression models revealed several potentially 
influential observations. In sensitivity analyses without the influential data points, the 
estimated associations for the linear regression models were similar to those from the 
full models (data not shown). However, the cut-points estimated in the nonlinear 
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analyses were no longer identifiable or statistically significant for all outcomes, other 
than ST (50 (95% CI: 32, 67) kg). Associations between LMS and ST were 
significant in women with LMS both below and above the LMS cut-point (0.081 
(95% CI: 0.030, 0.133) vs. 0.014 (0.002, 0.026) respectively). 
 
Figure 8.2: LOWESS scatter plots for adjusted lower limb muscle strength and 
balance tests, vertical lines indicate cut-points identified by nonlinear least-
squares estimation (adjusted values used, see statistical section for details). 
Higher values of timed up and go test represent poorer performance whereas 
higher values of all the other tests represent better performance. 
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Table 8.3: Cut-points for associations between lower limb muscle strength (LMS) and balance, and associations in participants with 
LMS below or above the identified cut-points† 
 Lower limb muscle strength (kg) 
 Cut-points  Below cut-point  Above cut-point 
Balance measures n β (95% CI) n β (95% CI) 
Timed up and go test (seconds) 29 (24, 33) 5 -0.16 (-0.21, -0.11) 338 -0.006 (-0.008, -0.003) 
Step test (steps) 47 (28, 66) 37 0.09 (0.03, 0.15) 306 0.02 (0.01, 0.03) 
Functional reach test (cm) 50 (14, 85) 42 0.15 (0.02, 0.28) 301 0.06 (0.03, 0.09) 
Lateral reach test (cm) 33 (12, 54) 10 0.20 (-0.05, 0.45) 333 0.02 (0.01, 0.04) 
Bold denotes statistical significance, p<0.05. 
Higher values of timed up and go test represent poorer performance whereas higher values of all the other tests represent better performance. 
†Adjusted lower limb muscle strength and balance measures were used (Adjusted for age, weight and height, education level and strenuous physical activity). 
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8.4 Discussion 
This is the first study to our knowledge that has investigated both linear associations 
between LMS and clinical tests of balance in middle-aged women, and the potential 
for thresholds that could identify women at higher risk of balance problems. Results 
from linear analyses provide strong evidence that even in middle-aged women, poorer 
LMS is associated with reduced balance. This supports the concept that prevention of 
falls by addressing poorer muscle strength could begin far earlier than old age, in an 
attempt to ameliorate the impacts of age-related losses in muscle strength on balance 
and ultimately falls and fracture. However, the benefits to falls and fractures may be 
only likely if the higher strength and balance are maintained. While cut-points were 
identified, the confidence intervals for these were wide other than for the TUG, and 
with balance measures other than the ST were driven by a few influential data points. 
Thus, even though identifying cut-points may be useful to assist screening middle-
aged women early to identify women at potentially higher risk of developing impaired 
balance, our study does not provide evidence to definitively identify appropriate cut-
points for this purpose. 
Few other studies have examined associations between muscle strength and balance in 
middle-aged adults [13, 28, 29]. Two are consistent with our findings. One cross-
sectional study in 1346 women aged 53 years reported that greater grip strength was 
associated with better chair rise performance and the ability to balance on one leg 
with eyes open for 5 seconds[28]. Analysis of baseline data in a pre-post study of a 
muscle strengthening intervention in 26 middle-aged women (mean age 52.8 (SD 2.4) 
years) reported that greater maximal isometric bilateral leg extension force was 
moderately associated with better performance in the test of “10-m walk time” at 
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baseline (r = -0.6), though no effects on static balance or time of standing on 1 leg or 
climbing for 10 steps were observed[29]. This may be explained by the fairly good 
physical condition and moderate muscle strength of study participants before training. 
This study also demonstrates the potential for strength training to improve balance in 
middle-aged women as the intervention improved LMS, 10-m walking time (at 
maximal or normal speed) and dynamic balance tests[29]. In contrast, one small 
cross-sectional study did not identify any associations between balance and LMS 
measures in middle-aged adults (n=32 of whom only 9 were female, mean age 56 (SD 
4) years) [13], probably due to the very small sample size[13]. This cross-sectional 
data does not allow causal inferences to be made and longitudinal data in middle-aged 
women are currently lacking. Longitudinal data in healthy middle-aged men (45-68 
years old) has shown that those in the lowest and middle tertile of baseline grip 
strength were at greater risk of developing functional limitations and disabilities than 
those in the highest tertile. This suggests that those with greater reserve of muscle 
strength in midlife can lose more strength before they reach the safety margin of 
disability[30] and with our data  provides some support for a potential strategy of 
intervening early to improve muscle strength reserves in midlife. Nevertheless, further 
prospective longitudinal studies in middle-aged women would assist with establishing 
a causal relationship between LMS and balance in this population. 
Interventions targeting LMS are likely to be exercise interventions, as these are 
effective at improving muscle strength throughout lifespan[31-33]. For example, as 
mentioned, the study of Holviala et al showed that both LMS and balance could be 
significantly improved by strength training in middle-aged women[29]. However, this 
was a pre-post design and these findings need confirmation by well-designed 
randomised controlled trials. Importantly, whether improving muscle strength and 
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balance in midlife can reduce the risk of falls in older age remains unknown.  
Potentially, long-term trials with decades of follow-up would be needed to assess this. 
Such studies will be logistically difficult to undertake, and it may be that this will 
need to be inferred from high quality longitudinal observational studies. 
Importantly, there is a rapid age-related decline in balance and muscle strength 
commencing between 45 and 55 years of age[7], suggesting potential benefits of early 
interventions targeted to improve muscle strength and balance for the prevention of 
falls and disability in older age. While we identified statistically significant cut-points 
for associations between LMS and balance tests, these had wide confidence intervals, 
and were driven by a few influential data points. Sparse data at the low end of LMS 
may be explained by the relatively younger age and good physical condition of 
participants, or alternatively by the inability of participants with the lowest LMS to 
participate in studies such as this.  Evidence for threshold values from larger studies is 
required before being considered for clinical use. 
Our study has other limitations. Causality cannot be inferred from our cross-sectional 
results. For example, physical limitations from impaired balance could adversely 
influence muscle strength, if people perform less physical activity. Thus even though 
our results are consistent with limited longitudinal observational [30], and trial data 
[29, 34], a direct causal relationship needs to be confirmed by well-designed RCTs in 
younger or middle-aged women. Generalisability of our findings may be limited by 
the original study’s inclusion and exclusion criteria, the predominantly Caucasian 
nature of the population [35] and the present study being a cross-sectional analysis of 
data from the 74% of the cohort retained 12 years after the original population-based 
study[17].  However, our previous comparison of baseline characteristics with the 
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Tasmanian population at baseline suggested that there were only minor effects of the 
potential of selection bias towards a healthy cohort [35]. Women who were lost to 
follow-up were younger, had lower levels of education, and were more likely to be 
current or past smokers, and less likely to be married or in a de facto relationship 
compared to those who were retained[27], but the wide spread of education levels at 
baseline and employment rate at 12 years approximates the overall population figures 
for these socioeconomic factors and adjustment for potential confounders was 
performed. Therefore, while this sample may be not fully representative of the 
Tasmanian population and the generalizability of our study findings to other 
racial/ethnic populations is uncertain, our findings are likely to be generalisable to 
healthy Caucasian women in this age range. 
In summary, our study shows that in middle-aged women, poorer LMS is associated 
with reduced balance, while no evidence was found for thresholds of LMS below 
which there are stronger associations with balance. A useful strategy to improve 
balance and reduce falls risk in later life may be to intervene to improve muscle 
strength in middle-age. However, this needs to be confirmed by trials with long term 
follow-up.  
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Chapter 9: Summary and future directions 
Given its substantial public health implications and the poor compliance with drug 
therapies, the prevention of osteoporosis is of great importance. Although 
osteoporosis occurs most often in postmenopausal women, the long-term maintenance 
of peak bone mass by slowing premenopausal bone loss is critical. Several strategies 
to address this were explored in this thesis. 
9.1 Summary of findings 
In Chapter 4, by performing an additional 10 years follow-up of a 2-yr osteoporosis 
education RCT, the first study was able to determine the long-term effects of the 
feedback of bone density derived relative fracture risk in combination with 
osteoporosis education on osteoporosis knowledge and self-efficacy. The 
improvements in osteoporosis knowledge from group education (the OPSMC) and 
from receiving feedback of high fracture risk previously reported at two years(1) did 
not persist 12 years from baseline. At 12 years, osteoporosis knowledge remained 
higher than baseline in all intervention groups but the change in osteoporosis over 12 
years was similar in both fracture risk groups and both education groups. There were 
no differences in changes in self-efficacy between intervention groups at either 2 
years or at 12 years. This suggests that more frequent intervention is likely to be 
needed to maintain the additional benefits of feedback of high fracture risk and group 
education on osteoporosis knowledge in the long-term and that other approaches to 
improve self-efficacy are required. A more specific education session focusing on 
improving self-efficacy may be useful, and it should be designed based on the four 
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main sources that form and affect self-efficacy: personal accomplishment, verbal 
persuasion, vicarious experience, and physiological or affective states(2). 
Chapter 5, examines the long-term effects of the above-mentioned interventions on 
more clinically important outcomes; that is, BMD and several osteoporosis preventive 
behaviours (calcium supplement, vitamin D supplement, light and moderate physical 
activity, cessation of smoking). In the only data of its kind, we demonstrated that 
feedback of high fracture risk slowed loss of FN BMD, improved the use of calcium 
and vitamin D supplements and were suggestive of a favourable effect on smoking 
status. Group education (OPSMC) improved smoking behaviour compared to a leaflet 
but did not have additional benefits for FN BMD. These findings have implications 
for osteoporosis prevention in that fracture risk feedback based on BMD could be 
considered in young women as a strategy to improve long-term bone health and 
prevent osteoporosis in later life. Importantly, the resulting improvements in 
behaviours could also be beneficial for other health issues beyond bone. The fact that 
a relatively simple behavioural intervention was able to produce such long-standing 
effects is also likely to be influential for the design of interventions for other chronic 
diseases. 
Chapters 6 and 7 report on associations between modifiable risk factors of serum 
25(OH)D levels (Chapter 6) and physical activity and time spent sedentary (Chapter 
7) on a range of outcomes relevant to musculoskeletal health, namely FN and LS 
BMD, LMS and measures of static and dynamic balance. 
Chapter 6 presents the first report estimating the optimal level of serum 25(OH)D for 
a range of musculoskeletal outcomes in middle-aged women. This is based on its 
cross-sectional associations with multiple clinically important musculoskeletal 
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endpoints, namely BMD, LMS and balance in a population-based cohort of Australian 
middle-aged women (aged 36-57 years). We identified cut-points for associations 
between serum 25(OH)D level and most outcomes (range from 29 to 33 nmol/L), 
below which greater 25(OH)D level was associated with increased BMD and LMS as 
well as better performance on balance tests, while above which, there were no such 
associations. These associations suggest that a 25(OH)D level of at least 29 to 33 
nmol/L could be required for optimal musculoskeletal health in this population. The 
current cut-off of 50 nmol/L, as recommended by the Institute of Medicine, may be 
higher than needed for some outcomes but appears warranted overall. Additionally, 
these cut-points can assist in designing dose-response intervention trials to determine 
the definitive optimal vitamin D status. 
In Chapter 7, the fourth study assessed independent associations between objectively-
measured physical activity and time spent sedentary with musculoskeletal health 
outcomes (especially BMD) in a population-based sample of middle-aged women. In 
middle-aged women, greater total physical activity (CPM) and MVPA was associated 
with better outcomes (BMD, LMS and balance) and sedentary time with poorer 
musculoskeletal health outcomes (balance). Greater time spent in MVPA contributes 
to better musculoskeletal health, independent of time spent sedentary but not vice 
versa, suggesting that increasing time spent in MVPA may be more important than 
decreasing sedentary time, for musculoskeletal health in middle-aged women. These 
findings are important for developing interventions to improve habitual physical 
activity that are targeted at improving musculoskeletal health among women in 
midlife when an accelerated process of decline in BMD, muscle strength and balance 
starts. 
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As both muscle strength and balance begin attenuating in middle age, Chapter 8 
explored both linear and nonlinear associations between LMS and balance in a 
population-based sample of middle-aged women. LMS was associated with poorer 
performance on a range of balance measures (timed up and go test, step test, 
functional reach test and lateral reach test) in middle-aged women. There are cut-
points of LMS for all balance tests (29-50 kg); however, excepting step test, cut-
points did not persist after excluding potentially influential data points. These findings 
suggest that in middle-aged women, poorer LMS is associated with reduced balance. 
Therefore, improving muscle strength in middle-age may be a useful strategy to 
improve balance and reduce falls risk in later life. Middle-aged women with low 
muscle strength may be an effective target group for future RCTs. 
In summary, the findings from this thesis underline the importance of fracture risk 
feedback based on BMD for improving osteoporosis preventive behaviours and long-
term maintenance of BMD in younger women. In addition, we have identified other 
potentially modifiable factors that could be targeted to improve musculoskeletal 
health, in middle-aged women, specifically, vitamin D status, MVPA and LMS. 
9.2 Future directions 
Future directions as suggested by this thesis are to: 
1. Examine whether the findings in this thesis are generalisable to men 
It should be noted that all these findings in Chapter 9.1 may not be 
generalisable to men, and similar studies will be needed to confirm this in 
men. This is important for developing guidelines that cover the whole 
population. 
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2. Determine whether the observed long-term effects of BMD feedback on 
osteoporosis preventive behaviours and BMD in younger women will reduce 
fracture risk in later life. 
This could provide more direct and stronger evidence for considering adding 
this intervention to the guideline as a strategy for early prevention of fractures 
in younger women. 
3. Improve the evidence base for identifying optimal levels of serum vitamin D 
for musculoskeletal health in middle-aged women by: 
a. Examining whether the identified cut-points for associations between 
serum 25(OH)D and musculoskeletal health outcomes in middle-aged 
women exist in longitudinal studies, and if so,  
b. Performing a randomised controlled trial to determine whether 
supplementation of vitamin D is more beneficial in women with 
baseline 25(OH)D level below than above the identified cut-points. 
This could be used to identify a subgroup of individuals whose 25(OH)D level 
are suboptimal for musculoskeletal health so we can better target 
supplementation to those most likely to benefit and avoid supplementation in 
those who are not vitamin D deficient. Furthermore, by accurately determining 
the magnitude of the effect of supplementation in at-risk individuals, the cost-
effectiveness of vitamin D screening and supplementation in the age group can 
be more accurately assessed. In addition, studies have been conducted mainly 
in Caucasian populations and estimates for the 25(OH)D threshold may differ 
across racial groups because of differences in the extent of vitamin D 
deficiency and the associations between 25(OH)D levels and bone health. 
Therefore, such studies in non-Caucasian populations are also needed. 
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Nonetheless, such RCTs of vitamin D supplementation would be challenging 
as there are potential ethical issues of not supplementing someone who is 
clearly vitamin D deficient. Rosen and Khosla have argued that women at very 
high risk should be excluded in a placebo-controlled trial of a new 
intervention when standard treatments are known to be effective at reducing 
fracture risk(3), and a history of a fragility fracture of the hip or spine, a very 
low BMD (T-score<-2.5), or both could be considered as the criteria of 
identifying high risk women(3). Therefore, a RCT of vitamin D 
supplementation aiming to improve BMD, muscle strength and balance might 
still be feasible in middle-aged women as most of them are not likely to have 
osteoporosis(4) or fractures of hip(5) or spine(6) and a treatment would not be 
recommended. 
4. Determine whether greater muscle strength and/or better balance in middle-
aged women is associated with reduced risks of falls and fractures in older 
age. 
Some physical performance assessments, such as timed up and go test, have 
been demonstrated to be highly predictive of fracture risk even after 
accounting for the effects of low BMD and other clinical risk factors for 
fracture in older women(7). However, it remains unknown whether these 
feasible inexpensive performance assessments if performed in younger women 
could also improve the value of BMD in terms of prediction of fracture risk in 
older age. This will provide important evidence to support suggestions that 
prevention of functional limitations, falls and fractures in older age via 
improving muscle strength and balance should begin in midlife. 
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5. Determine whether interventions to improve LMS could help maintain balance 
in middle-aged women. 
This could provide stronger evidence to support important role of muscle 
strength for maintaining balance in middle-aged women. If this could be 
confirmed, improving muscle strength should be considered in strategies for 
maintaining balance in midlife, and possibly preventing falls and fractures in 
later life. The most effective intervention for improving muscle strength might 
be resistance training, which has been demonstrated in older adults(8). In 
addition, supplementation of nutrients, such as vitamin D(9) and protein(10) may 
also be promising and feasible. 
6. Determine whether promoting MVPA could preserve bone density, muscle 
strength and balance in middle-aged women by performing a RCT. 
The observational data of Chapter 7 have shown that MVPA is more 
important to musculoskeletal health outcomes than light physical activity or 
sedentary time in middle-aged women, but stronger evidence is required to 
support implementing programs to improve MVPA for improving 
musculoskeletal health in middle-aged women. RCT data would provide such 
evidence. Moderate-to-high intensity progressive resistance training, such as 
jumping exercises, could be an ideal and feasible exercise modality for 
improving MVPA in order to improve BMD and muscle strength in 
premenopausal women(11,12).   
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Appendix 1. Questionnaires used in the original 2-yr RCT  
A. General Measures 
 
BONE DENSITY STUDY FOR
PRE-MENOPAUSAL WOMEN LIVING IN
THE HOBART AREA







Phone: (03) 6226 7700
Facsimile: Nat: (03) 6226 7704
Int:  +61 03 6226 7704
Instructions for completing questionnaire:
Indicate your response by filling in the circle next to the most
appropriate answer or by writing clearly in the boxes or space provided.
Example:
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1.  Sunlight Exposure
What is the average length of time per day that you spend outside
(please fill one circle in each section for summer and winter)
a)  Weekdays Less than two hours per day
2 - 3 hours per day
3 - 4 hours per day
More than four hours per day
Summer (Dec/Jan/Feb) Winter (Jun/Jul/Aug)
Less than two hours per day
2 - 3 hours per day
3 - 4 hours per day
More than four hours per day
b)  Weekends Less than two hours per day
2 - 3 hours per day
3 - 4 hours per day
More than four hours per day
Summer (Dec/Jan/Feb) Winter (Jun/Jul/Aug)
Less than two hours per day
2 - 3 hours per day
3 - 4 hours per day
More than four hours per day
2.  Is the main financial provider in your household unemployed or on a pension? Yes No
3.  Are you in paid employment? No
Yes (< 20 hours per week)
Yes (>20 hours per week)




Unmarried, living together (defacto)
Unmarried, not living together
Divorced
5.  Bone Density Results
Lumbar Spine .
Femoral Neck .
Total  Body .

































If there is no significant increase in the participants heart rate between the second and third minutes
of the test then increase the work load to 1.0 Kg and commence readings from there.  This is the only
time at which a work load of 2.0 Kg will be used.
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Phone: (03) 6226 7700
Facsimile: Nat: (03) 6226 7704
Int:  +61 03 6226 7704
First Name :









Instructions for completing questionnaire:
• Indicate your response by filling in the circle next to the most
  appropriate answer or by writing clearly in the boxes or space provided.
Example:
• Please write in block letters using a black pen (if possible)
• Consider your usual dietary habits over the past 12 months.
Maiden Name :
Firstname:
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2.  If you eat breakfast cereal how much milk do you usually add?
None  .....................
1/4 cup  .................
1/2 cup  .................
1 cup  .....................
more than one cup  ..
3.  How many cups of tea or coffee with milk do you usually drink each day?
1.  How much milk in total do you usually use each day for yourself?
None  .....................
Less than 150 mls  ..
150 to 300  ..............
300  to 600 mls .......
600 mls to 1 litre  .....
More than one litre  ..
CHEESE
5.  What type of cheese do you usually eat?  Please write each type  eg cheddar
How much of the following foods do you eat each DAY?
Food Type Amount  per DAY
EXAMPLE











Please record YOUR intake of the following foods:
MILK
No Milk  .............................
Whole milk  ........................
Diet lite  .............................





Soy Milk  ............................
Other  ................................
4.  What type of milk do you usually drink?
Equivalents
1 slice = 25 g
1 slice = 25 g
1 slice = 25 g
1 tablespoon = 30 g
1 tablespoon = 30 g
1 small carton = 200 g
1 small carton = 200 g
6144640724
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How much of the following foods do you eat each WEEK?
Food Type Amount  per WEEK
EXAMPLE
Muesli 13 tablespoons per week
7.  CHEESE
Hard / tasty cheese
Slices
g



























12. FRUITS / VEG. / NUTS



















1 stubby = 375 mls
1 glass  = 200 ml
1 glass  = 100 ml
1 glass  = 100 ml
1 large glass  = 200 ml
4 squares  = 20 g
18 - 20 nuts = 15 g
1 tablespoons  = 15 g
1/2 cup  = 60 g
1 slice = 40 g
1 biscuit = 15 g
1 biscuit = 15 g
2 tablespoons  = 10 g
3 tablespoons  = 60 g
1 medium fillet = 100 g
5 - 6 = 90 g
3 - 4 pieces  = 90 g
4 - 5 sardines = 60 g
1/2 cup = 120 g
1 large = 60 g
1 medium = 45 g
1 scoop = 50 g
1 small carton = 250g
1 slice = 30 g
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15.  Do you take any calcium or multivitamin tablets?
16.  Do you take any antacids or indigestion tablets?
If so please specify type, amount and frequency.
Yes No
Yes No
If so please specify type, amount and frequency.
9034640725
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Phone: (03) 6226 7700
Facsimile: Nat: (03) 6226 7704
Int:  +61 03 6226 7704
On how many days during the last 14 days did you spent at least 20 minutes doing strenuous exercise?
E.g. bicycling, brisk walking, jogging, aerobics, etc that was severe enough to raise your pulse rate, cause you to breathe
faster.
A.
(1)   No days ..............................
(2)   1 to 2 days  ........................
(3)   3 to 5 days .........................
(5)   9 or more days ...................
(4)   6 to 8 days .........................
B. On how many days during the last 14 days have you spent at least 20 minutes doing light exercise?
E.g. walking, light housework, slow bicycling, etc.  Exercise which was not severe enough to cause a pulse rate rising and or
breathing increase.
(3)   3 to 5 days .........................
(5)   9 or more days ...................
(4)   6 to 8 days .........................
(2)   1 to 2 days  ........................
(1)   No days ..............................
Instructions for completing questionnaire:
Indicate your response by filling in the circle next to the most
appropriate answer or by writing clearly in the boxes or space provided.
Example:
Please write in block letters using a black pen (if possible)
For purposes of this questionnaire consider your physical activity over the past 12 months.
Reg #:
9435613887
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C. During a normal week, how many hours a day do you spend watching T.V. or videos?
(3)   2 to 3 hours a day  .............
(5)   6 or more hours a day  .......
(4)   4 to 5 hours a day  .............
(2)   1 hour or less a day  ...........
(1)   No hours a day  ..................
D. During the last 12 months, how many team or individual sports activities did you participate in either on a competitive or
professional level?  E.g.  tennis, netball or golf.
(3)   2 sports or activities  ..........
(5)   4 or more sports or activities
(4)   3 sports or activities  ..........
(2)   1 sport or activity  ..............
(1)   No sports or activities  .......







E. Please tick off all the sports or activities which you participated in more than 10 times during the last 12 months.




















Gym-work weight training  .
Golf  ..................................
(Laps or water sports like water polo or underwater hockey)
Any other activities or sports which are not mentioned here
6269613889
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D. The Osteoporosis Knowledge Assessment Tool
 
Questionnaire on Osteoporosis
True False Don't know1. Osteoporosis leads to increased risk of bone fractures.
True False Don't know2. Osteoporosis usually causes symptoms (e.g. pain) before fractures occur.
True False Don't know3. Having a higher peak bone mass at the end of childhood gives no
 protection against the development of osteoporosis in later life.
True False Don't know4. Osteoporosis is more common in men.
True False Don't know5. Cigarette smoking can contribute to osteoporosis.
True False Don't know6. White women are at highest risk of fracture as compared to other races.
True False Don't know7. A fall is just as important as low bone strength in causing fractures.
8. By age 80, the majority of women have osteoporosis. True False Don't know
9. From age 50, most women can expect at least one fracture before they
die.
True False Don't know
10. Any type of physical activity is beneficial for osteoporosis. True False Don't know
11. It is easy to tell whether I am at risk of osteoporosis by my clinical risk
factors 
True False Don't know
12. Family history of osteoporosis and fractures strongly predisposes a
person to osteoporosis.
True False Don't know
13. An adequate calcium intake can be achieved from two glasses of milk a
day.
True False Don't know
14. Sardines and broccoli are good sources of calcium for people who
cannot take dairy products.
True False Don't know
15. Calcium supplements alone can prevent bone loss. True False Don't know
16. Alcohol in moderation has little effect on osteoporosis. True False Don't know
18. There is a small amount of bone loss in the ten years following the onset
of menopause.
True False Don't know17. A high salt intake is a risk factor for osteoporosis.
True False Don't know
19. Hormone therapy prevents further bone loss at any age after menopause. True False Don't know
20. There are no effective treatments for osteoporosis available in Australia
at present.
True False Don't know
Please answer each of the following questions with either
True, False or Don't know.
Reg #:
5443241980
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We are interested in learning how confident you feel about dong the following activities.  We all have different
experiences, which will make us more or less confident in doing the following things.  Thus, there are no right
or wrong answers to this questionnaire.  It is your opinion that is important.  In this questionnaire, EXERCISE
means activities such as walking, swimming, golfing, biking and aerobic dancing.
Reg #:
Please fill the circle of the option that best
describes your confidence level.
If it were recommended that you do any of the following THIS WEEK, how confident or certain would you be that you could:
1. Begin a new or different exercise program
Not at all confident Mildly Confident Confident Very Confident
2. Change your exercise habits
3. Summon up  the effort required to exercise
4. Perform exercises even if they are difficult
5. Exercise for the appropriate length of time
6. Do the type of exercises that you are supposed to do
7. Increase your calcium intake
8. Change your diet to include more calcium rich foods
9. Eat calcium rich foods as often as you are supposed to
10. Select appropriate foods to increase your calcium intake
11. Stick to a diet which gives an adequate amount of calcium
12. Obtain foods that give an adequate amount of calcium
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
Not at all confident Mildly Confident Confident Very Confident
0609614477
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Appendix 2. Questionnaires used in the 12 years follow-up of the 
original 2-yr RCT  
Please see Appendix 1 for questionnaires used for Calcium Food Frequency, Physical 
Activity, Osteoporosis Knowledge and Self-efficacy. 
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A. General questionnaire 
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B. Accelerometer Diary 
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C. Clinic questionnaire 
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